Research on the Alkaloids of Amaryllidaceae Plants: Genera Lycoris and Hippeastrum by Guo, Ying
 
 
 
 
 
 
 
 
 
 
 
 
 
Research on the Alkaloids of Amaryllidaceae 
Plants: Genera Lycoris and Hippeastrum 
 
Ying Guo 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ADVERTIMENT. La consulta d’aquesta tesi queda condicionada a l’acceptació de les següents condicions d'ús: La difusió 
d’aquesta tesi per mitjà del servei TDX (www.tdx.cat) i a través del Dipòsit Digital de la UB (diposit.ub.edu) ha estat 
autoritzada pels titulars dels drets de propietat intel·lectual únicament per a usos privats emmarcats en activitats 
d’investigació i docència. No s’autoritza la seva reproducció amb finalitats de lucre ni la seva difusió i posada a disposició 
des d’un lloc aliè al servei TDX ni al Dipòsit Digital de la UB. No s’autoritza la presentació del seu contingut en una finestra 
o marc aliè a TDX o al Dipòsit Digital de la UB (framing). Aquesta reserva de drets afecta tant al resum de presentació de 
la tesi com als seus continguts. En la utilització o cita de parts de la tesi és obligat indicar el nom de la persona autora. 
 
 
ADVERTENCIA. La consulta de esta tesis queda condicionada a la aceptación de las siguientes condiciones de uso: La 
difusión de esta tesis por medio del servicio TDR (www.tdx.cat) y a través del Repositorio Digital de la UB 
(diposit.ub.edu) ha sido autorizada por los titulares de los derechos de propiedad intelectual únicamente para usos 
privados enmarcados en actividades de investigación y docencia. No se autoriza su reproducción con finalidades de lucro 
ni su difusión y puesta a disposición desde un sitio ajeno al servicio TDR o al Repositorio Digital de la UB. No se autoriza 
la presentación de su contenido en una ventana o marco ajeno a TDR o al Repositorio Digital de la UB (framing). Esta 
reserva de derechos afecta tanto al resumen de presentación de la tesis como a sus contenidos. En la utilización o cita de 
partes de la tesis es obligado indicar el nombre de la persona autora. 
 
 
WARNING. On having consulted this thesis you’re accepting the following use conditions:  Spreading this thesis by the 
TDX (www.tdx.cat) service and by the UB Digital Repository (diposit.ub.edu) has been authorized by the titular of the 
intellectual property rights only for private uses placed in investigation and teaching activities. Reproduction with lucrative 
aims is not authorized nor its spreading and availability from a site foreign to the TDX service or to the UB Digital 
Repository. Introducing its content in a window or frame foreign to the TDX service or to the UB Digital Repository is not 
authorized (framing). Those rights affect to the presentation summary of the thesis as well as to its contents. In the using or 
citation of parts of the thesis it’s obliged to indicate the name of the author. 
  
 
 
 
 
 
 
 
 
 
 
Research on the Alkaloids of Amaryllidaceae Plants: 
Genera Lycoris and Hippeastrum 
 
 
 
 
 
 
 
 
 
Ying Guo 
 
 
 
 
  
 
 
 
 
 
UNIVERSITAT DE BARCELONA 
 
FACULTAT DE FARMÀCIA 
 
DEPARTAMENT DE PRODUCTES NATURALS, BIOLOGIA VEGETAL I 
EDAFOLOGIA 
 
 
 
 
 
 
 
 
 
Research on the Alkaloids of Amaryllidaceae Plants: 
Genera Lycoris and Hippeastrum 
 
 
 
 
 
 
 
 
 
 
 
 
YING GUO 
2015 
 
 
  
 
 
 
UNIVERSITAT DE BARCELONA 
 
FACULTAT DE FARMÀCIA 
 
DEPARTAMENT DE PRODUCTES NATURALS, BIOLOGIA VEGETAL I 
EDAFOLOGIA 
 
PROGRAMA DE DOCTORAT: 
RECERCA, DESENVOLUPAMENT I CONTROL DE MEDICAMENTS  
 
 
 
 
Research on the Alkaloids of Amaryllidaceae Plants: 
Genera Lycoris and Hippeastrum 
 
 
 
 
 
 
 
Memòria presentada per Ying Guo per optar al títol de doctor per la  
Universitat de Barcelona  
 
  
Director i Tutor: Co-Director: Doctoranda: 
 
 
 
 
Dr. Jaume Bastida Armengol 
 
 
Dr. Francesc Viladomat Meya 
 
 
Ying Guo 
   
 
 
YING GUO 
2015 
  
 
Acknowledgements 
First and foremost, I would like to express my sincere gratitude to my advisor Prof. 
Dr. Jaume Bastida, for giving me the chance to study and live in Barcelona, a life’s 
dream for me to be near my beloved team Barça. Thank you for the continuous support 
of my Ph.D study and research, for your patience, humor, enthusiasm, and immense 
knowledge, which I believe will accompany me and encourage me for a life-long time. I 
would also like to thank Prof. Dr. Francesc Viladomat and Prof. Dr. Carles Codina for 
your warmhearted encouragement and insightful comments.  
I am deeply grateful to present and past committee members: Laura, Natalia, 
Luciana and Jean, who provided valuable suggestions and opinions on academic work 
and personal life during my PhD time. I would like to thank Jean, for your hugely 
valuable guidance in helping me to improve my experiments and writing skills. Special 
thanks to Natalia, your academic support and friendship are greatly appreciated. 
Similarly, I want to thank all the people who ever worked in the lab: Carmelina, 
Caroline, Patricia, Olivia, Karen, Gabriela, Lucy etc., thank you for your friendship and 
for making the laboratory such a pleasant place to work.  
Heartiest thanks to all friends around the Department of Natural Products, we share 
lunch times, have parties and travel together: Ana, Rafa, Karla, Diego, Lili, Kosta, 
Miriam etc. 
I am particularly thankful to all my friends whether in Barcelona or in China: 
Congcong, Jing, Chaoren, Xin, Lin, Zhitong, Yaoqing, Miaomiao, Haiyan, Tiantian, 
Xiaoxie, Xiaoqian, Xiaoyi etc., thank you for always being there for me. 
My heartiest thanks go to all the staff of CCIT-UB, especially Dr. Ana Linares 
(NMR, Faculty of Pharmacy), Dr. Ma. Antonia Molins, Dr. Miguel Feliz (NMR, PCB), 
and Dr. Asuncion Marin (GC-MS, Faculty of Pharmacy). 
I am deeply grateful to Dr. Marcel Kaiser of the Swiss tropical Institute for kindly 
carrying out the pharmacological assays against parasitic protozoa. 
I would also like to acknowledge the China Scholarship Council (CSC) for 
 awarding me the scholarship to support my study at University of Barcelona. Dr. 
Yuhong Zheng, Prof. Dr. Feng Peng (Institute of Botany, Jiangsu Province and the 
Chinese Academy of Sciences) and Prof. Dr. Jian Zhou (Nanjing Forestry University) 
should be thanked for providing plant material. 
Lastly, I would like to thank my parents Zhili Xia and Maobao Guo for all their 
love, encouragement, spiritual and financial support, you are everything to me. 
 
 
Ying Guo 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Abbreviations and symbols 
AChE Acetylcholinesterase 
AD Alzheimer’s Disease 
APG Angiosperm Phylogeny Group 
BSTFA N,O-Bis-(trimethylsilyl)trifluoroacetamide 
br Broad 
Calcd Calculated 
CD Circular Dichroism 
COSY Correlation Spectroscopy 
d Doublet 
dd Doublet of doublets 
ddd Doublet of doublet of doublets 
dddd Doublet of doublet of doublet of doublets 
DW Dry Weight  
EI Electron Ionization (also Electron Impact) 
EIMS Electron Impact Mass Spectrometry 
GAL Galanthamine 
GC Gas Chromatography 
GC-MS Gas Chromatography-Mass Spectrometry 
HMBC Heteronuclear Multiple Bond Correlation spectroscopy 
HPLC High Performance Liquid Chromatography 
HR-ESI-MS High Resolution-Electrospray Ionization-Mass Spectrometry 
HRMS High Resolution Mass Spectrometry 
HSQC Heteronuclear Single Quantum Correlation spectroscopy 
IC50 Half maximal inhibitory concentration 
IR Infrared spectroscopy 
J Coupling constant 
L-Phe L-Phenylalanine 
L-Tyr L-Tyrosine 
m Multiplet 
M Molecular 
MHz Megahertz 
MS Mass Spectrometry 
m/z Mass/charge 
NOESY Nuclear Overhauser Effect Spectroscopy 
NTPDase Nucleoside Triphosphate Diphosphohydrolase 
 ppm Parts per million 
PTLC Preparative Thin Layer Chromatography 
q Quartet 
R. I. Retention Index 
r-DA retro-Diels-Alder 
NMR Nuclear Magnetic Resonance spectroscopy 
1
H NMR Proton Nuclear Magnetic Resonance spectroscopy 
13
C NMR Carbon-13 Nuclear Magnetic Resonance spectroscopy 
1D NMR One-dimensional Nuclear Magnetic Resonance spectroscopy 
2D NMR Two-dimensional Nuclear Magnetic Resonance spectroscopy 
TIC Total Ion Current 
TLC Thin Layer Chromatography 
TMS Tetramethylsilane 
UV Ultraviolet 
VLC Vacuum Liquid Chromatography 
WHO World Health Organization 
[α]D Optical rotation 
δ Chemical shit 
[θ] Molar ellipticity 
 
 
 
 
  
Index 
1. Introduction .................................................................................................................. 1 
1.1. Natural products ................................................................................................. 3 
1.2. The Amaryllidaceae family ................................................................................ 4 
1.3. The Amaryllidaceae alkaloids ............................................................................ 5 
1.3.1. Biosynthesis and structural types of Amaryllidaceae alkaloids ................... 6 
1.3.2. Other structural types of Amaryllidaceae alkaloids ..................................... 8 
1.3.3. Other alkaloids ........................................................................................... 10 
1.4. Alkaloids from the genus Lycoris ...................................................................... 11 
1.5. Alkaloids from the genus Hippeastrum ............................................................ 30 
1.6. GC-MS and NMR ............................................................................................. 30 
1.6.1. GC-MS ....................................................................................................... 30 
1.6.1.1. Lycorine type ................................................................................ 31 
1.6.1.2. Homolycorine type ....................................................................... 32 
1.6.1.3. Crinine and Haemanthamine types ............................................... 33 
1.6.1.4. Tazettine type ................................................................................ 34 
1.6.1.5. Montanine type ............................................................................. 35 
1.6.1.6. Galanthamine type ........................................................................ 36 
1.6.2. Proton nuclear magnetic resonance ............................................................ 37 
1.6.2.1. Lycorine type ................................................................................ 38 
1.6.2.2. Homolycorine type ....................................................................... 38 
1.6.2.3. Crinine and Haemanthamine types ............................................... 39 
1.6.2.4. Tazettine type ................................................................................ 40 
1.6.2.5. Narciclasine type .......................................................................... 40 
1.6.2.6. Montanine type ............................................................................. 40 
1.6.2.7. Galanthamine type ........................................................................ 40 
1.6.3. Carbon
13
 nuclear magnetic resonance ........................................................ 41 
1.6.4. Two-dimensional nuclear magnetic resonance spectroscopy .................... 41 
 1.7. Biological activities .......................................................................................... 42 
1.7.1. Lycorine type ............................................................................................. 42 
1.7.2. Homolycorine type ..................................................................................... 44 
1.7.3. Crinine type ................................................................................................ 45 
1.7.4. Hemanthamine type ................................................................................... 45 
1.7.5. Tazettine type ............................................................................................. 46 
1.7.6. Narciclasine type ........................................................................................ 47 
1.7.7. Montanine type .......................................................................................... 48 
1.7.8. Galanthamine type ..................................................................................... 48 
1.7.9. Other types ................................................................................................. 50 
2. Objectives ................................................................................................................... 51 
3. Results ........................................................................................................................ 55 
3.1. Article 1 ............................................................................................................ 56 
3.2. Article 2 ............................................................................................................ 65 
3.3. Article 3 ............................................................................................................ 83 
4. Discussion ................................................................................................................... 93 
4.1. Alkaloid profiles of the genus Lycoris .............................................................. 95 
4.2. Alkaloids from Hippeastrum papilio ................................................................ 99 
4.2.1. GC-MS analysis of Hippeastrum papilio................................................. 100 
4.2.2. Hippapiline ............................................................................................... 101 
4.2.3. Papiline..................................................................................................... 102 
4.2.4. 3-O-(3’-hydroxybutanoyl)haemanthamine .............................................. 102 
4.3. Alkaloids from Hippeastrum calyptratum ...................................................... 103 
4.3.1. 3-O-methyl-epimacowine ........................................................................ 103 
4.4. Parasitic protozoa in vitro assays .................................................................... 105 
4.4.1. Trypanosoma brucei rhodesiense ............................................................ 105 
4.4.2. Trypanosoma cruzi ................................................................................... 106 
4.4.3. Leishmania donovani ............................................................................... 106 
4.4.4. Plasmodium falciparum ........................................................................... 107 
  
4.4.5. Cytotoxicity .............................................................................................. 107 
5. Conclusions .............................................................................................................. 109 
6. References ................................................................................................................ 113 
7. Appendices ............................................................................................................... 133 
7.1. Appendix I ...................................................................................................... 135 
7.2. AppendixⅡ: Supplementary data for new alkaloids ...................................... 153 
7.2.1. Hippapiline ............................................................................................... 153 
7.2.2. Papiline..................................................................................................... 159 
7.2.3. 3-O-(3’-Hydroxybutanoyl)haemanthamine ............................................. 166 
7.2.4. 3-O-methyl-epimacowine ........................................................................ 171 
7.3. Appendix Ⅲ ................................................................................................... 176 
7.3.1. Genus Lycoris .......................................................................................... 176 
7.3.1.1. Lycoris albiflora ......................................................................... 176 
7.3.1.2. Lycoris aurea .............................................................................. 176 
7.3.1.3. Lycoris chinensis ........................................................................ 177 
7.3.1.4. Lycoris haywardii ....................................................................... 177 
7.3.1.5. Lycoris incarnata ........................................................................ 178 
7.3.1.6. Lycoris longituba ........................................................................ 178 
7.3.1.7. Lycoris radiata ........................................................................... 179 
7.3.1.8. Lycoris radiata var. pumila ........................................................ 179 
7.3.1.9. Lycoris sprengeri ........................................................................ 180 
7.3.1.10. Lycoris squamigera .................................................................. 180 
7.3.2. Genus Hippeastrum ..................................................................................... 181 
7.3.2.1. Hippeastrum papilio ................................................................... 181 
7.3.2.2. Hippeastrum calyptratum ........................................................... 181 
 
Introduction 1 
 
 
 
 
 
 
  
 
 
1. INTRODUCTION 
 
 
Introduction 3 
 
 
1. Introduction  
1.1. Natural products  
Natural products can generate a variety of goods and services, including medicine, 
food products and new materials. Additionally, natural areas are increasingly becoming 
centers of tourism. Active principles of natural origin are sometimes the treatment of 
choice for certain illnesses, and generate benefits by meeting the pharmaceutical 
demand. 
The history of natural products dates back practically to the emergence of human 
civilization (Lahlou, 2013). Since then, natural products have played a considerable role 
in health protection and disease prevention. The ancient civilians of Mesopotamia, 
Egypt, China, Indian, and Greece provided written evidence for the use of natural 
sources for curing diverse diseases (Dias et al., 2012). The usefulness of plants for 
treating diseases was recorded in the Emperor Shennung’s classic herbals of China 
(2700 BC) and Eber’s papyrus in Egypt (1550 BC). However, it was not until the 19th 
century that scientists isolated active components from various medicinal plants. 
Friedrich Sertuerner isolated morphine from Papaver somniferum in 1806, and since 
then natural products have been extensively screened for their medicinal purposes. A 
recent review of natural products as sources of new drugs over the 30 years from 1981 
to 2010 composed by Newman and Cragg is a very significant contribution to this area 
of investigation. In their review, they point out that around 35% molecular structures 
approved as drugs correspond to compounds of natural and semisynthetic derivatives, 
while 30% are synthetic molecular compounds inspired by natural products or with a 
pharmacophore developed from a natural compound (Newman and Cragg, 2012). They 
consider the rapid identification of effective, novel lead structures is a vital necessity, 
now made posible by the emergence of novel screening systems and the explosion of 
genetic information (Cragg and Newman, 2013).  
According to studies conducted by the World Health Organization (WHO), about 
80% of the world’s population relies on traditional medicine (WHO, 2002), and 
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available data suggests that the market for traditional medicine is still substantial (WHO, 
2014). The output of Chinese materia medica was estimated to amount to US$ 83.1 
billion in 2012, an increase of more than 20% from the previous year. Out-of-pocket 
spending for natural products in the United States was US$ 14.8 billion in 2008 by 
WHO’s investigation last year (WHO, 2014). Over all, many natural products and 
synthetically modified natural product derivatives have been successfully developed for 
clinical use to treat human diseases in almost all therapeutic areas. 
1.2. The Amaryllidaceae family  
The Amaryllidaceae are a family of herbaceous, mainly perennial and bulbous 
(rarely rhizomatous) flowering plants included in the monocot order Asparagales. 
According to the latest update and classification of the Angiosperm Phylogeny Group 
(APG), the family Amaryllidaceae J.St.-Hil. has three subfamilies: Agapanthoideae, 
Allioideae and Amaryllidoideae (Chase et al., 2009; APG III, 2009), supported by 
studies of molecular biology and taxonomy (Meerow et al., 1999; Meerow and Snijman, 
2006). These subfamilies were previously regarded as families: Agapanthaceae, 
Alliaceae and Amaryllidaceae, respectively.  
Important misunderstandings as a result of using both classifications and the 
presence or absence of alkaloids may occur, since the concept used more widely 
associated with the term “Amaryllidaceae’’ implies only a subfamily of the current 
taxon. 
The species of the subfamily Amaryllidoideae are preferably distributed in tropical 
and subtropical regions, but also in temperate zones. Thus, one of its distinguishing 
features is great adaptability. We can find the species of this subfamily in mountainous 
areas of the Andes, Mediterranean, temperate Asia, Oceania and southern Africa 
(Meerow and Snijman, 1998). The species of the subfamily Amaryllidoideae are 
perennial bulbous herbs, often with showy flowers, which provide ornamental value. 
The subfamily comprises about 54 genera and 796 species. Taking into consideration 
the whole Amaryllidaceae family, including the Alliaceae and Agapanthaceae 
subfamilies, these values reach 73 genera and about 1600 species (Dutilh et al., 2013). 
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1.3. The Amaryllidaceae alkaloids  
Since the first isolation of lycorine from Lycoris radiata, almost 450 structurally 
diverse alkaloids have been isolated from plants of the Amaryllidaceae family. The 
alkaloids of this family represent a large and still expanding group of isoquinoline 
alkaloids, which are classified mainly into nine skeleton types. The representative 
alkaloids are: norbelladine, lycorine, homolycorine, crinine, haemanthamine, 
narciclasine, tazettine, montanine and galanthamine (Bastida et al., 2006) (Figure 1.1). 
Their general chemical characteristics can be summarized as follows: a fundamental 
ring system composed of a C1-C6 and an N-C2-C6 building block, derived from the 
amino acids L-phenylalanine and L-tyrosine, respectively. They are moderately weak 
bases (pKa values between 6 and 9). Commonly, each alkaloid contains one nitrogen 
atom, which is secondary, tertiary or even quaternary. Typically, the carbon content 
varies from 16 to 20 atoms, depending on the substituents of the ring system (Bastida 
and Viladomat, 2002). 
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Figure 1.1: Amaryllidaceae alkaloid types. 
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1.3.1. Biosynthesis and structural types of Amaryllidaceae alkaloids  
The biosynthetic pathway of the Amaryllidaceae alkaloids usually follows four 
stages, starting with the enzyme preparation of precursors from the amino acids 
L-phenylalanine (L-Phe) and L-tyrosine (L-Tyr). Although L-Phe and L-Tyr are closely 
related in chemical structure, they are not interchangeable in plants (Bastida et al., 
2006). 
In the Amaryllidaceae alkaloids, L-Phe serves as a primary precursor of the C6-C1 
fragment, corresponding to ring A and the benzylic position (C-6), whereas, L-Tyr is the 
precursor of ring C, the two-carbon side chain (C-11 and C-12) and nitrogen, C6-C2-N. 
The conversion of L-Phe to the C6-C1 unit requires the loss of two carbon atoms from the 
side chain as well as the introduction of at least two oxygenated substituents into the 
aromatic ring, which occurs through cinnamanic acid or its derivatives, involving the 
participation of the enzyme phenylalanine ammonia lyase (PAL). The fragmentation of 
the cinnamic acid involves oxidation of the β-carbon to the ketone or acid level, where 
the final product is protocatechuic aldehyde. On the other hand, L-Tyr is degraded no 
further than tyramine before incorporation into the Amaryllidaceae alkaloids (Figure 1.2) 
(Machocho, 2000; Bastida et al., 2011; Pigni, 2013). 
The second stage involves merging the biosynthesis of tyramine and the 
protocatechuic aldehyde, resulting in norbelladine by forming a Schiff’s base. This 
reaction occupies a pivotal position since it represents the entry of primary metabolites 
into a secondary metabolic pathway (Figure 1.2) (Bastida et al., 2011). 
Norbelladine can undergo oxidative coupling of phenols in Amaryllidaceae plants, 
once ring A has been suitably protected by methylation, which is considered as the third 
step (Figure 1.3).  
Finally, the last stage includes a series of sequential reactions resulting in the 
diversification into the other eight skeletons shown in Figure 1.4. Ortho-para’ phenol 
oxidative coupling of O-methylnorbelladine results in the formation of a lycorine-type 
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Figure 1.4: Phenol oxidative coupling in Amaryllidaceae alkaloids. 
skeleton, from which homolycorine-type compounds proceed as well. The 
galanthamine-type is the only skeleton which originates from para-ortho’ phenol 
oxidative coupling. And para-para’ phenol oxidative coupling leads to the formation of 
crinine, haemanthamine, tazettine, narciclasine and montanine structures (Figure 1.4) 
(Bastida et al., 2006). Subsequent transformations may involve oxidation, reduction, 
ring opening and rotation, where one alkaloid may be converted into another 
(Machocho, 2000). 
1.3.2. Other structural types of Amaryllidaceae alkaloids  
Although the majority of alkaloids found in the Amaryllidoideae family can be 
cataloged in one of nine skeleton types discussed so far, some structures could be 
described as representatives of new types that are not common in the family (Figure 
1.4). 
The new group of alkaloids was led by galanthindol. This compound, initially 
isolated from Galanthus plicatus ssp. byzantinus, is described as a representative of an 
unfused indole ring (Unver et al., 2003; Unver, 2007). Lycosinine A and its derivatives 
(Yang et al., 2005) have the same origin. In fact, both structures are very similar to 
ismine (Suau et al., 1990), and are considered the products of catabolism of the alkaloid 
(Bastida et al., 2006). 
Galasine was isolated from Galathus elwesii. Its molecule is linked to infinite 
Introduction 9 
 
 
one-dimensional chains by intermolecular hydrogen bonds between the hydroxyl group 
and the N-atom of a neighboring molecule (Latvala et al., 1995). 
Possibly cherylline, augustamine and graciline derivatives represent the most 
distinct structures within the classic nine skeleton types. Cherylline is an unusual 
phenolic alkaloid first isolated from Crinum powellii (Brossi et al., 1970). Augustamine 
was described in Crinum augustum (Ali et al., 1983) and some of its derivatives were 
isolated years later from Crinum kirkii (Machocho et al., 2004). Graciline and its 
derivatives have been isolated from various species of the genus Galanthus (Noyan et 
al., 1998; Unver et al., 2001). 
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Figure 1.4: Other structural types of Amaryllidaceae alkaloids. 
Buflavine and 8-O-demethylbulflavine were isolated for the first time from the 
bulbs of Boophane flava (Viladomat et al. 1995). Their structures have been established 
by spectroscopic methods and are representative of the unusual natural Amaryllidaceae 
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alkaloids with an eight-membered N-heterocyclic ring, which had been previously 
reported only from Galanthus nivalis (Hoshino, 1998). 
Pallidiflorine was obtained from Narcissus pallidiflorus (Codina et al., 1990), and 
its formation can be explained by the attack of the nitrogen of N-demethyllycoramine on 
C-6’ of tazzettine with opening of the B ring and formation of the keto group (Hoshino, 
1998). Plicamine derivatives isolated from the genus Galanthus (Unver et al., 1999), 
Cyrtanthus (Brine et al., 2002) and more recently in Narcissus (de Andrade et al., 2012a) 
have been proposed as alkaloids of a new skeleton type within this family (Unver, 2007). 
However, its similarity to the skeleton of the tazettine should be considered. 
1.3.3. Other alkaloids 
Mesembrano-type or Sceletium alkaloids, which are generally present in the 
Aizoaceae family, have been isolated in some species of the Amaryllidoideae subfamily. 
Thus, mesembrenol was obtained from Crinum oliganthum (Doepke et al., 1981) and 
mesembrenone was isolated and characterized from Narcissus pallidulus (Bastida et al., 
1989). Recently, numerous mesembrano-type alkaloids form Narcissus triandrus have 
been identified and isolated, among which we can highlight 4’-O-demethylmesembre- 
none and 6-epimesembranol (Figure 1.5) (Pigni et al., 2013).  
In addition, bulbocapnine and capnoidine, found in typical Fumarioideae, 
Lauraceae and Papaveraceae plants, have been isolated from Galanthus nivalis subsp. 
cilicicus (Figure 1.5) (Kaya et al., 2004). 
On the opposite side, in two cases the isolation and characterization of typical 
Amaryllidaceae alkaloids have been described in other plant families. Thus, the 
crinamine alkaloid isolated from Dioscorea dregeana was the first Amaryllidaceae 
alkaloid reported in another botanical family, the Dioscoreaceae (Mulholland et al., 
2002). Recently, some alkaloids with a homolycorine and narciclasine skeleton were 
identified in Hosta plantaginea (Asparagaceae) (Wang et al., 2007b). These secondary 
metabolites could constitute a tool of great interest in chemotaxonomic studies of the 
Amaryllidaceae family. 
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Figure 1.5: Other alkaloids.  
1.4. Alkaloids from the genus Lycoris 
The Lycoris genus is distributed in Asia, mainly in China, Japan, Korea, Laos, 
Myanmar, Pakistan, Thailand, Vietnam and so forth. Until April of 2015, 22 species and 
one hybrid of this genus were recognized by the World Checklist of Selected Plant 
Families. Notably, there are 15 species (ten endemic) in China. 
The plants of Lycoris are perennial bulb herbs. The bulbs are subglobose to ovoid, 
with a brown or black skin. Leaves are ligulate, appearing before or after anthesis, 
30-60 cm long and only 0.5-2 cm broad. The scape is erect, simple and solid, 30-70 cm 
tall, bearing a terminal umbel of four to eight flowers, which can be white, creamy, gold, 
pink or bright red. Perianths, sometimes with an undulate margin, are funnelform, 
consisting of six oblanceolate or narrowly elliptic tepals. The long filiform stamens are 
inserted at the throat of the perianth tube. Most flower from July to September. The 
ovary is trilocular with few ovules, and the fruit is a three-valved capsule containing 
several black subglobose seeds (Ji and Meerow, 2000; Yu et al., 2006).  
The taxonomy of the genus Lycoris is difficult because of its wide distribution area 
and easy natural hybridization. To distinguish and classify the genus, morphology 
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(Zhou et al., 2005, 2006), cytology (In et al., 1996), and genetics aspects have been 
considered (Xie et al., 2007). In genomics research, RAPD (random amplified 
polymorphism DNA) and ISSR (inter-simple sequence repeats) molecular markers (Roh 
et al., 2002; Zhang et al., 2002; Deng et al., 2006), ITS (internal transcribed spacers) 
sequencing (Chen et al., 2009; Quan et al., 2012), isozyme (Lee et al., 2001), trnL-F 
sequencing and phylogenetic clustering (Yuan et al., 2008) have been applied in 
research into the genetic relationship among Lycoris species, as well as the taxonomy of 
the genus (Jiang et al., 2009b). 
Phytochemical studies of the genus Lycoris began at the end of the 19
th
 century. 
The first study was carried out with L. radiata, which yielded the alkaloids lycorine (1) 
and sekisanine (tazettine) (88) (Morishima, 1899). In the 1930s, Kondo et al. initiated a 
series of in-depth studies on Lycoris alkaloids, resulting in the elucidation of the 
structures of lycorine (1), tazettine (88), lycoramine (105) and homolycorine (32) 
(Kondo and Ikeda, 1940; Kondo and Katura, 1940; Kondo et al., 1932, 1954). 
Galanthamine (97) was isolated from Lycoris species in 1957 (Boit and Ehmke, 1957). 
In 1959, two new phenolic alkaloids, norpluviine (9) and 8-O-demethylhomolycorine 
(40), were isolated from L. radiata (Uyeo and Yanaihara, 1959). From the 1960s to the 
1980s, exhaustive research work led to the first isolation of sanguinine (100) from L. 
sanguinea, as well as O-demethyllycoramine (107) from L. radiata; at the same time, 
other species such as L. squamigera, L. guangxiensis and L. chinensis were studied 
(Hung and Ma, 1964; Takagi and Yamaki, 1974; Kobayashi et al., 1976, 1980; Li et al., 
1987; Ma et al., 1987). In the 1990s, Kihara et al. isolated a new alkaloid from flowers 
of L. incarnata named incartine (22), which has been proposed as a biosynthetic 
intermediate in the conversion of galanthine (5) to narcissidine (17) (Kihara et al., 1994). 
Two new alkaloids, norsanguinine (102) and 3’-hydroxybutanoylnorsanguinine (103), 
were isolated and characterized from the bulbs of L. sanguinea, in addition to five 
known Amaryllidaceae alkaloids (Abdallah, 1995). 
During the first decade of the current century, the continued investigation of 
Lycoris plants yielded further novel structures. Reported in L. radiata bulbs, lycosinine 
A (113) and lycosinine B (114) were classified as a new structural group 
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(galanthindole-type), in addition to the unusual lycorine-type alkaloids, lycoranine A 
(23) and lycoranine B (24), all of them completely characterized by spectroscopic 
methods (Yang et al., 2005; Wang et al., 2009). Moreover, a new montanine-type 
alkaloid named squamigine (95), together with 3-O-ethyltazettinol (90) and 
2R-hydroxy-N,O-dimethylnorbelladine (116), were isolated from the bulbs of L. 
squamigera and L. aurea (Pi et al., 2009; Takayama et al., 2009).  
In the last five years, investigations in the genus Lycoris have increased rapidly, 
and a number of new alkaloids have been isolated, especially in the species Lycoris 
radiata. Studies with bulbs of L. radiata resulted in the isolation of 14 new alkaloids, 
including 1-hydroxyungeremine (27), 5,6-dehydrolycorine (28) and 5,6-dehydrodihy- 
drolycorine (29), classified as lycorine-type; 3-acetyl-6β-acetyoxybulbispermine (66), 
6β-acetoxycrinamine (73), 6β-acetoxybulbispermine (74), and 6β-acetyl-8-hydroxy- 
9-methoxycrinamine (75), belonging to the haemanthamine-type; four new 
homolycorine-type alkaloids, 2α-methoxy-6-O-ethyloduline (49), 8-O-acetylhomolyco- 
rine-N-oxide (52), 2α-hydroxy-8-O-demethylhomolycorine-N-oxide (54), and 
8,9-methylenedioxylhomolycorine-N-oxide (56), together with 5,6-dihydro-N-methyl- 
2-hydroxyphenanthridine (84), O-demethyllycoramine-N-oxide (111), and N-methoxy- 
carbonyl-2-demethylnorisocorydione (124) (Feng et al., 2011; Hao et al., 2013; Huang 
et al., 2013; Li et al., 2013; Liu et al., 2015). 
Similarly, the new alkaloids 1,2-dihydroxyanhydrolycorin-6-one (15), 
1,2-dihydroxyanhydrolycorine-N-oxide (31), O-n-butyllycorenine (39) 
2α-hydroxy-6-O-n-butyloduline (50), 8-O-demethyhomolycorine-N-oxide (55), 
8-demethyldehydrocrebanine (121), and 2-demethylisocorydione (123) have been 
isolated from Lycoris aurea (Jin et al., 2014; Song et al., 2014). In addition, further 
work by Wu et al. resulted in the isolation of two new alkaloids, lycosprenine (14) and 
2α-methoxy-6-O-methyl- lycorenine (37), from the bulb of Lycoris sprengeri, which 
was the first time new alkaloids have been reported in this species (Wu et al., 2014). 
Three new bulbocapnine-type alkaloids, 2-hydroxyanhydrolycorine-N-oxide (30), 
N-methoxycar- bonylnandigerine (119), and N-methoxycarbonyllindcarpine (120), 
14 Research on the Alkaloids of Amaryllidaceae Plants: Genera Lycoris and Hippeastrum 
 
together with 10-O-methylhernovine-N-oxide (125) were extracted from Lycoris 
caldwellii (Cao et al., 2013).  
To the best of our knowledge, seventeen species from the genus Lycoris have been 
phytochemically studied to date and 125 alkaloids have been found and classified in 
different structural types (Table 1.1, Figure 1.6-1.15).  
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Table 1.1: Alkaloids reported in the genus Lycoris. 
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Lycorine-type                   
lycorine (1) 
1,2,3, 
42 
1 
1,5,6,27,39, 
42 
 
1,7,8,9, 
42 
11 1,42 1 
1,12, 
42 
1,14, 
42 
1,15,17,18,20,21, 
23,24,27,28,37,42 
42 1 40,42 
25,29, 
31 
1,27,32, 
42 
1 
pseudolycorine (2)   27   11    42 21,27,37    29 27,32  
9-O-methylpseudolycorine (3)          42      42  
11-methoxylycorine (4)          42 37     42  
galanthine (5) 42  42  42  42  1242  16 42  40,42 29 42  
hippamine (6)           37       
caranine (7) 42  42  42  42  42 42 18,42 42  42  42  
pluviine (8)   39  7  42   42 37 42  40  27,42  
norpluviine (9) 42  27        27,28       
assoanine (10)          42        
hippadine (11)              40    
anhydrolycorine (12) 42  42  42  42  42 42 42 42  42  42  
2-hydroxyanhydrolycorin-6-one (13)   38               
lycosprenine (14)              40    
1,2-dihydroxyanhydrolycorin-6-one (15)   38               
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narcissidine (16)              40    
ungiminorine (17)         12  18       
6-oxodihydrolycorine (18)           15       
dihydrolycorine (19)           15,37       
epizephyranthine (20)           37       
amarbellisine (21)          14        
incartine (22) 42  42  42  42  12,42  34 42  42  42  
lycoranine A (23)           19       
lycoranine B (24)           19       
11,12-dehydroanhydrolycorine (25) 42  42  42  42  42 42 42 42  42  42  
ungeremine (26)           34       
1-hydroxyungeremine (27)           36       
5,6-dehydrolycorine (28)           35       
5,6-dehydrodihydrolycorine (29)           15       
2-hydroxyanhydrolycorine-N-oxide (30)    41              
1,2-dihydroxyanhydrolycorine-N-oxide 
(31) 
  38               
Homolycorine-type                  
homolycorine (32) 2,3  5,10,27,39  7  42    
15,17,21,24,27, 
28,33,42 
42  40  27  
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2α-hydroxyhomolycorine (33)           33       
lycorenine (34) 2,3  27  7      21,24,27,33   40  27  
deoxylycorenine (35)   5        17,23,42   40    
O-methyllycorenine (36)   39        33,37       
2α-methoxy-6-O-methyllycorenine (37)              40    
O-ethyllycorenine (38)           33,37       
O-n-butyllycorenine (39)   39               
8-O-demethylhomolycorine (40)       42    17,20,23,24,33,42 42      
9-O-demethylhomolycorine (41) 3          37,33       
9-O-demethyl-2α-hydroxyhomolycorine 
(42) 
          37       
oduline (43)   10        33       
2α-hydroxyoduline (44)   10        37       
2α-hydroxy-6-O-methyloduline (45) 3  10,39        37       
2α-methoxy-6-O-methyloduline (46)   10        15,33       
ungerine (47)           18       
hippeastrine (48) 2,3  5,10,39  7      
15,17,18,23,24, 
28,37,42 
    27  
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2α-methoxy-6-O-ethyloduline (49)            33       
2α-hydroxy-6-O-n-butyloduline (50)   39               
homolycorine-N-oxide (51)           35       
8-O-acetylhomolycorine-N-oxide (52)           15       
9-O-demethylhomolycorine-N-oxide (53)           34       
2α-hydroxy-8-O-demethylhomolycorine-
N-oxide (54) 
          36       
8-O-demethyhomolycorine-N-oxide (55)   38        36       
8,9-methylenedioxyl 
homolycorine-N-oxide (56) 
          35       
Crinine-type                  
crinine (57)   39  7 11    14 28       
macowine (58)          13        
buphanamine (59)           28       
crinamidine (60)           28       
undulatine (61)           28       
Haemanthamine-type                  
haemanthamine (62) 2,3  5,42  42    42  26,28,42   40,42 31 32  
haemanthidine (63)/ 
epihaemanthidine (64)
 
* 
3  5  7      17,18,20   40 31 32,42  
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3-methyl-6β-acetoxybulbispermine (65)           35       
3-acetyl-6β-acetyoxybulbispermine (66)           35       
vittatine (67)           17,26,28     27  
oxovittatine (68)           34       
11-hydroxyvittatine (69)          14 18     32  
8-O-demethylmaritidine (70)           16       
6α-hydroxycrinamine (71)          13        
6β-hydroxycrinamine (72)          13 16       
6β-acetoxycrinamine (73)           15,36       
6β-acetoxybulbispermine (74)           35       
6β-acetyl-8-hydroxy-9-methoxycrinamine 
(75) 
          36       
apohaemanthamine (76)           34       
Narciclasine-type                  
narciclasine (77) 3    7     14 18,23,37   40 31 32  
lycoricidine (78) 3          15,23    31 32  
5,6-dihydrobicolorine (79)           15   40    
crinasiadine (80)              40    
N-isopentylcrinasiadine (81)              40    
arolycoricidine (82)               31   
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arolycoricidinol (83)               31   
5,6-dihydro-N-methyl-2-hydroxyphenanth
ridine (84) 
  38        35      
 
 
trisphaeridine (85)          42 16,33   40,42    
bicolorine (86)           16       
ismine (87)           34       
Tazettine-type                  
tazettine (88) 42  6,,27,42  42  42   13,42 17,21,22,27,28,42 42  40,42 31 27,32,42  
deoxytazettine (89 )           42 42       
3-O-ethyltazettinol (90)   4               
pretazettine (91)           24,25       
6-O-methylpretazettine (92)                32  
Montanine-type                  
montanine (93) 42  42  42     42      32,42  
pancracine (94)   6       14 15,37       
squamigine (95)          14,42 37     27,32  
montabuphine (96)           37   40    
Galanthamine-type                  
galanthamine (97) 
1,2,3, 
42 
1 
1,5,6,27,39, 
42 
 
1,7,8,9, 
42 
11 1,42 1 
1,12, 
42 
1,13, 
42 
1,15,17,18,20,21,
22,23,27,28,37,42 
 1 40,42 
25,29, 
30,31 
1,27,32, 
42 
1 
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epigalanthamine (98)                27  
norgalanthamine (99)   5,39   11          32  
sanguinine (100)   5,42  42    12 42 16,37    
25,29, 
30 
32  
N-allylnorgalanthamine (101)      11            
norsanguinine (102)               29   
3’-hydroxybutanoylnorsanguinine (103)               29   
narwedine (104) 42     11    42      42  
lycoramine (105) 1,3,42 1 1,6,27,42  1,7,8,42 11 1,42 1 
1,12, 
42 
1,13, 
42 
1,17,18,20,21,22,
23,24,27,28,37,42 
 1 40,42 30,31 
1,27,32, 
42 
1 
3-epilycoramine (106)     7             
O-demethyllycoramine (107)   5      12 42 16,17,18,24,37     32  
norlycoramine (108) 42    42    42 42 18,42   42  42  
galanthamine-N-oxide (109)           37       
lycoramine-N-oxide (110)           37       
O-demethyllycoramine-N-oxide (111)           37       
Miscellaneous                  
galanthindole (112)   42       42        
lycosinine A (113)   5        19       
lycosinine B (114)   5        19       
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cheryline (115)     42             
2R-hydroxy-N,O-dimethylnorbelladine 
(116) 
               32  
hostasinine A (117) 3                 
7-demethoxyhostasine (118)            18       
N-methoxylcarbonylnandigerine (119)    41              
N-methoxycarbonyllindcarpine (120)    41              
8-demethyldehydrocrebanine (121)   38               
isocorydione (122)   38               
2-demethylisocorydione (123)   38               
N-methoxycarbonyl-2-demethylnorisoco 
rydione (124) 
          36       
10-O-methylhernovine-N-oxide (125)    41              
* haemanthidine (63) and epihaemanthidine (64) are found as a mixture of epimers.  
1) Yuan et al., 2010; 2) Boit et al., 1958; 3) Jitsuno et al., 2011; 4) Pi et al., 2009; 5) Yang et al., 2005; 6) Wang et al., 2007a; 7) Ma et al., 1987; 8) Mu et al., 2010; 9) Mu et 
al., 2009; 10) Liao et al., 2012; 11) Li et al., 1987; 12) Kihara et al., 1994; 13) Liang et al., 2010; 14) Zhao et al., 2011; 15) Feng et al., 2011; 16) Wang et al., 2010; 17) 
Kihara et al., 1991; 18) Wang et al., 2011; 19) Wang et al., 2009; 20) Yang et al., 2010; 21) Jiang and Liu, 2009; 22) Ao et al., 2008; 23) Numata et al., 1983; 24)Kobayashi et 
al., 1980; 25) Kobayashi et al., 1976; 26) Uyeo et al., 1966; 27) Hung and Ma, 1964; 28) Takagi et al., 1968; 29) Abdallah, 1995; 30) Kobayashi et al., 1991; 31) Takagi and 
Yamaki, 1974; 32) Kitajima et al., 2009; 33) Huang et al., 2013; 34) Liu et al., 2013; 35) Hao et al., 2013; 36) Liu et al., 2015; 37) Li et al., 2013; 38) Song et al., 2014; 39) 
Jin et al., 2014; 40) Wu et al., 2014); 41) Cao et al., 2013; 42) Guo et al., 2014.
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N
H
R2
R1
H
R3O
R4O
R7
R5 R6  
1 R1=OH, R2=OH, R3+R4=CH2, R5=H, R6=H, R7=H lycorine 
2 R1=OH, R2=OH, R3=H, R4=Me, R5=H, R6=H, R7=H  pseudolycorine 
3 R1=OH, R2=OH, R3=Me, R4=Me, R5=H, R6=H, R7=H 9-O-methylpseudolycorine 
4 R1=OH, R2=OH, R3+R4=CH2, R5=H, R6=H, R7=OMe        11-methoxylycorine 
5 R1=OH, R2=OMe, R3=Me, R4=Me, R5=H, R6=H, R7=H galanthine 
6 R1=OH, R2=OMe, R3+R4=CH2, R5=H, R6=H, R7=H  hippamine  
7 R1=OH, R2=H, R3+R4=CH2, R5=H, R6=H, R7=H                 caranine  
8 R1=OH, R2=H, R3=Me, R4=Me, R5=H, R6=H, R7=H          pluviine 
9 R1=OH, R2=H, R3=Me, R4=H, R5=H, R6=H, R7=H      norpluviine 
  
N
R3O
R4O
R6
R2
R1
R5  
10 R1=H, R2=H, R3=Me, R4=Me, R5=H, R6=H      assoanine 
11 R1=H, R2=H, R3+R4=CH2, R5+R6=O           hippadine 
12 R1=H, R2=H, R3+R4=CH2, R5=H, R6=H            anhydrolycorine 
13 R1=H, R2=OH, R3+R4=CH2, R5+R6=O 2-hydroxyanhydrolycorin-6-one 
14 R1=H, R2=OMe, R3=Me, R4=Me, R5+R6=O      lycosprenine 
15 R1=OH, R2=OH, R3+R4=CH2, R5+R6=O           1,2-dihydroxyanhydrolycorin-6-one 
  
N
R1O
R2O
OHHO
OMe
H
H
 
N
O
O
OH
H
HH
R1
R2 R3  
16 R1=Me, R2=Me narcissidine 18 R1=α-OH, R2+R3=O 6-oxodihydrolycorine 
17 R1+R2=CH2 ungiminorine 19 R1=α-OH, R2=H, R3=H dihydrolycorine 
  20 R1=β-OH, R2=H, R3=H epizephyranthine 
    
N
H
OMe
HO
O
O
H
H
 
N
H
OMe
HO
H
MeO
MeO
O
 
 21 amarbellisine 22 incartine 
Figure 1.6: Lycorine-type alkaloid structures I. 
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R2 R3  N
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23 R1=OMe, R2+R3=O, R4=H       lycoranine A                     26 R=H ungeremine 
24 R1=OMe, R2+R3=O, R4=Me     lycoranine B 27 R=OH 1-hydroxyungeremine 
25 R1=H, R2=H, R3=H, R4=H       11,12-dehydroanhydrolycorine  
   
N
O
O
OH
H
H
OH
 
N
O
O
OH
H
HH
OH
 
28 5,6-dehydrolycorine 29 5,6-dehydrodihydrolycorine 
  
N
O
O
OH
R
O  
 30 R=H 2-hydroxyanhydrolycorine-N-oxide 
 31 R=OH 1,2-dihydroxyanhydrolycorine-N-oxide 
Figure 1.7: Lycorine-type alkaloid structures II. 
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O
R6N
R1O
R2O
H
H
H
R5
R3 R4  
32 R1=Me, R2=Me, R3+R4=O, R5=H, R6=Me homolycorine 
33 R1=Me, R2=Me, R3+R4=O, R5=OH, R6=Me 2α-hydroxyhomolycorine 
34 R1=Me, R2=Me, R3=OH, R4=H, R5=H, R6=Me lycorenine 
35 R1=Me, R2=Me, R3=H, R4=H, R5=H, R6=Me deoxylycorenine 
36 R1=Me, R2=Me, R3=OMe, R4=H, R5=H, R6=Me O-methyllycorenine 
37 R1=Me, R2=Me, R3=OMe, R4=H, R5=OMe, R6=Me 2α-methoxy-6-O-methyllycorenine 
38 R1=Me, R2=Me, R3=OEt, R4=H, R5=H, R6=Me O-ethyllycorenine 
39 R1=Me, R2=Me, R3=O-n-C4H9, R4=H, R5=H, R6=Me O-n-butyllycorenine 
40 R1=Me, R2=H, R3+R4=O, R5=H, R6=Me 8-O-demethylhomolycorine 
41 R1=H, R2=Me, R3+R4=O, R5=H, R6=Me 9-O-demethylhomolycorine 
42 R1=H, R2=Me, R3+R4=O, R5=OH, R6=Me 9-O-demethyl-2α-hydroxyhomolycorine 
43 R1+R2=CH2, R3=OH, R4=H, R5=H, R6=Me oduline 
44 R1+R2=CH2, R3=OH, R4=H, R5=OH, R6=Me 2α-hydroxyoduline 
45 R1+R2=CH2, R3=OMe, R4=H, R5=OH, R6=Me 2α-hydroxy-6-O-methyloduline 
46 R1+R2=CH2, R3=OMe, R4=H, R5=OMe, R6=Me 2α-methoxy-6-O-methyloduline 
47 R1+R2=CH2, R3+R4=O, R5=OMe, R6=Me ungerine 
48 R1+R2=CH2, R3+R4=O, R5=OH, R6=Me hippeastrine 
49 R1+R2=CH2, R3=OEt, R4=H, R5=OMe, R6=Me 2α-methoxy-6-O-ethyloduline 
50 R1+R2=CH2, R3=O-n-C4H9, R4=H, R5=OH, R6=Me 2α-hydroxy-6-O-n-butyloduline 
  
O
R6N
R1O
R2O
H
H
H
R5
R3 R4
O
 
51 R1=Me, R2=Me, R3+R4=O, R5=H, R6=Me homolycorine-N-oxide 
52 R1=Me, R2=Ac, R3+R4=O, R5=H, R6=Me 8-O-acetylhomolycorine-N-oxide 
53 R1=H, R2=Me, R3+R4=O, R5=H, R6=Me 9-O-demethylhomolycorine-N-oxide 
54 R1=Me, R2=H, R3+R4=O, R5=OH, R6=Me 2α-hydroxy-8-O-demethylhomolycorine-N-oxide 
55 R1=Me, R2=H, R3+R4=O, R5=H, R6=Me 8-O-demethyhomolycorine-N-oxide 
56 R1+R2=CH2, R3+R4=O, R5=H, R6=Me 8,9-methylenedioxylhomolycorine-N-oxide 
Figure 1.8: Homolycorine-type alkaloid structures. 
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57 R1+R2=CH2         crinine 
58 R1= Me, R2=H      macowine 
 
N
H
O
O
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OMe  
N
H
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O
 
59 buphanamine 60 R1=OH        crinamidine 
 61 R1=OMe       undulatine 
Figure 1.9: Crinine-type alkaloid structures. 
N
R4O
R3O
R1
R2
R5 R6
H
R7
 
62 R1=OMe, R2=H, R3+R4=CH2, R5=H, R6=H, R7=OH  haemanthamine 
63 R1=OMe, R2=H, R3+R4=CH2, R5=H, R6=OH, R7=OH    haemanthidine 
64 R1=OMe, R2=H, R3+R4=CH2, R5=OH, R6=H, R7=OH epihaemanthidine 
65 R1=H, R2=OMe, R3+R4=CH2, R5=OAc, R6=H, R7=OH           3-methyl-6β-acetoxybulbispermine 
66 R1=H, R2=OAc, R3+R4=CH2, R5=OAc, R6=H, R7=OH           3-acetyl-6β-acetyoxybulbispermine 
67 R1=OH, R2=H, R3+R4=CH2, R5=H, R6=H, R7=H         vittatine 
68 R1+R2=O, R3+R4=CH2, R5=H, R6=H, R7=H                      oxovittatine 
69 R1=OH, R2=H, R3+R4=CH2, R5=H, R6=H, R7=OH  11-hydroxyvittatine 
70 R1=OH, R2=H, R3=Me, R4=H, R5=H, R6=H, R7=H           8-O-demethylmaritidine 
71 R1=H, R2=OMe, R3+R4=CH2, R5=H, R6=OH, R7=OH      6α-hydroxycrinamine 
72 R1=H, R2=OMe, R3+R4=CH2, R5=OH, R6=H, R7=OH      6β-hydroxycrinamine 
73 R1=H, R2=OMe, R3+R4=CH2, R5=OAc, R6=H, R7=OH    6β-acetoxycrinamine 
74 R1=H, R2=OH, R3+R4=CH2, R5=OAc, R6=H, R7=OH                6β-acetoxybulbispermine 
75 R1=H, R2=OMe, R3=Me, R4=H, R5=OAc, R6=H, R7=OH     6β-acetyl-8-hydroxy-9-methoxycrinamine 
  
N
H
O
O
O  
76 apohaemanthamine 
Figure 1.10: Haemanthamine-type alkaloid structures. 
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O NH
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OH
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OH
H
R  
77 R=OH     narciclasine 
78 R=H        lycoricidine 
  
 
N
O
O R3
R1
R5 R4
R2
R6   
79 R1=H, R2=H, R3=Me, R4=H, R5=H, R6=H                           5,6-dihydrobicolorine 
80 R1=H, R2=H, R3=H, R4+ R5=O, R6=H                                  crinasiadine 
81 R1=H, R2=H, R3=CH2CH2CH(CH3)2, R4+R5=O, R6=H       N-isopentylcrinasiadine 
82 R1=H, R2=OH, R3=H, R4+R5=O, R6=H            arolycoricidine 
83 R1=H, R2=OH, R3=H, R4+R5=O, R6 =OH         arolycoricidinol 
84 R1=OH, R2=H, R3=Me, R4=H, R5=H, R6=H                      5,6-dihydro-N-methyl-2-hydroxyphenanthridine 
  
O
O N  
O
O N Me 
O
O HN
OH
Me
 
85 trisphaeridine 86 bicolorine 87 ismine 
Figure 1.11: Narciclasine-type alkaloid structures. 
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88 R1=Me, R2=OH  tazettine 91 R=H        pretazettine 
89 R1=Me, R2=H     deoxytazettine 92 R=Me     6-O-methylpretazettine 
90 R1=Et, R2=OH      3-O-ethyltazettinol   
Figure 1.12: Tazettine-type alkaloid structures. 
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93 R=Me      montanine 95 squamigine 96 montabuphine 
94 R=H        pancracine   
Figure 1.13: Montanine-type alkaloid structures. 
 
NR3
O
R1
R2
R4O
H
 
97 R1=OH, R2=H, R3=Me, R4=Me                               galanthamine
98 R1=H, R2=OH, R3=Me, R4=Me                               epigalanthamine 
99 R1=OH, R2=H, R3=H, R4=Me                                  norgalanthamine
100 R1=OH, R2=H, R3=Me, R4=H                                sanguinine
101 R1=OH, R2=H, R3=CH2CHCH2, R4=Me                N-allylnorgalanthamine 
102 R1=OH, R2=H, R3=H, R4=H                                   norsanguinine
103 R1=OCOCH2CHOHMe, R2=OH, R3=H, R4=H       3’-hydroxybutanoylnorsanguinine 
104 R1+R2=O, R3=Me, R4=Me                                     narwedine
  
NR3
O
R1
R2
R4O
H
 
105 R1=OH, R2=H, R3=Me, R4=Me lycoramine 
106 R1=H, R2=OH, R3=Me, R4=Me 3-epilycoramine 
107 R1=OH, R2=H, R3=Me, R4=H O-demethyllycoramine 
108 R1=OH, R2=H, R3=H, R4=Me norlycoramine 
  
NMe
O
MeO
O
OH
 
NMe
O
RO
O
OH
 
109 galanthamine-N-oxide 110 R=Me   lycoramine-N-oxide 
 111 R=H    O-demethyllycoramine-N-oxide 
Figure 1.14: Galanthamine-type alkaloid structures. 
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MeN
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R2O  
112 R1+R2=CH2, R3=CH2OH             galanthindole 
113 R1=Me, R2=Me, R3=CH2OH         lycosinine A 
114 R1=Me, R2=Me, R3=CHO lycosinine B 
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115 cheryline 116 2R-hydroxy-N,O-dimethylnorbelladine 
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117 hostasinine A 118 7-demethoxyhostasine 
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119 R1+R2=CH2, R3=Me, R4=Me      N-methoxycarbonylnandigerine 121 8-demethyldehydrocrebanine 
120 R1=H, R2=Me, R3=H, R4=Me      N-methoxycarbonyllindcarpine  
   
R1O
MeO NR2
O
MeO O  
HO
MeO NMe
MeO
MeO
O
 
122 R1= Me, R2= Me,  isocorydione 125 10-O-methylhernovine-N-oxide 
123 R1= H, R2= Me,  2-demethylisocorydione  
124 R1= H, R2= COOCH3 N-methoxycarbonyl-2-demethylnorisocorydione  
Figure 1.15: Miscellaneous 
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1.5. Alkaloids from the genus Hippeastrum 
A review on the genus Hippeastrum by our research group has been recently 
published in Revista Latinoamericana de Química (de Andrade et al., 2012). 
As a co-author of this publication, I have included it as Appendix I, even though it 
does not form part of the work presented in this thesis. 
1.6. GC-MS (Gas Chromatography-Mass Spectrometry) and 
NMR (Nuclear Magnetic Resonance) 
The analysis of alkaloids from plant extracts, as well as identifying new 
compounds of Amaryllidaceae species, has been possible through the development of 
two fundamental techniques that have become part of routine application procedures: 
gas chromatography-mass spectrometry (GC-MS) and nuclear magnetic resonance 
(NMR). Extensive research conducted during the last 50 years in the field of 
Amaryllidaceae alkaloids has achieved the characterization of certain patterns for 
various structural types. This enables a rapid identification of known compounds and 
the elucidation of detailed structures in the case of new isolated products.  
1.6.1. GC-MS 
Gas chromatography, which was introduced in the 1950s, is a known technique 
with the ability to separate components in a mixture, which involves sample 
volatilization by heating. The equipment includes a column with the stationary phase, 
an inert carrier gas, and a detector. Only molecules that can be vaporized without 
decomposition are suitable for this analysis. Moreover, the mass spectrometer is a basic 
instrument that measures the mass to charge (m/z) of ions in the gas phase, providing 
information on the abundance of each ion, and offers the possibility of being coupled to 
a detector (Kitson et al., 1996). Generally, organic compounds have distinctive 
fragmentation patterns after being ionized, which allows identification by comparison 
with previously obtained data. The combination of both techniques is a powerful tool 
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commonly known as GC-MS, which has a relatively low cost, as well as high resolution 
and efficiency. 
During the 60s and 70s, numerous studies on Electron Impact Mass Spectrometry 
(EIMS) of Amaryllidaceae alkaloids were conducted, allowing characteristic 
fragmentation patterns to be established for various kinds of skeletons (Bastida et al., 
2006).  
Extracts of Amaryllidaceae are usually complex mixtures with a large number of 
compounds. The GC-MS technique, either electron impact (EI) or chemical ionization 
(CI), has proved to be a very useful method for a rapid separation and detection of 
components. Amayllidaceae alkaloids can be analyzed without prior derivatization since 
they retain their particular patterns of fragmentation under the conditions of GC, 
allowing the identification of previously characterized compounds or providing valuable 
structural information when it comes to new molecules (Berkov et al., 2005). Notably, 
small changes in the stereochemistry of these alkaloids often cause significant 
differences in the mass spectrum of the stereoisomers (Duffield et al., 1965; Berkov et 
al., 2012b). 
Recently, GC-MS validation has been reported as a method of choice for quality 
control of plant materials used in the production of galantamine (Berkov et al., 2011a), 
demonstrating the advantages of its use in qualitative analysis and quantity of these 
plants, even compared with other methodologies (Gotti et al., 2006).  
The further development of the new methods, as well as the characterization of 
other structures, has generated well-documented information of considerable diagnostic 
value for identifying this group of alkaloids. Therefore, it is worth making some 
comments on the most representative cases. The examples described below demonstrate 
the value of GC-MS methodology in identifying Amaryllidaceae alkaloids, although it 
is not suitable for all structures. 
1.6.1.1. Lycorine type  
The molecular peak appears with appreciable intensity, and generally suffers the 
loss of water, as well as C-1 and C-2 and their substituents, by a r-DA fragmentation 
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(Fig 1.16). Interestingly, the loss of water from the molecular ion depends on the 
stereochemistry of the hydroxyl group at C-2, and does not occur in acetyl derivatives. 
Thus, in the mass spectrum of lycorine the relative intensity is low, while in 
2-epilycorine it is the base peak (Bastida et al., 2006). 
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Figure 1.16: Mass fragmentation pattern of lycorine. 
1.6.1.2. Homolycorine type 
In this type of alkaloid, the cleavage of the labile bonds in ring C by a r-DA 
reaction is predominant, generating two fragments: the most characteristic one 
represents the pyrrolidine ring (together with the substituents at position 2), and the 
other (a less-abundant fragment) encompasses the aromatic lactone or hemilactone 
moiety. Therefore, in the case of homolycorine, the base peak is observed at m/z 109, 
while hippeastrine (with a hydroxyl group at C-2) presents at m/z 125. A significant 
aspect is the low abundance of the molecular ion (Figure 1.17) (Bastida et al., 2006). 
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Figure 1.17: Mass fragmentation pattern of homolycorine. 
1.6.1.3. Crinine and Haemanthamine types  
Various fragmentations of the two types of alkaloids have been studied in detail. In 
most cases, the molecular ion is the base peak. The aromatic ring plays a significant role 
in the stabilization of the ions, which is retained in all fragments of high mass, while the 
nitrogen atom is often lost. The fragmentation mechanisms are initiated by the rupture 
of the bond β to the nitrogen atom, which implies the opening of the C-11/C-12 bridge. 
Several described characteristic patterns have taken into account the presence of 
substituents at various positions, saturation of the C ring and the influence of 
stereochemistry. There are three patterns of fragmentation: loss of CH3OH, C2H6N and 
CHO (Figure 1.18) (Bastida and Viladomat, 2002). 
34 Research on the Alkaloids of Amaryllidaceae Plants: Genera Lycoris and Hippeastrum 
 
N
O
O
OMe
HO
O
O
O
N
O
O
OMe
OH
O
O
O O
O
N
O
O
O
OMe
O
N
O
O
OMe
H
O
O
O
OMe
N
O
O N
O
O
O
OO
O
O
O
O
O
OMe
OMe
m/z 301
haemanthamine
m/z 269 m/z 240 m/z 211
m/z 258
m/z 258
m/z 257 m/z 225
m/z 227
m/z 181
•
•
+ + +
+ •
+•
+•
+•
+
+
+
+ +
+
•
•
•- CHO
- H
•
- MeO
- CH2O- CH2=NH
- CH2=NMe
•
•
- MeOH
- MeOH
 
(mainlib) Crinan-11-ol, 1,2-didehydro-3-methoxy-, (3?5?11R,13?19?-
40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220 230 240 250 260 270 280 290 300 310
0
50
100
41
43
51 56
58
63
67
71
77
91 102
114
128 141
153
160
173
181
187
200
211
227
240
257 269
286
301
 
Figure 1.18: Mass fragmentation patterns of haemanthamine.  
1.6.1.4. Tazettine type  
The tazettine skeleton is a good example to illustrate how small changes in 
stereochemistry can be reflected in the fragmentation patterns. Criwelline and Tazettine 
only differ in the methoxy group setting at C-3, but this is enough to produce significant 
variations in their mass spectra. Consequently, in the MS of tazettine, with a 
β-conﬁguration of the methoxy group at C-3, the dominant ion occurs at m/z [M+-84], 
following a C-ring fragmentation by an r-DA process. In contrast, the mass spectrum of 
its epimer criwelline contains a peak of low abundance at m/z [M
+
-84]. Ions occur in 
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both stereoisomers owing to the successive loss of a methyl radical and water from the 
molecular ion (Figure 1.19) (Bastida et al., 2006). 
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Figure 1.19: Mass fragmentation patterns of tazettine (A) and criwelline (B). 
1.6.1.5. Montanine type  
The mass spectral fragmentation patterns observed for alkaloids containing the 
5,11-methanomorphanthridine nucleus depend on the substituents at C-2 and C-3. Their 
nature, as well as their particular conﬁguration, have a considerable effect. Therefore, 
all the alkaloids that possess a methoxyl group give rise to an [M-31]
+
 ion. The 
A 
B 
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conﬁguration of the C-2 substituent has a considerable effect on the extent to which the 
r-DA fragmentation ion is observed. There is a definite enhancement of this 
fragmentation when C-2 has an α-conﬁguration (Figure 1.20) (Bastida and Viladomat, 
2002).  
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Figure 1.20: Mass fragmentation patterns of montanine. 
1.6.1.6. Galanthamine type  
This series of structures are probably the most studied among the Amaryllidaceae 
alkaloids. In this type of structure, the intense molecular ion as well as the [M
+
-1] peak, 
the breaking of ring C (losing a C4H6O fragment), and the elimination of elements of 
ring B (including the nitrogen atom) are characteristic (Figure 1.21). This behavior is 
similar for the dihydro derivatives. Recently, GC-MS methodology has been used for 
detailed analysis of the various galanthamine-type skeletons, and has been established 
as a routine technique for the study of plant extracts that contain these alkaloids (Berkov 
et al., 2012b). 
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Figure 1.21: Mass fragmentation patterns of galanthamine. 
1.6.2. Proton nuclear magnetic resonance  
Nuclear magnetic resonance (NMR) spectroscopy is a research technique that 
exploits the magnetic properties of certain atomic nuclei. It determines the physical and 
chemical properties of atoms or the molecules in which they are contained. It relies on 
the phenomenon of nuclear magnetic resonance and can provide detailed information 
about the structure, dynamics, reaction state, and chemical environment of molecules. It 
is also a kind of absorption spectrum, like infrared (IR) or ultraviolet (UV). The NMR 
technique is mainly applied in the identification of pure organic compounds, but in 
recent years it has also been extended to the analysis of mixtures in the field of 
metabolomics, which is being used in many plant extract studies, including analysis of 
the species and varieties of Amaryllidaceae (Kim et al., 2010; Lubbe et al., 2010). 
1
H NMR spectroscopy provides the most extensive and fundamental information 
on the different structural types of Amaryllidaceae alkaloids, while its combination with 
13
C NMR spectroscopy and two-dimensional NMR techniques (2D-NMR) has 
facilitated structural assignments and the settling of their stereochemistry. 
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The most significant features of the spectra of 
1
H NMR alkaloids of 
Amaryllidaceae have been outlined, providing keys for their identification (Bastida et 
al., 2011). In general, the aromatic region (6.5-8.5ppm) defines the skeleton type, 
whereas the observation of substitution of the aromatic ring corresponds to one or more 
methoxyl signals around 3.6-4.0 ppm, or the presence of the typical signal of 
methylenedioxy about 6.0 ppm. In many structures, the benzylic C-6 position is 
saturated, as in lycorine, galanthamine and haemanthamine. The presence of an AB 
system is characteristic of these protons. Interestingly, the chemical shift is influenced 
by the orientation of the free electron pair of the nitrogen atom. In addition to these 
common features, it is worth mentioning some peculiarities for each type of alkaloid 
(Bastida et al., 2006). 
1.6.2.1. Lycorine type  
Key features of the 
1
H NMR spectrum of lycorine and its derivatives are the two 
singlets of the para-oriented aromatic protons, with a single olefinic proton and the two 
doublets as an AB system corresponding to the benzylic position 6. The deshielding 
observed in the β-proton positions 6 and 12, in relation to their counterparts, is due to 
the effect of the cis-lone pair of the nitrogen atom. Generally, alkaloids isolated from the 
genus Narcissus, Lycoris and Hippeastrum show a trans B/C ring junction, with a 
constant coupling between protons 4a-10b of about 11 Hz. Only kirkine form Narcissus 
and amarbellisine from Lycoris have a cis B/C ring junction, with a smaller coupling 
constant (8 Hz) (Bastida et al., 2011; Zhao et al., 2011). 
1.6.2.2. Homolycorine type  
These compounds include a characteristic group that can be a lactone, a hemiacetal 
or a cyclic ether. Generally, in the 
1
H NMR spectrum, there are two singlets for the 
para-oriented aromatic protons. In lactone alkaloids, the deshielding of H-7 is caused 
by the peri-carbonyl group. The hemiacetal alkaloids always show the substituent at C-6 
in α-disposition.  
Most of these alkaloids belong to a single enantiomeric series containing a cis B/C 
ring junction, which is congruent with the small size of the coupling constants between 
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protons H-1 and H-10b. In the Narcissus genus no exception to this rule has been 
observed. In addition, the high value of the constant between α-orientation H-4a and 
H-10b (J ~ 10 Hz) is only consistent with a trans-diaxial relationship. The exception is 
hippapiline from the genus Hippeastrum with a β-orientation of H-1 and H-10b. 
Typically, ring C has a vinyl proton. If position 2 is replaced by a hydroxyl, 
methoxy or acetyl group, it always displays an α-disposition. The N-methyl group is 
often found in the range of 2.0-2.2 ppm, but in the case of alkaloids with the saturated C 
ring, some empirical correlations have been described for the stereochemistry of the 
connections between rings B/C and C/D, where more deshielded signals are reported 
(Jeffs and Mueller, 1988). The H-12α is more deshielded than H-12β as a consequence 
of the cis-lone pair of the nitrogen atom (Bastida and Viladomat, 2002). 
1.6.2.3. Crinine and Haemanthamine types  
The absolute configuration of these alkaloids is determined by the circular 
dichroism (CD) spectrum. The alkaloids of the genus Narcissus are exclusively of the 
haemanthamine-type, whereas in some genera such as Brunsvigia, Boophane etc., the 
crinine-type alkaloids are predominant. The alkaloids from the genus Lycoris and 
Hippeastrum include both haemanthamine and crinine types. It is also reported that the 
alkaloids isolated from the Narcissus genus do not show additional substitutions in the 
aromatic ring apart from those of C-8 and C-9. On the contrary, in the genera where 
crinine-type alkaloids predominate, the presence of compounds with a methoxy 
substituent at C-7 is quite common.  
Using CDCl3 as the solvent, the magnitude of the coupling constants between each 
olefinic proton (H-1 and H-2) and H-3 gives information about the configuration of the 
C-3 substituent. Thus, in those alkaloids in which the two-carbon bridge (C-11 and C-12) 
is cis to the substituent at C-3, H-1 shows an allylic coupling with H-3 (J1, 3 ~1-2 Hz) 
and H-2 shows a smaller coupling with H-3 (J2, 3 ~ 0-1.5 Hz), as occurs in crinamine. 
On the contrary, in the corresponding C-3 epimeric series, e.g. haemanthamine, a larger 
coupling between H-2 and H-3 (J2, 3 ~5 Hz) is shown, the coupling between H-1 and 
H-3 being undetectable. This rule is also applicable to the crinine-type alkaloids.  
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In the haemanthamine series, there is frequently an additional W coupling of H-2 
with the equatorial H-4, while the axial proton H-4 shows a large coupling with H-4a 
(J4α, 4a ~13 Hz) due to their trans-diaxial disposition. The same is applicable in the 
crinine series.  
The pair of alkaloids with a hydroxy substituent at C-6, like papyramine/ 
6-epipapyramine, haemanthidine/ 6-epihaemanthidine etc, appear as a mixture of 
epimers not separable even by HPLC (Bastida et al., 2011).  
1.6.2.4. Tazettine type  
The presence of an N-methyl group (2.4-2.5 ppm) distinguishes this type of 
alkaloid from crinine and haemanthamine types, from which they proceed 
biosynthetically. What is more, the spectrum of 
1
H NMR always shows the signal 
corresponding to the methylenedioxy group (Bastida et al., 2011). 
1.6.2.5. Narciclasine type  
In the alkaloids of this type, the only aromatic proton appears as a singlet, the 
chemical shift exceeding 7 ppm. Additionally, the compounds do not exhibit the classic 
double bond in C-1/C-10b, and show a trans fusion ring B/C, confirmed by its coupling 
constant J4a-10b (Bastida et al., 2006). 
1.6.2.6. Montanine type 
The absolute configuration of montanine-type alkaloids must be determined by CD. 
Their 
1
H NMR spectrum is very similar to that of lycorine-type alkaloids, but their 
structures can be distinguished by analysis of the COSY spectrum. The most shielded 
signals in montanine-type alkaloids are attributed to protons H-4 and show correlation 
with H-3 and H-4a, while the highly shielded lycorine-type alkaloid signals correspond 
to two protons at positions 11 and 12 (Bastida and Viladomat, 2002). 
1.6.2.7. Galanthamine type  
Among the Amaryllidaceae alkaloids, only the galanthamine-type show an 
ortho-coupling constant (~ 8 Hz) between both aromatic protons of ring A. The 
assignment of the substituent stereochemistry at C-3 is made in relation with the 
coupling constants of the oleﬁnic protons H-4 and H-4a. When the coupling constant 
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J3, 4 is about 5Hz, the substituent is pseudoaxial, while if it is ~ 0 Hz this indicates that 
the substituent at C-3 is pseudoequatorial.  
This type of alkaloids usually show the presence of an N-methyl group, although 
N-formyl has also occasionally been reported. The presence of the furan ring causes a 
deshielding effect on H-1 (Bastida et al., 2006). 
1.6.3. Carbon
13
 nuclear magnetic resonance  
13
C NMR spectroscopy has been widely used for determining the carbon skeleton 
of Amaryllideceae alkaloids. Overall, the 
13
C NMR spectra of Amarillydeceae alkaloids 
can be divided in two regions. The low-ﬁeld region (﹥90 ppm) contains signals of the 
carbonyl group, the oleﬁnic and aromatic carbons, as well as that of the methylenedioxy 
group. The other signals corresponding to the saturated carbon resonances are found in 
the high-ﬁeld region, the N-methyl being the only characteristic group, easily 
recognizable by a quartet signal between 40 and 46 ppm. The effect of a substituent 
(OH, OMe, OAc) on the carbon resonances is of considerable importance in localizing 
the position of the functional groups (Bastida et al., 2006). 
1.6.4. Two-dimensional nuclear magnetic resonance spectroscopy 
Finally, as already mentioned, two-dimensional experiments are important for 
proper allocation of 
1
H NMR and 
13
C NMR signals, especially in the case of unknown 
structures. 2D NMR techniques are used more broadly, and include the following: 
 1H-1H COSY (Correlated Spectroscopy), in which the correlations observed 
correspond to direct couplings between protons. It is quite useful in assigning the 
geminal and vicinal links. 
 1H-1H NOESY (Nuclear Overhauser Effect Spectroscopy) provides information on 
the spatial proximity of protons, and therefore has great value in defining the 
stereochemistry. 
 1H-13C HSQC (Heteronuclear Single Quantum Correlation) shows correlations 
between 
1
H-
13
C directly linked, allowing adequate allocation of all carbons, except 
the quaternary. 
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 1H-13C HMBC (Heteronuclear Multiple Bond Correlation) is extremely useful in 
determining correlations between long-range 
1
H-
13
C, and allows identification of 
quaternary carbons by observing their correlation with protons located three links 
away. 
1.7. Biological activities  
The Amaryllidaceae alkaloids have shown a broad range of pharmacological and 
biological activities, including acetylcholinesterase (AChE) inhibition, and antitumoral, 
antibacterial, antifungal, antiviral and antimalarial activities (Bastida et al., 2006; Jin, 
2009). Until now, only galanthamine is being marketed as a hydrobromide salt 
(Razadyne
®
, Reminyl
®
) for the palliative treatment of mild to moderate Alzheimer's 
disease (AD), but the significant activities of other alkaloids in the family demonstrated 
in recent years could favour their therapeutic use in the near future (Bastida et al., 
2011).  
1.7.1. Lycorine type  
Lycorine, which is one of the most frequently occurring alkaloids in 
Amaryllidaceae plants, has been found in all Lycoris species. Generally speaking, the 
compound has been reported as a potent inhibitor of ascorbic acid biosynthesis, cell 
growth and division, and organogenesis in higher plants, algae and yeasts, inhibiting the 
cell cycle during the interphase (Bastida et al., 2006). In addition, lycorine is a novel 
contributor to the control of the length of mammalian cell life (Onishi et al., 2012). 
The lycorine series compounds have recently emerged as novel inhibitors of AChE, 
in some instances with higher levels of activity than galanthamine, making them 
attractive targets for natural product and synthetically-driven structure-activity 
relationship studies. Thus, in the past decade lycorine has emerged as a promising lead 
in therapeutic approaches towards AD and may advance into the clinical stage in the 
future (Nair and van Staden, 2012). Additionally, lycorine induces cell-cycle arrest in 
the G0/G1 phase in K562 cells via histone deacetylase (HDAC) inhibition, which 
exhibits significant antitumor activity (Li et al., 2012b). Other studies of lycorine have 
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reported potential antinociceptive, anti-inflammatory, hepatoprotective and hypotensive 
activities (McNulty et al., 2010; Schmeda-Hirschmann et al., 2000). Lycorine isolated 
from H. santacarina has remarkable inhibitory activity of the enzymes NTPDase and 
ecto-5’-nucleotidase from Trichomonas vaginalis, which contributes to an increased 
susceptibility of this parasite to the host immune response. Lycorine has also 
demonstrated anti-T.vaginalis activity, involving a mechanism of cell death induction 
associated with paraptosis rather than the apoptosis observed in tumor cells (Giordani et 
al., 2010, 2011, 2012). In particular, the alkaloid shows biological activity against 
Entamoeba histolytica (Machocho et al., 1998), while structures of lycorine exhibited 
both antimalarial and cytotoxic activity in tests with 2 strains of cultured Plasmodium 
falciparum and cytotoxicity in BL6 mouse melanoma cells (Campbell et al., 1998, 2000; 
Ramires et al., 2001).  
Similarly, galanthine shows AChE inhibitory, cytotoxic and antiproliferative 
activities (Jensen et al., 2011; Dalecka et al., 2013). 5,6-Dehydrolycorine, in turn, 
exhibits significant cytotoxic activities against HL-60 (IC50 values<10μM), and 
antimalarial activities against the two strains of P. falciparum (Hao et al., 2013). 
Pseudolycorine shows good activity in in vitro assays against Trypanosoma brucei 
rhodesiense, T. cruzi and Plasmodium falciparum (Osorio et al., 2010). It also exhibits 
in vitro activity against three medically important RNA viruses, Japanese encephalitis 
(JE), yellow fever (YF) and dengue type-4 viruses (flaviviruses) (Gabrielsen et al., 
1992b). Furthermore, the alkaloid has anticancer activity as well as remarkable 
antileukemic activity (Furusawa et al., 1971, 1973; Suzuki et al., 1974; Pan et al., 1979; 
Kong et al., 1982). Dihydrolycorine, and pseudolycorine halts HeLa cell growth at 10
-1 
mM or lower concentrations (Jimenez et al., 1976). What is more, dihydrolycorine has 
protective effects on myocardial ischemia reperfusion injury rats, focal cerebral 
ischemia-reperfusion injury rats, and hypoxia/reoxygenation injury rats (Jiang and Gong, 
2005; Jiang et al., 2006, 2007, 2009a, 2010; Zhang et al., 2008). Additionally, it exhibits 
hypotensive, protective effects in ischemia and reperfusion brain damage (Chen et al., 
1993; Zhang et al., 2007). Ungiminorine displays a mild inhibitory effect on AChE 
(Ingkaninan et al., 2000). The lycorine-type alkaloid, amarbellisine, has a pronounced 
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antiproliferative effect, shows antibacterial activity against the Gram-positive 
Staphylococcus aureus, exhibits activity against the Gram-negative Escherichia coli, 
and also shows antifungal activity against Candida albicans (Evidente et al., 2004, 
2009). 
1.7.2. Homolycorine type  
Generally, the homolycorine-type alkaloids, such as homolycorine, 
8-O-demethylhomolycorine, dubiusine, hippeastrine, lycorenine, and  
O-methyllycorenine, present cytotoxic effects on c-ﬁbroblastic LMTK cells, Molt 4 
lymphoma, HepG2 human hepatoma, LNCaP human prostate cancer, HT, HCT-116 and 
HeLa cell lines (Bastida et al., 2006; Jokhadze et al., 2011). Dubiusine, lycorenine and 
8-O-demethylhomolycorine also show DNA binding activity comparable to that of 
vinblastine. Additionally, dubiusine, homolycorine, 8-O-demethylhomolycorine, and 
lycorenine have a hypotensive effect on the arterial pressure of normotensive rats 
(Bastida et al., 2006). Homolycorine, 2α-hydroxyoduline, oduline, hippeastrine, 
2α-hydroxy-6-O-methyloduline, and 2α-methoxy-6-O-methyloduline from Lycoris 
aurea have been evaluated for anticancer efficacy both in vivo and in vitro using murine 
sarcoma S180 cells, indicating that their anticancer effects, at least in part, are the result 
of inducing cancer cell apoptosis (Liao et al., 2012). 
Lycorenine demonstrates a vasodepressor action ascribed to the maintenance of its 
adrenergic blocking action, and produces bradycardia by modifying vagal activity. 
Another feature of lycorenine is its analgesic activity. Homolycorine possesses high 
antiretroviral activity, accompanied by low therapeutic indices; it is also an inductor of 
delayed hypersensitivity in animals. Hippeastrine, in turns, exhibits antiviral activity 
against Herpes simplex type 1 and highly pathogenic avian influenza virus H5N1, 
antifungal activity against C. albicans and also weak insect antifeedant activity (Bastida 
et al., 2006; He et al., 2013). In particular, the compounds ungerine and hippeastrine 
have an effect in the inhibition and treatment of muscular atrophy (Adams et al. 2012). 
2α-methoxy-6-O-ethyloduline and 2α-methoxy-6-O-methyloduline showed weak 
antiviral activities against the flu virus A (Huang et al., 2013). 
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1.7.3. Crinine type 
As well as AChE inhibitory activity (Elgorashi et al., 2004; Abou-Donia et al., 
2012), crinine shows antiproliferative effects against human tumor cell lines (Berkov et 
al., 2011b). In particular, it displays affinity to the serotonin reuptake transport protein 
(Elgorashi et al., 2006), and interaction with P-glycoprotein mediated calcein-AM efﬂux 
effect (Eriksson et al., 2012). 
The crinine-type alkaloid buphanamine has affinity to the serotonin transporter and 
shows important anti-proliferative effects, being well-tolerated even at a high 
concentration (Evidente et al., 2009; Neergaard et al., 2009). Similarly, undulatine 
exhibits promising AChE and prolyl oligopeptidase inhibitory activities (Cahlikova et 
al., 2013). 
1.7.4. Hemanthamine type  
Hemanthamine and hemanthidine display pronounced cell growth inhibitory 
activities against a variety of tumor cells, such as Rauscher viral leukemia, Molt 4 
lymphoma, BL6 mouse melanoma, HepG2 human hepatoma, HeLa, LNCaP human 
prostate cancer, HT, Glioma Cells, glioblastoma, melanoma, non-small-cell lung and 
metastatic cancers, C-6 (rat glioma cells), CHO-K1 (Chinese hamster ovary cells) and 
non-tumoral ﬁbroblastic LMTK cells, and p53-negative human leukemic Jurkat cells 
(Bastida et al., 2006; van Goietsenoven et al., 2010a; Luchetti et al., 2012; Havelek et 
al., 2013; Katoch et al., 2013). 
Additionally, hemanthamine exhibits antiviral activity against Herpes simplex type 
1 and highly pathogenic avian influenza virus H5N1 (He et al., 2013). Furthermore, the 
alkaloid has an antiprotozoal effect, showing good activity in in vitro assays against T. 
brucei rhodesiense, T. cruzi and P. falciparum (Osorio et al., 2010). In particular, the 
antimalarial activity against strains of chloroquine-sensitive P. falciparum observed in 
hemanthamine and hemanthidine can be attributed to the methylenedioxybenzene part 
of the molecule and the tertiary nitrogen without methyl (Bastida et al., 2006). 
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Moreover, hemanthamine has hypotensive, antioxidant and anticonvulsant effects 
(Oloyede et al., 2010). Like lycorine, hemanthidine has stronger analgesic and 
anti-inflammatory activity than aspirin (Bastida et al., 2006). 
Among the other alkaloids of this type, vittatine has been found to potentiate the 
analgesic effect of morphine, and exhibits antibacterial activity against the 
Gram-positive S. aureus and the Gram-negative E. coli (Evidente et al., 2004; Bastida et 
al., 2006). 11-Hydroxyvittatine and 8-O-demethylmaritidine present antimicrobial 
activity (Abou-Donia et al., 2008), and the latter also exhibits significant AChE 
inhibition activity (Kulhankova et al., 2013). The compound 6-hydroxycrinamine, in 
turn, which has two epimers, 6α-hydroxycrinamine and 6β-hydroxycrinamine, possesses 
AChE inhibitory activity and is toxic to the neuroblastoma cells (Adekanmi et al., 2012). 
Additionally, 6β-hydroxycrinamine shows cytotoxicity against HL-60, A-549, and 
MCF-7 cells (Feng et al., 2011). 
1.7.5. Tazettine type 
Tazettine exhibits AChE inhibitory activity, and also shows promising human 
plasma butyrylcholinesterase inhibitory activity (Cahlikova et al., 2011; Sarikaya et al., 
2013). Tazettine is also mildly active against certain tumor cell lines with cytotoxicity 
when tested on ﬁbroblastic LMTK, HCT-116 and HeLa cell lines. It also displays weak 
hypotensive and antimalarial activities and interacts with DNA (Bastida et al., 2006; 
Jokhadze et al., 2011). One feature of tazettine is its affinity to the serotonin-reuptake 
transport protein (Elgorashi et al., 2006). Finally, tazettine and pretazettine demonstrate 
notable in vitro activity against T. cruzi (de Andrade et al., 2012a). It should be 
emphasized that tazettine is an isolation artefact of chemically labile pretazettine (de 
Andrade et al. 2012a), the latter being far more interesting due to its anticancer and 
antiviral activities (Bastida et al. 2006).  
Several studies in the literature report excellent antiproliferative effects of 
pretazettine on human MDR1-gene-transfected L5178 mouse lymphoma cells (Zupko et 
al., 2009). In addition, pretazettine displays cytotoxicity against ﬁbroblastic LMTK cell 
lines and inhibits HeLa cell growth, being therapeutically effective against advanced 
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Rauscher leukemia, Ehrlich ascites carcinoma, spontaneous AKR lymphocytic leukemia, 
Lewis lung carcinoma, and Molt4 lymphoid cells. Notably, pretazettine has also been 
shown to be active against Rauscher leukemia virus, Herpes simplex type 1 virus and 
selected RNA-containing ﬂavoviruses (Japanese encephalitis, yellow fever, and dengue) 
and bunyaviruses (Punta Toro and Rift Valley fever) in organ culture (Bastida et al., 
2006)  
1.7.6. Narciclasine type 
Narciclasine displays marked proapoptotic and cytotoxic activities. It involves the 
impairment of actin cytoskeleton organization by targeting GTP-ases, including RhoA 
and the elongation factor eEF1A, making it a promising GTP-ase targeting agent against 
brain cancers (van Goietsenoven et al., 2013). Narciclasine was also found to possess 
potent inhibitory activity against Human Cytochrome P450 (McNulty et al., 2011). 
Moreover, narciclasine induces marked apoptosis-mediated cytotoxic effects in two 
kinds of human cancer cells, human MCF-7 breast and PC-3 prostate carcinoma cells 
(Dumont et al., 2007). Narciclasine also impairs eEF1A-related actin bundling activity, 
EEF1A being a potential target to combat melanomas (van Goietsenoven et al., 2010b). 
Finally, narciclasine activates Rho and stress fibers in glioblastoma cells (Lefranc et al., 
2009). 
Narciclasine, an antimitotic alkaloid, affects cell division at the metaphase stage 
and inhibits protein synthesis in eukaryotic ribosomes. In particular, it also retards DNA 
synthesis and inhibits calprotectin-induced cytotoxicity at a concentration more than 
10-fold lower than lycorine. The important effects of narciclasine seem to arise from the 
functional groups and conformational freedom of its C-ring, with the 7-hydroxyl group 
believed to play a considerable role in its biological activity (Bastida et al., 2006). 
Additionally, narciclasine displays a prophylactic effect on the adjuvant arthritis 
model in rats. The alkaloid is active against Corynebacterium fascians, inhibits the 
pathogenic yeast Cryptococcus neoformans, and modifies the growth of the pathogenic 
bacterium Neisseria gonorrhoeae. Antiviral activity has been observed against 
RNA-containing ﬂaviviruses and bunyaviruses (Bastida et al., 2006). 
48 Research on the Alkaloids of Amaryllidaceae Plants: Genera Lycoris and Hippeastrum 
 
In plants, narciclasine is a potent inhibitor, showing a broad range of effects, 
including the ability to inhibit seed germination and seedling growth of some plants in a 
dose-dependent manner, interacting with hormones in some physiological responses 
(Bastida et al., 2006). 
Some alkaloids of this type, such as lycoricidine, possess anti-HCV activity (Chen 
et al., 2013). Lycoricidine also exhibits in vitro activity against the important RNA 
viruses, JE, YF and dengue-4, flavoviruses, vunyaviruses, Punta Toro and Rift Valley 
fever virus (Gabrielsen et al., 1992a, 1992b). 
Arolycoricidine presents inhibitory activity against African trypanosomiasis T. 
brucei rhodesiense and also has signiﬁcant antimalarial activity against drug-resistant P. 
falciparum K1 (Kaya et al., 2011). Trisphaeridine possesses antiretroviral activities, 
accompanied by low therapeutic indices (Bastida et al., 2006).  
1.7.7. Montanine type 
Like other Amaryllidaceae alkaloids, montanine has psychopharmacol activities 
including anxiolytic, antidepressive, anticonvulsive, antiproliferative, antiinflammatory, 
antioxidant, antimicrobial, and inhibition of the AChE activity effects (da Silva et al., 
2006, 2008; Castilhos et al., 2007; Pagliosa et al., 2010). Montanine also exhibits an 
effect on binding to the serotonin transporter protein in vitro, and presents low binding 
affinity to P-glycoprotein (Stafford et al., 2013). 
In turn, pancracine, which shows antibacterial activity against S. aureus and 
Pseudomonas aeroginosa, also shows a weak activity against T. brucei rhodesiense, T. 
cruzi, and P. falciparum (Bastida et al., 2006). 
1.7.8. Galanthamine type 
Galanthamine is a long-acting, selective, reversible and competitive inhibitor of 
AChE and an allosteric modulator of the neuronal nicotinic receptor for acetylcholine. 
AChE is responsible for the degradation of acetylcholine at the neuromuscular junction, 
in peripheral and central cholinergic synapses. Galanthamine has the ability to cross the 
blood-brain barrier and to act within the central nervous system (Berkov et al., 2012a). 
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Galanthamine, therefore, is the most studied Amaryllidaceae alkaloid in terms of 
biological activity, clinical response, tolerance and safety, being marketed as a 
hydrobromide salt under the name of Razadine
®
, formerly Reminyl
®
 (de Andrade et al., 
2012b). 
Galanthamine has other noteworthy pharmacological actions, including an ability 
to amplify the nerve-muscle transfer, affecting membrane ionic processes. Besides this, 
galanthamine acts as a mild analeptic, shows an analgesic power as strong as morphine, 
compensates for the effects of opiates on respiration, relieves jet lag, fatigue syndrome, 
male impotence, and alcohol dependence, and when applied in eye drops, reduces the 
intraocular pressure. It also acts as a hypotensive and has a weak antimalarial activity 
(Bastida et al., 2006). 
Recently, more effects of galanthamine have been found. The alkaloid presents a 
protective effect on myocardial ischemia-reperfusion injury in rats (Li et al., 2012a). 
Galanthamine plus estradiol treatment enhances cognitive performance in aged 
ovariectomized rats (Gibbs et al., 2011). Moreover, the compound also has an inhibitory 
effect on tumor necrosis factor alpha (TNF-α) release in rats with 
lipopolysaccharide-induced peritonitis, and the vagus nerve plays a role in the process 
of the action of galanthamine (Liu et al., 2010). 
After the therapeutic success of galanthamine, the search for new AChE inhibitors 
has intensified. Consequently, epigalanthamine, with a hydroxyl group at the α-position, 
and narwedine, with a keto group at C-3, are also reported as active AChE inhibitors, 
but about 130 times less powerful than galanthamine. The loss of the methyl group at 
the N atom, as in N-demethylgalanthamine, decreases the activity 10-fold. 
Hydrogenation of the C4-C4a double bond, as in lycoramine, results in a complete loss of 
AChE inhibitory activity (de Andrade et al., 2012b). 
On the other hand, sanguinine, which has a hydroxyl group at C-9 instead of a 
methoxyl group, is an even more powerful inhibitor of AChE than galanthamine 
(Torras-Claveria et al., 2013). Quite recently, N-allylnorgalanthamine, was isolated 
from the bulbs of Lycoris guangxiensis and inhibits AChE considerably more than the 
approved drug galanthamine ( Li et al., 1987; Berkov et al., 2008). 
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1.7.9. Other types 
Hostasinine A from Lycoris albiflora exhibits potent cytotoxic activities against 
not only HL-60 cells but also HSC-2 cells (Jitsuno et al., 2011). 
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2. Objectives  
Overall, the main objective of this thesis is the chemical and biological study of the 
Chinese genus Lycoris. To our knowledge, there are only two reports in the literature 
about the use of GC-MS for the identiﬁcation of alkaloids in Lycoris species (L. radiata 
and L. aurea) (Sun et al., 2012; Wang et al., 2007a). Consequently, the aim is to provide 
detailed alkaloid profiles of a range of Lycoris species for the first time. In addition, the 
other general aim is to study two species from the South American genus Hippeastrum, 
namely Hippeatsrum papilio and H. calyptratum. 
Specific Objectives: 
 To provide alkaloid profiles of species belonging to the genus Lycoris. The 
application of GC-MS to evaluate and quantify the alkaloids in L. albiflora, L. 
aurea, L. chinensis, L. haywardii, L. incarnata, L. longituba, L. radiata, L. 
sprengeri, L. squamigera and L. radiata var. pumila, all from China. 
 To evaluate the alkaloid content of the species Hippeastrum papilio and H. 
calyptratum through GC-MS. To characterize new compounds, and provide 
complete spectral data for unknown compounds, using different spectroscopic 
techniques including NMR, IR, UV, ORD, CD and HRMS. 
 To identify species with potential pharmaceutical interest due to a high content of 
compounds showing remarkable bioactivity. 
 To carry out activity tests by in vitro assays on new alkaloids against the parasitic 
protozoa Trypanosoma brucei rhodesiense, Trypanosoma cruzi, Leishmania 
donovani, and Plasmodium falciparum, as well as to evaluate cytotoxicity by use of  
L-6 myoblast cells. 
 To contribute to the taxonomical revision of the species under study, based on the 
presence of certain types of alkaloids as chemical markers. 
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3. Results 
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The genus Lycoris, a group of Amaryllidaceae plants distributed in temperate regions of Eastern Asia, is already known for containing representative alkaloids 
typical of this botanical family with a wide range of biological activities (for example, lycorine and galanthamine). In the present work, the alkaloid profiles   
of nine species, L. albiflora, L. aurea, L. chinensis, L. haywardii, L. incarnata, L. longituba, L. radiata, L. sprengeri, and L. squamigera, and one variety       
(L. radiata var. pumila) have been evaluated by GC-MS. Structures belonging to the lycorine-, homolycorine-, haemanthamine-, narciclasine-, tazettine-, 
montanine- and galanthamine-series were identified and quantified, with galanthamine- and lycorine-type alkaloids predominating and usually showing a high 
relative abundance in comparison with other alkaloids of the extracts. Interestingly, L. longituba revealed itself to be a potential commercial source of 
bioactive alkaloids. In general terms, our results are consistent with the alkaloid profiles reported in the literature for previously studied species. 
 
Keywords:  Lycoris, Amaryllidaceae Alkaloids, GC-MS, Lycorine, Galanthamine. 
 
 
 
The Amaryllidaceae family is comprised of about 1100 perennial 
bulbous species, classified into 85 genera, and distributed 
throughout the tropics and warm temperate regions of the world. It 
is one of the 20 most important alkaloid-containing plant families 
[1]. Lycoris, a genus belonging to the Amaryllidaceae, includes 22 
species and one hybrid, and is found in temperate woodlands of 
Eastern Asia. In particular, fifteen of these species grow in China, 
of which 10 are endemic [2]. 
 
The Amaryllidaceae alkaloids represent a large and still expanding 
group of isoquinoline alkaloids, usually classified into nine skeleton 
types whose representative compounds are: norbelladine, lycorine, 
homolycorine, crinine, haemanthamine, narciclasine, tazettine, 
montanine and galanthamine. Biogenetically, these structures are 
the result of an intramolecular oxidative coupling of the key 
intermediate O-methylnorbelladine, derived from the amino acids  
L-phenylalanine and L-tyrosine. Ortho-para´ phenol oxidative 
coupling of O-methylnorbelladine results in the formation of a 
lycorine-type skeleton, from which homolycorine-type alkaloids are 
derived. The galanthamine-type skeleton is the only one originating 
from para-ortho´ phenol oxidative coupling; while para-para´ 
coupling leads to the formation of crinine, haemanthamine, 
tazettine, narciclasine and montanine structures (Figure 1) [3]. 
 
To date, almost 500 structurally diverse alkaloids have been isolated 
from plants of this family, showing a broad range of biological 
effects, including acetylcholinesterase (AChE)-inhibitory, 
antitumor, antibacterial, antifungal, antiviral and antimalarial 
activities [4]. Lycorine is one of the most frequently occurring 
alkaloids in Amaryllidaceae species and has been found in all 
Lycoris species. It has been reported as a potent inhibitor of 
ascorbic acid synthesis, cell growth and division, and organogenesis 
in higher plants, algae and yeasts, inhibiting the cell cycle during 
the interphase [3]. In addition, recent studies have reported potential 
antinociceptive, anti-inflammatory, hepatoprotective and 
hypotensive activities [5,6]. In terms of bioactivity, the most 
prominent alkaloid of the group is galanthamine, a long-acting, 
selective, reversible and competitive inhibitor of AChE, the enzyme 
responsible for the degradation of acetylcholine at the 
neuromuscular junction in peripheral and central cholinergic 
synapses. AChE inhibition is the current strategy of choice for the 
treatment of mild and moderate stages of Alzheimer´s disease. 
Besides its good inhibitory activity, a dual mechanism of action as 
an allosteric modulator of the neuronal nicotinic receptor for 
acetylcholine has been proposed for galanthamine, which also has 
the ability to cross the blood-brain barrier and act within the central 
nervous system [1]. As a result, its use was approved by the FDA in 
2001, and galanthamine is currently marketed as a hydrobromide 
salt under the name of Razadine® (formerly Reminyl®)[7]. Finally, 
among other notable structures previously reported in the Lycoris 
genus are tazettine and montanine. The former has also shown 
AChE-inhibitory activity [8, 9], but is considered to be an isolation 
artifact of the chemically labile pretazettine [10]. Montanine, a 
widespread alkaloid in the genus, has psychopharmacological 
activities including anxiolytic, antidepressive and anticonvulsive, as 
well as antiproliferative, antiinflammatory, antioxidant, 
antimicrobial, and AChE-inhibitory effects [11-14]. 
 
The extracts obtained from Amaryllidaceae plants usually show 
complex alkaloid profiles. Traditionally, isolation and identification 
of alkaloids has been achieved through a combination of 
chromatography, and IR, UV, NMR and CD techniques, which can 
be time-consuming and laborious. Phytochemical study of the genus 
Lycoris began at the end of the 19th century. The first study was 
carried out with L. radiata, which yielded the alkaloids lycorine and 
sekisanine (tazettine) [15]. In the 1930s, Kondo et al. initiated a 
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series of in-depth studies on Lycoris alkaloids, resulting in the 
elucidation of the structures of lycorine, tazettine, lycoramine and 
homolycorine [16-19]. Galanthamine was first found in Lycoris 
species in 1957 [20]. In 1959 two new phenolic alkaloids 
(norpluviine and 8-O-demethylhomolycorine) were isolated from L. 
radiata [21]. From the 1960s to the 1980s, exhaustive research 
work led to the first isolation of sanguinine from L. sanguinea, as 
well as O-demethyllycoramine from L. radiata; at the same time, 
other species such as L. squamigera, L. guangxiensis and L. 
chinensis were studied [22-27]. In the 1990s, Kihara et al. isolated a 
new alkaloid from flowers of L. incarnata named incartine, which 
has been proposed as a biosynthetic intermediate in the conversion 
of galanthine to narcissidine [28]. Two new alkaloids, 
norsanguinine and norbutsanguinine, were isolated and 
characterized from the bulbs of L. sanguinea, in addition to five 
known Amaryllidaceae alkaloids [29]. During the first decade of the 
current century, the continued investigation of Lycoris plants 
yielded further novel structures. Reported in L. radiata bulbs, 
lycosinine A and lycosinine B were classified as a new structural 
group (galanthindole-type), in addition to the unusual lycorine-type 
alkaloids, lycoranine A and lycoranine B, all of them completely 
characterized by spectroscopic methods [30, 31]. Moreover, a new 
montanine-type alkaloid named squamigine, together with 2R-
hydroxy-N,O-dimethylnorbelladine and 3-O-ethyltazettinol, were 
isolated from the bulbs of L. squamigera and L. aurea [32, 33]. 
Recent studies with bulbs of L. radiata resulted in the isolation of 
5,6-dehydrodihydrolycorine, 6β-acetoxycrinamine, 8-O-acetylho-
molycorine-N-oxide, 5,6-dehydrolycorine, 3α,6β-diacetylbulbis-
permine, 3α-hydroxy-6β-acetylbulbispermine, 8,9-methylene-
dioxylhomolycorine-N-oxide, 5,6-dihydro-5-methyl-2-hydroxyphe-
nanthridine, and 2α-methoxy-6-O-ethyloduline [34-36]. 
 
To summarize, fifteen species of Lycoris, L. albiflora, L. 
anhuiensis, L. aurea, L. chinensis, L. guangxiensis, L. haywardii, L. 
houdyshelii, L. incarnata, L. longituba, L. radiata, L. rosea, L. 
sanguinea, L. sprengeri, L. squamigera and L. straminea have been 
phytochemically studied to date, and around one hundred alkaloids 
of mainly 8 structural types have been found and classified, with 
lycorine- and galanthamine-type alkaloids predominating in all the 
species (Table 1). 
 
The aim of the present work was to analyze the alkaloid content of 
9 Lycoris species collected in China, using a simple and rapid 
methodology that combines the advantages of gas chromatography-
mass spectrometry (GC-MS) for alkaloid profiling and direct 
quantification from dry plant material. GC-MS is a proven useful, 
rapid and specific method with good sensitivity for the investigation 
and identification of complex alkaloid mixtures of different groups 
from various plants, requiring a very low quantity of plant material 
and no derivatization step [37, 38]. To our knowledge, there are 
only two reports in the literature about the use of this method for the 
identification of alkaloids in Lycoris species (L. radiata and L. 
aurea) [39, 40]. In the current work, the alkaloid profiles of L. 
albiflora, L. aurea, L. chinensis, L. haywardii, L. incarnata, L. 
longituba, L. radiata, L. sprengeri, L. squamigera and the variety L. 
radiata var. pumila, all from China, were evaluated and quantified 
by GC-MS. The aim was to contribute to a better knowledge of the 
variability and quantification of Lycoris alkaloids. 
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Figure 1: Biosynthetic pathway of Lycoris alkaloids with representative compounds. 
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Table 1: Different types of alkaloids in Lycoris species. 
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Narciclasine + + + + + + + 
Tazettine + + + + + 
Montanine + + + + 
Galanthamine + + + + + + + + + + + + + + + + 
Other + + + + 
 
GC-MS analysis of the bulbs of different species of Lycoris resulted 
in the identification of 31 alkaloids, the majority of them belonging 
to the lycorine, homolycorine, haemanthamine, narciclasine, 
tazettine, montanine and galanthamine types, together with one 
unusual alkaloid known as cherylline. In general, the results 
coincided with previously reported alkaloids found in the genus, 
including lycorine and galanthamine. The alkaloid profile of the 
extracts of all the studied species was dominated by alkaloids 
arising from ortho-para´ (lycorine-type) and para-ortho´ 
(galanthamine-type) oxidative coupling of O-methylnorbelladine 
(Table 2). The number of alkaloids detected varied among extracts, 
from 10 in L. incarnata and L. radiata var. pumila to 20 in L. 
longituba. 
 
In all the species, lycorine- and galanthamine-type alkaloids were 
predominant. L. longituba and L. sprengeri showed the highest 
content of lycorine-type compounds, with values above 2.5 mg 
GAL/g DW. The maximum level of galanthamine-type alkaloids 
was  detected  in  L. longituba  bulbs (4.75 mg  GAL/g DW),  while  
 
Table 2: Alkaloid profiles of studied species. Values are expressed as μg GAL/g DW. 
 
Alkaloids M+ 
Base 
Peak RI L.
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Lycorine-type 863.2 1445.9 1113.1 1280.1 1291.7 2572.4 2037.9 976.4 2514.3 1912.2 
Lycorine 287 226 2766.1 370.7 502.8 360.8 349.7 337.6 656.9 923.8 298.7 687.4 257.1 
Pseudolycorine 289 228 2837.2 - - - - - 224.8 - - - - 
Galanthine 317 242 2703.4 trace 222.0 trace 228.0 239.8 - - - 337.4 467.5 
Pluviine 287 242 2571.7 - - - trace - 237.3 - 223.1 - trace 
Norpluviine 273 228 2602.2 trace - - - - - - - trace - 
Caranine 271 226 2537.4 245.4 248.5 264.3 236.3 237.7 260.1 299.3 trace 267.1 trace 
Methylpseudolycorine 303 242 2792.3 - - - - - 490.8 - - - 233.1 
Incartine 333 332 2457.8 trace trace trace trace 224.4 - - - 446.9 265.1 
2-Dehydroxylycorine 271 250 2551.3 - trace - - - 222.2 226.2 - 224.3 - 
Galanthine derivative* 315 240 2782.1 - trace trace trace - - - - trace 240.5 
Anhydrolycorine 251 250 2516.2 trace 222.0 228.0 221.3 trace 226.7 283.8 222.7 227.2 216.1 
11,12-Dehydroanhydrolycorine 249 248 2622.1 247.1 250.7 259.9 244.7 252.2 253.7 304.7 231.9 324.0 232.9 
Assoanine 267 266 2581.4 - - - - - trace - - - - 
Homolycorine-type - - - 550.5 - - 1408.8 534.2 - -
Homolycorine 315 109 2765.0 - - - 238.0 - - 256.8 245.7 - - 
8-O-Demethylhomolycorine 301 109 2822.0 - - - 312.5 - - 659.3 288.4 - - 
Hippeastrine 315 125 2903.4 - - - - - - 266.0 - - - 
O-Methyllycorenine 331 109 2487.9 - - - - - - 226.7 - - - 
Haemanthamine-type - 251.5 224.3 - trace - trace - 286.2 trace
Haemanthamine 301 272 2644.3 - 251.5 224.3 - trace - trace - 286.2 - 
Haemanthidine 317 317 2731.0 - - - - - - - - - trace 
Narciclasine-type - - - - - trace - -  trace -
Trisphaeridine 233 233 1866.0 - - - - - trace - - trace - 
Tazettine-type 221.1 238.3 368.5 275.7 - 863.3 692.1 226.4 331.9 300.8
Tazettine 331 247 2655.0 221.1 238.3 368.5 275.7 - 863.3 692.1 226.4 331.9 300.8 
Deoxytazettine 315 231 2546.6 - - - - - trace trace - - - 
Montanine-type 260.3 314.9 353.8 - - 831.3       - -  - 327.0
Montanine 301 301 2637.3 260.3 314.9 353.8 - - 607.2 - - - 327.0 
Pancratinine C 287 176 2600.2 - - - - - 224.1 - - - - 
Galanthamine-type 721.6 1455.6 1786.1 895.5 722.4 4754.3 2386.5 411.7 2425.2 1804.0
Galanthamine 287 286 2403.7 trace 674.1 618.0 227.1 227.4 836.0 425.0 trace  289.9 501.1 
Sanguinine 273 273 2427.6 - 550.9 380.0 - - 241.5 - - - - 
Lycoramine 289 288 2430.3 458.5 230.6 538.0 668.4 264.3 1808.6 1694.7 411.7 1870.0 1046.4 
O-Demethyllycoramine 274 275 2459.7 - - - - - 344.9 - - - - 
Norlycoramine 274 275 2471.7 263.1 - 249.4 - 230.7 1523.3 266.8 - 265.4 256.5 
Narwedine 285 284 2485.3 trace - - - - trace - - - trace 
Other-type - - - - - - - - - -
Cherylline 285 242 2574.0 - - trace - - - - - - - 
Total 2066.2 3706.2 3845.8 3001.8 2014.1 9021.3 6525.3 2148.6 5557.6 4343.9 
*Although not reported in the literature, the MS of this compound indicates a structure derived from galanthine. 
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Figure 2: Alkaloid and alkaloid-type predominance in extracts of the genus Lycoris. 
 
the lowest level was found in the bulbs of L. radiata var. pumila 
(0.4 mg GAL/g DW). Tazettine-type alkaloids were present in all 
the species, with the exception of L. incarnata, while the montanine 
type was not detected in five of the ten extracts analyzed. 
Homolycorine-type alkaloids were only found in L. radiata, L. 
radiata var. pumila and L. haywardii. Narciclasine-type alkaloids 
were present as mere traces in L. longituba and L. sprengeri. 
Although in low quantities (values less than 0.29 mg GAL/g DW), 
the haemanthamine type was detected in five species, L. aurea, L. 
chinensis, L. radiata, L. sprengeri and L. squamigera (Table 2; 
Figure 2). 
 
In a more detailed examination of the alkaloid profiles, L. albiflora 
showed the presence of lycorine-, tazettine-, montanine- and 
galanthamine-type alkaloids, while those with homolycorine-, 
haemanthamine- and narciclasine-type skeletons were not detected. 
The alkaloid profile of L. aurea and L. squamigera was similar, 
with lycorine, haemanthamine, tazettine, montanine, and 
galanthamine types found in both species, but not narciclasine-type 
nor homolycorine-type alkaloids. In L. chinensis galanthamine-type 
(1786.1 μg GAL/g DW) and lycorine-type (1113.1 μg GAL/g DW) 
alkaloids predominated, with a relatively low amount of tazettine 
(368.5 μg GAL/g DW), only traces of the haemanthamine type, and 
no homolycorine-type alkaloids detected. Lycorine-, homolycorine-, 
tazettine- and galanthamine-type alkaloids were found in L. 
haywardii. The only species in which tazettine was not detected was 
L. incarnata, which showed mainly lycorine- and galanthamine-
type, as well as traces of haemanthamine-type alkaloids. It should 
be noted that the total alkaloid content of L. incarnata was the 
lowest of all the species studied (2014.1 μg GAL/g DW). On the 
other hand, the species with the highest total content of alkaloids 
was L. longituba, which showed the maximum values of 
galanthamine, lycorine, montanine and tazettine types. In L. radiata 
and its variety, L. radiata var. pumila, the most important feature 
was the noticeable abundance of homolycorine-type compounds. 
While both showed similar alkaloid profiles, containing lycorine, 
homolycorine, tazettine and galanthamine types, the quantity of 
each type was far higher in L. radiata than the variety. As shown in 
Table 2, lycorine, haemanthamine, narciclasine, tazettine and 
galanthamine types occurred in bulbs of L. sprengeri, but 
homolycorine and montanine skeletal types were not detected. 
 
Regarding specific alkaloids, the extracts contained mainly 
lycorine, tazettine, galanthamine and lycoramine. Lycorine was the 
predominant alkaloid of its series (about 30%) in all species. The 
highest lycorine-containing species was L. radiata, which yielded 
almost 1 mg GAL/g DW. L. longituba and L. sprengeri also 
contained a large amount lycorine (656.9 μg GAL/g DW and 687.4 
μg GAL/g DW, respectively). Almost the only tazettine-type 
alkaloid found was tazzetine, with the highest abundance in L. 
longituba (863.3 μg GAL/g DW). The other predominant alkaloids 
detected were galanthamine and lycoramine, both of them classified 
in the same group due to structural similarity, the only difference 
being an extra double bond at position 4-4a in galanthamine. The 
quantity of galanthamine was quite considerable in L. aurea, L. 
chinensis, L. radiata and L. squamigera, but particularly high in L. 
longituba (836.0 μg GAL/g DW). L. aurea and L. chinensis 
contained more galanthamine than lycoramine, which was the 
reverse in the other species. L. longituba, L. radiata, L. sprengeri 
and L. squamigera showed the highest amounts of lycoramine. 
 
Figure 2 shows the alkaloid profile of each extract as a bar graph. 
The results are grouped into 3 main bars: two of them comprise 
lycorine- and galanthamine-type alkaloids, colored blue and red, 
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respectively, to highlight their predominance, whereas the third one 
represents all the remaining skeleton types (including tazettine-, 
homolycorine-, haemanthamine- and montanine-). The lycorine, 
galanthamine and lycoramine alkaloids are represented by different 
shades of red or blue, and tazettine is in green, given that these are 
the most frequently found structures. 
 
The analysis of bioactive Amaryllidaceae alkaloid profiles in 9 
species and one variety of Lycoris by GC-MS revealed some 
similarities and differences. This kind of analysis could be useful in 
guiding the search for compounds with pharmacological activity. 
Among the species analyzed in the present work, L. longituba could 
be considered as a potential commercial source of bioactive 
alkaloids (such as galanthamine and lycorine) due to its high 
content in comparison with the other species. In particular, the 
galanthamine content is nearly two times the amount calculated for 
L. radiata, which is currently the main source for the production of 
this drug in China. Finally, the GC-MS technology here applied has 
demonstrated to be sufficiently sensitive for the detection of 
Amaryllidaceae alkaloids, allowing the application of quantitative 
methodologies to obtain valuable information in relatively short 
times. 
 
Experimental 
 
Plant material: Bulbs of the genus Lycoris were collected from 
Nanjing Botanical Garden (Mem. Sun Yat-Sen) in China (2011-
2014) and identified by Professor Gan Yao (Institute of Botany, 
Jiangsu Province and Chinese Academy of Sciences). Voucher 
specimens of L. albiflora (0653963), L. aurea (0653958), L. 
chinensis (0653960), L. haywardii (0653964), L. incarnata 
(0653959), L. longituba (0653969), L. radiata (0653965), L. 
sprengeri (0653967), L. squamigera (0653962) and L. radiata var. 
pumila (0653966) have been deposited in the Herbarium of the 
Institute of Botany, Jiangsu Province and Chinese Academy of 
Sciences. 
 
Chemicals: Methanol, CHCl3 and NH4OH (25%) were purchased 
from SDS (Val de Reuil, France), and H2SO4 (96%) from Carlo-
Erba (Rodano, Italy). Codeine (purity ≥ 99%), used as an internal 
standard, was purchased from Sigma Aldrich (St. Louis, MO, 
USA). 
 
Alkaloid extraction: Fifty mg of dried and powdered bulbs of each 
sample was macerated in 1 mL of methanol at pH 8 for 2 h, together 
with codeine (0.05 mg) as the internal standard. During this time, 
the samples were submitted to 15 min in an ultrasonic bath every  
30 min. The extract was acidified with 500 μL H2SO4 (2%) and the 
neutral compounds were removed with CHCl3 (2 x 500 μL). The 
polar fraction was then basified with 200 μL NH4OH (25%), and the 
alkaloids extracted with CHCl3 (3 x 500 μL). 
 
GC-MS analysis of alkaloid extracts: Dried alkaloid extracts were 
re-dissolved in 100 μL of CHCl3 and directly injected into the GC-
MS apparatus (Hewlett Packard 6890 coupled with MSD5975; 
Hewlett Packard, Palo Alto, CA, USA) operating in EI mode at 
70eV. An HP-5 MS column (30 m x 0.25 mm i.d., film thickness 
0.25 μm) was used. The temperature gradient performed was the 
following: 100-180ºC at 15ºC/min, 180-300ºC at 5ºC/min, 10 min 
hold at 300ºC, and 2 min at 100ºC. The injector temperature was 
250ºC and the flow-rate of carrier gas (helium) was 1 mL/min. A 
split ratio of 1:5 was applied. 
 
Galanthamine quantification: A calibration curve was constructed 
for 10 dilutions of galanthamine (5, 10, 25, 50, 100, 200, 400, 500, 
700, and 900 μg/mL). The same amount of codeine (0.05 mg) was 
added to each solution as an internal standard. The peak areas were 
manually obtained considering selected ions for each compound 
(usually the base peak of their MS, i.e. m/z at 286 for galanthamine, 
at 299 for codeine). The ratio between the values obtained for 
galanthamine and codeine in each solution was plotted against the 
corresponding concentration of galanthamine to obtain the 
calibration curve and its equation (y = 57.324x + 10.73; R2 = 
0.9981). 
 
GC-MS identification of alkaloids and determination of alkaloid 
profile: The alkaloids were identified by comparing their GC-MS 
spectra and Kovats Retention Index (RI) with those of authentic 
Amaryllidaceae alkaloids previously isolated and identified by 
spectrometric methods (NMR, UV, CD, MS), by the NIST 05 
Database or by literature data. RI values of compounds were 
measured with a standard n-hydrocarbon mixture (C9-C36) using 
AMDIS 2.64 software.  
 
Alkaloids were quantified considering the area of peaks in each 
chromatogram. All data were standardized to the area of the internal 
standard (codeine) and the equation obtained for the calibration 
curve of galanthamine was used to calculate the quantities 
expressed as μg GAL, which was finally related to the amount of 
dried plant material (g DW). It is important to remember that as the 
peak area does not only depend on the corresponding alkaloid 
concentration but also on the intensity of the mass spectral 
fragmentation, this was not an absolute quantification. However, the 
methodology is considered suitable for comparing the amount of 
specific alkaloids between samples [38]. 
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Abstract 
 
A new phytochemical study of the indigenous Brazilian species Hippeastrum papilio is 
reported herein. Three novel Amaryllidaceae alkaloids were isolated, including 
hippapiline (1), papiline (2) and 3-O-(3’-hydroxybutanoyl)haemanthamine (3). Their 
structures were determined by physical and spectroscopic methods. In addition, the 
known alkaloids haemanthamine (4), galanthamine (5), narwedine (6), 
11-hydroxygalanthamine (7), apogalanthamine (8) and 9-O-demethyllycosinine B (9) 
were identified. The unusual cis-B/C ring fusion for the new homolycorine 
representative hippapiline was ratified by NMR and CD spectroscopy. 
 
Keywords 
Alkaloid; Amaryllidaceae; CD; Hippeastrum papilio; homolycorine-type. 
Introduction 
The plant family Amaryllidaceae comprises around 1600 species in 73 genera which are 
distributed through the tropics and warm, temperate regions of the globe [1,2]. These 
perennial, bulbous geophytes belong to one of the twenty most significant 
alkaloid-producing plant families [1,2]. A striking feature of the Amaryllidaceae is the 
presence of an exclusive group of isoquinoline alkaloids, which are responsible for a 
wide-range of biological activities [3]. 
Structurally, these alkaloids have been grouped into nine skeletal-types formed via 
specific oxidative phenolic couplings from the common amino acid-derived biogenetic 
precursor norbelladine [3]. The homolycorine-type skeleton is characterized by a 
cis-B/C ring fusion in which H-1 and H-10b are both -oriented. The correct 
stereochemical characterization of Amaryllidaceae alkaloids thus allows for a better 
understanding of the biosynthetic pathway diagnostic for a particular skeleton. 
Over the past two decades gas chromatography-mass spectrometry (GC-MS) has been 
applied successfully in the analysis of Amaryllidaceae alkaloids [4]. A preliminary study 
of H. papilio via GC-MS indicated the presence of several unknown structures with MS 
fragmentation patterns diagnostic of Amaryllidaceae alkaloids [5]. A larger collection of 
H. papilio bulbs was here subjected to a comprehensive phytochemical investigation 
leading to the identification of hippapiline (1), papiline (2) and 
3-O-(3’-hydroxybutanoyl)haemanthamine (3) as the novel constituents, in addition to six 
other well-known Amaryllidaceae alkaloids. The -orientation for both H-1 and H-10b 
in compound 1, uncovered by rigorous spectroscopic analysis, is indicative of an unsual 
cis-B/C ring fusion previously not seen for homolycorine-type alkaloids. 
 
Results and Discussion 
GC-MS analysis (Table 1) revealed that galanthamine (5) was the main constituent in the 
n-hexane extract (86.3 %), also featuring as one of the major components in the EtOAc 
extract (39.0 %) together with haemanthamine (4) (26.9 %). These results are in 
agreement with a previous study of H. papilio in which these same alkaloids were 
isolated and identified by NMR and CD spectroscopic techniques [5]. However, 
apogalanthamine (8) and 9-O-demethyllycosinine B (9) are now reported in this species 
for the first time (Fig. 1), whilst narwedine (6) as in the previous instance [5] was here 
also detectable only in minimal quantity. 
Compound 1 had the HRESIMS [M+H]
+
 signal at m/z 318.1706 (calc. for C18H24NO4: 
318.1700) and a base peak at m/z 109 [C7H11N]
+
 in its GC-MS spectrum, arsing from a 
retro-Diels-Alder reaction, which is characteristic for a hexahydroindole ring in the 
homolycorine series lacking substitution at C-2 [4]. Although the basic structure of a 
homolycorine-type alkaloid for compound 1 was readily established by NMR evidence, 
the unusual chemical shift and splitting pattern were ratified via comparisons with the 
data for 8-O-demethyl-6-O-methyllycorenine found in the literature [6]. The 
1
H NMR 
data of 1 was atypical in the following three ways: (i) two para-oriented aromatic 
protons attributed to H-7 and H-10, the latter of which was assignable to the highly 
deshielded resonance singlet at δ 8.41 (confirmed by NOESY correlation with the 
N-methyl group); (ii) an uncommon coupling constant (J = 4.5 Hz) observed between 
H-1 and H-10b and the absence of the distinctive trans-diaxial coupling (J ~ 10 Hz) 
between H-10b and H-4a; (iii) a NOESY correlation between H-4a, H-10b and H-1. This 
data was thus pivotal in assigning both H-1 and H-10b to the β-face. CD analysis 
showed that there were positive, negative and positive Cotton effects at 225, 250 and 
290 nm, respectively, which are antipodal to those observed for typically cis-B/C 
ring-fused homolycorine-type alkaloids [7]. Taken together, the CD and NMR data 
(Table 2) are in agreement with this novel stereochemical arrangement involving cis-B/C 
ring fusion in 1, for which the name hippapiline is proposed. 
The HRESIMS of 2 suggested a molecular formula C19H24NO5 for [M+H]
+
 with the 
parent ion at m/z 346.1643 (calcd. 346.1649). The EIMS showed a signal ion at m/z 286 
[M-59]
+
 diagnostic for the loss of an acetoxy group. Characteristic NMR signals 
included: (i) a singlet proton resonance at  9.91, indicative of an aldehyde functionality 
which appears in nonfused dihydroindole lycosinine derivatives [8,9], with the 
correspondent signal at δ 191.7 (d) in the 13C NMR; (ii) two para-orientated aromatic 
protons at δ 7.32 and 7.29, the more deshielded of which was assigned to H-7 due to its 
NOESY correlation with H-6; (iii) the acetoxy substituent was assigned to C-1 due to 
the strong deshielding of H-1 (δ 5.45), confirmed by HMBC; (iv) the magnitude of the 
coupling constant (J4a,10b = J1,10b = 4.5 Hz) together with the observed NOESY 
correlations were congruent with the syn-disposition for H-1, H-10b and H-4a. The IR 
spectrum of 1 displayed strong absorbances at 1738 and 1674 cm
-1
 for two C=O groups 
ascribed to the acetoxy and conjugated aldehyde moieties, respectively. All 
spectroscopic data together were in agreement with a new compound bearing a nonfused 
hexahydroindole nucleus for which the name papiline has been proposed. The complete 
NMR data for compound 2 are listed in Table 3. 
The new alkaloid 3 exhibited a parent [M+H]
+ 
ion at m/z 374.1603 in its HRESIMS 
spectrum, suggesting the molecular formula C20H24NO6 (calcd. 374.1598). The EIMS 
fragmentation showed a loss of 87 mass units (m/z 287, [M-87]
+
) characteristic of a 
3’-hydroxybutanoyl substituent of unknown absolute configuration [10], which was 
confirmed by corresponding resonances in the 
1
H and 
13
C NMR spectra (Table 4). The 
remaining NMR data were very similar to those of haemanthamine [3]. Furthermore, a 
loss of 29 mass units from the molecular ion observed by GC-MS (m/z 344, [M-29]
+
) is 
typical of haemanthamine derivatives bearing a hydroxyl group at C-11 [4]. The 
magnitude of the coupling constant between H-2 and H-3 (J2,3 = 5.1 Hz) suggested a 
trans relationship between the substituent at C-3 and the 5,10b-ethano bridge [3]. The 
CD spectrum confirmed 3 as a haemanthamine-type derivative, showing positive and 
negative Cotton effects at 275 nm and 249 nm, respectively. A full set of NMR data for 
3-O-(3’-hydroxybutanoyl)haemanthamine (3) is shown in Table 4. 
In summary, a new phytochemical investigation of H. papilio led to the identification of 
nine alkaloids, among which hippapiline, papiline and 3-O-(3’-hydroxybutanoyl)hae- 
manthamine are reported for the first time. The unusual -orientation for both H-1 and 
H-10b in the homolycorine-type skeleton of hippapiline was confirmed by NMR and CD 
spectroscopy. This finding provides new insight on the biosynthesis of homolycorine 
compounds in particular and Amaryllidaceae alkaloids in general. 
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Experimental part 
General 
NMR spectra were recorded on a Varian VNMRS 500 MHz (Palo Alto, CA, USA), 
using CDCl3 as solvent and TMS as the internal standard. Chemical shifts are reported in 
δ units (ppm) and coupling constants (J) in Hz. EIMS were obtained on an Agilent 6890 
+ MSD 5975 GC-MS spectrometer (Agilent Technologies, Santa Clara, CA, USA) 
operating in EI mode at 70 eV. An HP-5 MS column (30 m × 0.25 mm × 0.25 μm) was 
used. The temperature program was as follows: 100-180 ºC at 15 ºC min
-1
, 1 min hold at 
180 ºC, 180-300 ºC at 5 ºC min
-1
 and 1 min hold at 300 ºC. The injector temperature was 
280 ºC. The flow rate of carrier gas (Helium) was 0.8 ml min
-1
. The 1:20, 1:10 and 1:5 
split ratios were applied, depending on sample concentration. GC-MS results were 
analyzed using AMDIS 2.64 software (NIST). HRESIMS data were obtained on an 
LC/MSD-TOF spectrometer (Agilent Technologies, Santa Clara, CA, USA) through 
direct injection of pure compounds dissolved in H2O/MeCN (1:1). Optical rotations 
were measured in CHCl3 at 22 ºC using a Perkin-Elmer 241 polarimeter (Waltham, MA, 
USA). A Jasco-J-810 Spectrophotometer (Easton, MD, USA) was used to obtain CD 
spectra, all recorded in MeOH. UV spectra were obtained on a Dinko UV2310 
instrument (Barcelona, Spain). Silica gel (Kieselgel – mesh 0.15/0.30, Val-de-Reuil, 
France) was used for all vacuum liquid chromatography (VLC) procedures. For thin 
layer chromatography (TLC), silica gel F254 was used as the stationary phase with plate 
dimensions of 20 cm x 20 cm x 0.20 mm for analytical TLC, and 20 cm x 20 cm x 0.25 
mm for semi-preparative TLC (SPTLC) (Val-de-Reuil, France). 
Plant material  
Hippeastrum papilio was collected during the flowering period (May, 2012) in the south 
of Brazil (Caxias do Sul - RS). A voucher specimen (ICN-149428) was authenticated by 
Dr. Julie Dutilh (University of Campinas) and deposited in the Institute of Botany, 
Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre. 
Identification of alkaloids by GC-MS 
The alkaloids were identiﬁed by comparing their GC-MS spectra and Kovats Retention 
Index (RI) with those of authentic Amaryllidaceae alkaloids previously isolated and 
identiﬁed by spectrometric methods (NMR, UV, CD, MS) [5,8,11], the NIST 05 
Database or literature data. RI values of compounds were measured with a standard 
n-hydrocarbon mixture (C9-C36) using AMDIS 2.64 software. The proportion of each 
individual compound in the alkaloid fractions analyzed by GC-MS (Table 1) is 
expressed as a percentage of the total alkaloids (TIC – total ion current). The area of the 
GC-MS peaks depends on the concentration of the corresponding compound and the 
intensity of their mass spectral fragmentation. Although data given in Table 1 do not 
express a real quantification, they can be used for a relative comparison of the amount of 
the respective alkaloids present in Hippeastrum papilio. 
Extraction and isolation of alkaloids 
Dried bulbs (220 g) of H. papilio were crushed and extracted with methanol at room 
temperature as following: twice using 900 ml for 48 h and twice with 400 ml for 72 h. 
The extract was evaporated under reduced pressure to yield 55 g. This crude extract was 
acidified to pH 2 with H2SO4 (2% v/v), and extracted with Et2O (170 ml × 6) to remove 
neutral material. The aqueous solution was basified with 25% ammonia up to pH 10, and 
extracted with n-hexane (170 ml × 13) to give extract A (1.3 g). Another extraction using 
EtOAc (170 ml × 20) gave extract B (1.5 g). Extract A yielded galanthamine (5, 130.71 
mg) and haemanthamine (4, 49.5 mg) by SPTLC (CH2Cl2/Acetone 10:7; in NH3 
atmosphere). Extract B was subjected to vacuum liquid chromatography (VLC) using a 
silica gel (7 g) column with a diameter of 2.5 cm and a height of 4.5 cm, eluting with 
n-hexane gradually enriched with EtOAc (0→100%), and then with EtOAc gradually 
enriched with MeOH (0→20%). Fractions of 40 ml were collected (340 in total) 
monitored by TLC (Dragendorff s´ reagent, UV 254 nm) and combined according to 
their profiles. From fractions 11-20, hippapiline (1, 22.2 mg) was directly obtained as a 
crystal. Fractions 90-160 were subjected to SPTLC (n-hexane/EtOAc 1:2; and a second 
time n-hexane/EtOAc/MeOH 5:10:7; in NH3 atmosphere) to give papiline (2, 26.7 mg). 
9-O-demethylycosinine B (9, 7.4 mg) was isolated from fractions 61-85 by SPTLC 
(n-hexane/EtOAc 4:1; in NH3 atmosphere), while 11β-hydroxygalanthamine (7, 1.2 mg) 
was obtained via SPTLC (n-hexane/EtOAc/MeOH, 10:3:3; in NH3 atmosphere) from 
fractions 206-210. A third VLC column (1.5 × 4.5 cm) was performed with fractions 
161-205 yielding 176 fractions (10 ml each), of which fractions 69-92 were further 
purified by SPTLC (n-hexane/EtOAc/MeOH, 2:4:1; in NH3 atmosphere) to furnish 
3-O-(3’-hydroxybutanoyl)haemanthamine (3, 12.5 mg). In addition, a small amount of 
narwedine (6) and apogalanthamine (8), which were identified by comparing their 
GC-EI-MS spectra and Kovats retention indices (RI) with our own library database. All 
known alkaloids isolated were identified by comparing their physical and spectroscopic 
data with those of alkaloids previously isolated and characterized by our group [5,8,11]. 
 
Hippapiline (1): white crystals; [α]24D +33 (c 0.15, CHCl3); UV (MeOH) λmax (log ε) 
316 (2.90), 282 (3.30), 228 (3.64) nm;
 
CD (MeOH, 20ºC): ϵ227 +1330, ϵ247.5 −455, 
ϵ281.5 +89, ϵ305.5 −176; IR (CHCl3) νmax: 3380, 2924, 1733, 1509, 1449, 1275, 1130, 
1058, 1043, 960, 913, 880, 802, 758 cm
-1
; 
1
H NMR (CDCl3, 500 MHz) and 
13
C NMR 
(CDCl3, 125 MHz) are shown in Table 2; EIMS data are detailed in Table 1; HREIMS of 
[M+H]
+
 m/z 318.1706 (calcd. for C18H24NO4, 318.1700). 
Papiline (2): amorphous solid; [α]24D −29 (c 0.26, CHCl3); UV (MeOH) λmax (log ε) 318 
(3.27), 280 (3.48), 236 (3.76) nm; IR (CHCl3) νmax: 2925, 2854, 1738, 1674, 1595, 1557, 
1514, 1455, 1378, 1260, 1148, 1099, 1020, 800 cm
-1
; for 
1
H NMR (CDCl3, 500 MHz) 
and 
13
C NMR (CDCl3, 125 MHz) see Table 3; EIMS data are shown in Table 1; 
HREIMS of [M+H]
+ 
m/z 346.1643 (calcd. for C19H24NO5, 346.1649). 
3-O-(3’-Hydroxybutanoyl)haemanthamine (3): amorphous solid; [α]24D −13 (c 0.49, 
CHCl3); UV (MeOH): λmax (log ε) 292 (3.46), 238 (3.36) nm; CD (MeOH, 20ºC): ϵ249 
−2375, ϵ275 +1569; IR (CHCl3) νmax: 3377, 2925, 1727, 1504, 1484, 1376, 1295, 1239, 
1173, 1064, 1037, 988, 936, 853, 758 cm
-1
; 
1
H NMR (CDCl3, 500 MHz) and 
13
C NMR 
(CDCl3, 125 MHz) are shown in Table 4; EIMS data are detailed in Table 1; HREIMS of 
[M+H]
+
 m/z 374.1603 (calcd. for C20H24NO6, 374.1598). 
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Fig. 1: Alkaloids identified in Hippeastrum papilio. 
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Table 1: GC-MS analysis of the alkaloid content of Hippeastrum papilio. 
 
  Alkaloid RI %A a) %B b) M+ MS 
Apogalanthamine (8) 2253 --- 3.12 269(88) 268(32), 254(26), 226(61), 211(54), 194(32), 193(50), 166(29), 165(100), 152(30) 
Hippapiline (1) 2301 --- 1.68 317(-) 110(8), 109(100), 108(18), 107(2), 94(24), 81(2), 77(2), 42(2) 
Galanthamine (5) 2335 86.26 39.01 287(82) 288(14), 286(100), 270(13), 244(26), 230(13), 216(36), 174(30), 115(13) 
Narwedine (6) 2402 1.31 0.52 285(85) 286(15), 284(100), 242(22), 216(23), 214(10), 199(26), 185(13), 181(12), 178(15), 174(43), 161(11), 
153(13), 141(10), 128(22), 115(22), 77(13), 42(22) 
9-O-Demethyllycosinine B (9) 2499 0.24 5.72 283(100) 284(19), 256(11), 255(70), 254(72), 240(30), 239(13), 223(11), 222(33), 210(11), 194(17), 167(10), 44(16) 
11β-Hydroxygalanthamine (7) 2510 traces 7.02 303(21) 302(12), 231(21), 230(100), 213(28), 181(13), 174(13), 115(13), 44(13) 
Haemanthamine (4) 2556 1.92 26.87 301(12) 273(18), 272(100), 242(15), 240(16), 214(13), 212(14), 211(15), 181(26), 153(10), 128(12), 115(11) 
Papiline (2) 2565 1.08 10.98 345(-) 286(3), 177(3), 165(1), 122(1), 110(6), 109(100), 108(14), 96(1), 82(3), 81(2), 44(1), 43(3), 42(2) 
3-O-(3’-Hydroxybutanoyl)haemanthamine (3) 3030 --- 1.00 373(5) 345(21), 344(95), 270(24), 269(37), 268(25), 240(55), 226(20), 225(30), 224(25), 212(53), 211(27), 
210(16), 182(20), 181(100), 153(33), 128(16), 115(17), 45(21) 
a) % A: Alkaloid percentage in the total mixture of alkaloids extracted with n-hexane. b) % B: Alkaloid percentage in the total mixture of alkaloids extracted with EtOAc. All values are expressed as a relative percentage of TIC 
 
 
 
  
Table 2: NMR data (500 MHz for 
1
H- and 125 MHz for 
13
C-NMR, CDCl3) of compound 1. [] in ppm and [J] in Hz. 
 
Position H [δ] COSY NOESY   C [δ]      HMBC 
1 4.29 ddd (9.8, 6.8, 4.5) H-2α, H-2β, H-10b H-2a, H-2β, H-4a, H-10b 70.5 d   
2α 2.41-2.47 m H-1, H-2β, H-3, H-4a, H-11 H-1, H-2β, H-3, 6-OMe 28.9 t   
2β 2.25-2.29 m H-1, H-2α, H-3, H-4a, H-11 H-1, H-2α, H-3   
3 5.07 br s H-2α, H-2β, H-4a, H-11 H-2α, H-2β, H-11 115.2 d   
4    138.4s   
4a 2.94 br s H-2α, H-2β, H-3, H-10b; H-11 H-1, H-10b, H-12β, NMe 70.6 d   
6 5.44 s H-7 H-7, H-10b, 6-OMe 97.1 d  C-1, C-10a, 6-OMe 
6a    127.8 s   
7 6.88 s H-6 H-6 112.4 d  C-6, C-8, C-9, C-10a 
8    143.7 s   
9    145.9 s   
10 8.41 s H-10b 9-OMe, NMe 110.6 d  C-6a, C-8 
10a    126.7 s   
10b 3.32 t (4.5) H-1, H-4a, H-10 H-1, H-4a, H-6, NMe 35.4 d  C-1, C-4, C-4a, C-6a 
11 (2H) 2.28-2.36 m H-2α, H-2β, H-3, H-4a, H-12α, H-12β H-3, H-12α,,H-12β 28.6 t   
12α 3.21 ddd (8.7, 6.7, 2.0) H-11, H-12β H-11, H-12β, NMe 56.1 t  C-4,C-4a 
12β 2.18 dt (9.8, 8.6) H-11, H-12α H-4a, H-11, H-12α, NMe   
6-OMe 3.57 s  H-2, H-6 55.3 q  C-6 
9-OMe 3.80 s  H-10 55.7 q  C-9 
NMe 2.44 s  H-4a, H-10, H-10b, H-12α, H-12β 40.0 q  C-4a, C-12 
 
 
 
 
 
 
 
 
 
 
Table 3: NMR data (500 MHz for 
1
H- and 125 MHz for 
13
C-NMR, CDCl3) of compound 2. [ in ppm and [J] in Hz. 
 
Position H [δ] COSY NOESY  C [δ]  HMBC 
1 5.45 ddd (10.0, 5.0, 5.0) H-2α, H-2β, H-10b H-2β, H-4a, H-10b 70.9 d  C-10a, MeCO 
2α 2.00-2.06 m H-1, H-2β, H-3, H-4a, H-11 H-2β, H-3, H-10 27.9 t  MeCO 
2β 2.44 dddd (16.5, 5.5, 4.5, 2.5) H-1, H-2α, H-3, H-4a, H-11 H-1, H-2α, H-3   
3 5.54 m H-2α, H-2β, H-4a, H-11 H-2α, H-2β, H-11 116.1 d   
4    131.1 s   
4a 3.10 s H-2α, H-2β, H-3, H-10b, H-11 H-1, H-10b, H-12β, NMe 69.5 d   
6 9.91 s  H-7, H-10b 191.7.d   
6a    127.2 s   
7 7.32 s  H-6 116.2 d  C-8, C-9, C-10a 
8    144.6 s   
9    150.1 s   
10 7.29 s 9-OMe H-2α, H-11, 9-OMe 112.5 d  C-6a, C-8, C-9, C-10b 
10a    129.0 s   
10b 4.74 t (4.5) H-1, H-4a H-1, H-4a, H-6, NMe 35.3 d  C-1, C-4a, C-10 
11 (2H) 2.55 m H-2α, H-2β, H-3, H-4a, H-12α, H-12β H-3, H-10, H-12α,,H-12β 28.0 t   
12α 3.26 br s H-11, H-12β H-11, H-12β, NMe 56.3 t   
12β 2.33 q (9.0) H-11, H-12α H-4a, H-11, H-12α, NMe  NMe 
9-OMe 3.84 s H-10 H-10 55.8 q  C-9 
MeCO 1.90 s   21.2 q  MeCO 
MeCO    170.6 s   
NMe 2.20 s  H-4a, H-10b, H-12α, H-12β 40.9 q  C-4a, C-12 
 
Table 4: NMR data (500 MHz for 
1
H- and 125 MHz for 
13
C-NMR, CDCl3) of compound 3. [ in ppm and [J] in Hz. 
 
Position H [δ] COSY NOESY C [δ]  HMBC 
1 6.52 d (10.1) H-2 H-2, H-10 129.3 d  C-3, C-4a, C-10a, C-10b 
2 6.31 ddd (10.1, 5.1, 0.7) H-1, H-3 H-1, H-3 130.2 d  C-3, C-4, C-10b 
3 5.44 td (4.8, 1.7) H-2, H-4α, H-4β H-2, H-4α, H-4β 67.2 d  C-1, C-2, C-4a, C-1’ 
4α 2.37 td (14.0, 4.6) H-3, H-4β, H-4a H-3, H-4β, H-4a H-12exo 29.5 t 
 
 C-4a  
4β 1.91 dd (14.0, 4.6) H-3, H-4α, H-4a H-3, H-4α, H-4a   C-2, C-3, C-4a, C-10b 
4a 3.36 dd (13.5, 4.5) H-4α, H-4β H-4α, H-4β, H-6β 63.0 d  C-6, C-12, C-11 
6α 3.72 d (17.0) H-6β, H-7 H-6β, H-12endo, H-7 61.5 t 
 
 C-4a, C-6a, C-7, C-10a 
6β 4.35 d (17.0) H-6α, H-7 H-4a, H-6α, H-7  C-6a, C-7, C-8, C-10a, C-11, C-12 
6a    126.9 s   
7 6.51 s H-6α, H-6β H-6α, H-6β 107.1 d  C-6, C-9, C-10a 
8    146.6 s   
9    146.8 s   
10 6.84 s  H-1 103.4 d  C-6a, C-8, C-10b 
10a    134.8 s   
10b    50.2 s   
11 4.03 ddd (6.5, 3.5, 1.5) H-12exo, H-12endo H-12endo 80.3 d  C-4a 
12exo 3.27 dd (14.0, 3.0) H-11, H-12endo H-4α, H-12 endo 63.6 t 
 
 C-4a, C-6, C-11 
12endo 3.41 dd (14.0, 6.5) H-11, H-12exo H-6α, H-11, H-12 exo  C-6, C-4a, C-10b, C-11 
OCH2O 5.91 d (7.5)   101.1 t  C-8, C-9 
1’    172.4 s  C-2’ 
2’a 2.45 dd (16.5, 3.0) H-2’b, H-3’ H-2’b 43.0 t  C-1’, C-3’, C-4’ 
2’b 2.36 dd (16.5, 9.0) H-2’a, H-3’ H-2’a  C-1’, C-3’, C-4’ 
3’ 4.17 ddq (9.5, 6.3, 3.3) H-2’a, H-2’b, H-4’ H-4’ 64.4 d   
4’ 1.19 d (6.3) H-3’ H-3’ 22.6 q  C-2’, C-3’ 
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a b s t r a c t
An ongoing search for alkaloids in the Amaryllidaceae species using GC–MS resulted in the identiﬁcation
of two crinine-type alkaloids, aulicine (1) and 3-O-methyl-epimacowine, (2) from the indigenous Brazil-
ian species Hippeastrum aulicum and Hippeastrum calyptratum, respectively. In addition, two alkaloids,
11-oxohaemanthamine (3) and 7-methoxy-O-methyllycorenine (4) were both isolated from H. aulicum.
Furthermore, we provide here complete NMR spectroscopic data for the homolycorine analogues neri-
nine (5) and albomaculine (6). The absolute stereochemistry of the 5,10b-ethano bridge in the crinine
variants was determined by circular dichroism and X-ray crystallographic analysis, thus presenting the
ﬁrst direct evidence for the presence of crinine-type alkaloids in the genus Hippeastrum.
 2014 Elsevier Ltd. All rights reserved.
1. Introduction
GC–MS has proven to be a useful tool in the identiﬁcation and
quantiﬁcation of Amaryllidaceae alkaloids (Berkov et al., 2011;
Torras-Claveria et al., 2013). This spectroscopic technique has been
used with success to assist with the isolation of new or unusual
structures from alkaloid-rich extracts by comparing their compo-
nent electron impact-mass fragmentation spectra (EI-MS) with
those of known standards (Berkov et al., 2011; Torras-Claveria
et al., 2013). For example, candimine from H. morelianum Lem.
and 11b-hydroxygalanthamine from H. papilio (Ravenna) Van
Scheepen were both isolated based on prior GC–MS screening of
these endemic Brazilian species (de Andrade et al., 2012a).
Interestingly, both alkaloids have since exhibited promising anti-
Trichomonas vaginalis and acetylcholinesterase (AChE) inhibitory
activities (de Andrade et al., 2011; Giordani et al., 2010). Therefore,
a similar guided approach is attractive in that it circumvents the
need for time and labour-intensive chromatographic steps for
extracts and alkaloid fractions devoid of new bioactive compounds.
Since the 1970s, X-ray crystallographic and/or circular dichro-
ism (CD) analyses of 5,10b-ethanophenanthridine alkaloids from
Hippeastrum have indicated that they belong exclusively to the
haemanthamine series, which are enantiomeric to the crinine ser-
ies. Earlier, a few crinine-type alkaloids were detected in European
Hippeastrum cultivars (Boit and Döpke, 1960; Döpke, 1962), but
their absolute conﬁgurations have been questioned based on the
lack of any tangible evidence, such as CD and X-ray crystallogra-
phy. These two techniques have since become integral to the
unambiguous assignment of the orientation of the 5,10b-ethano
bridge in the crinine/haemanthamine series of alkaloids (Bastida
et al., 2006; De Angelis and Wildman, 1969; Wagner et al., 1996).
In the present study, the use of CD and X-ray crystallographic
techniques as well as NMR and GC–MS analysis resulted in the
identiﬁcation of the novel crinine-type alkaloids aulicine (1) and
3-O-methyl-epimacowine (2) (Fig. 1) along with two new alkaloids
[11-oxohaemanthamine (3) and 7-methoxy-O-methyllycorenine
(4)] from the Brazilian species Hippeastrum aulicum Herb. and Hip-
peastrum calyptratum Herb. Nineteen additional known alkaloids
were identiﬁed in the process, and a complete NMR data set for
nerinine (5) and albomaculine (6) is also reported herein. These
ﬁndings are signiﬁcant in that they represent the ﬁrst direct evi-
dence for the presence of crinine-type alkaloids in Hippeastrum.
2. Results and discussion
Of the twenty-three alkaloids identiﬁed in H. aulicum and H.
calyptratum, thirteen were common to both, while ﬁve were
http://dx.doi.org/10.1016/j.phytochem.2014.03.007
0031-9422/ 2014 Elsevier Ltd. All rights reserved.
⇑ Corresponding author. Tel.: +34 934020268; fax: +34 934029043.
E-mail address: jaumebastida@ub.edu (J. Bastida).
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unique to either species (Table 1). The major alkaloids detected in
H. aulicum were aulicine (1), lycorine (10) and haemanthamine
(15), while lycorine (10) was the main constituent present in H.
calyptratum. HRESIMS gave a mass of 320.1864 for alkaloid 1,
which is expected for the molecular formula C18H26NO4 and the
theoretical mass (320.1856) for the parent [M+H]+ ion. Its GC–MS
fragmentation pattern was similar to that of the 1,2-dihydroethan-
ophenantridines powellane and deacetylbowdensine (Dufﬁeld
et al., 1965). As expected, no oleﬁnic proton signals were observed
in the 1H-NMR spectrum of 1 and the only low-ﬁeld resonance sig-
nal was assignable to H-7 (d 6.10, s) due to HSQC correlation with
C-7 (d 101.0, d), spatial NOESY connectivity to the benzylic 2H-6
protons and HMBC contour correlation with C-6 (d 62.7, t). These
data indicated that aulicine (1) possessed a penta-substituted aro-
matic A-ring and a saturated C-ring moiety. In essence, its 1H-NMR
spectrum (Table 2) was similar to that of hippeastidine
(Kulhánková et al., 2013; Pacheco et al., 1978; Watson and Zabel,
1982). Although the basic crinane structure of hippeastidine is
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Fig. 1. Alkaloids identiﬁed in H. aulicum (a) and H. calyptratum (b).
Table 1
GC–MS data for H. aulicum and H. calyptratum alkaloids. Values are expressed as a relative percentage of TIC.
Alkaloid RI H. aulicuma (%) H. calyptratumb (%) M+ MS
IA IIA IC IIC
Ismine (21)* 2280 – trc – 0.45 257(35) 238(100), 211(6), 196(8), 168(6), 154(3), 106(4), 77(3)
Trisphaeridine (22)* 2282 tr 0.61 – tr 223(100) 222(38), 167(8), 165(9), 164(14), 138(20), 137(9), 111(13)
Galanthamine (13)* 2395 11.26 1.75 12.93 6.60 287(83) 286(100), 270(13), 244(24), 230(12), 216(33), 174(27), 115(12)
Vittatine (17)* 2472 – 0.34 – – 271(100) 228(25), 199(95), 187(85), 173(28), 128(32), 115(33), 56(22)
3-O-Methyl-epimacowine (2)* 2477 – – 14.68 13.45 287 (100) 272(39), 256(34), 217(71), 203(21), 174(18), 157(18), 128(14)
Narwedine (14)* 2483 0.98 – 0.72 tr 285(84) 284(100), 242(18), 216(20), 199(18), 174(31), 128(16), 115(16)
Galanthindol (23)* 2487 – – – 1.11 281(100) 280(7), 264(13), 263(17), 262(20), 252(15), 204(7), 1(14), 132(8)
Anhydrolycorine (12)** 2501 – 1.84 – 5.31 251(43) 250(100), 192(13), 191(11), 165(4), 164(3), 139(2), 124(7)
Nerinine (5)* 2509 2.38 5.75 0.36 0.91 347(<1) 222(1), 207(2), 179(1), 164(1), 110(8), 109(100), 108(18), 94(2)
8-O-Demethylmaritidine (16)* 2510 – 2.41 – tr 273(100) 256(22), 230(20), 201(83), 189(42), 174(22), 128(23), 115(24)
7-Methoxy-O-methyllycorenine (4)* 2538 1.60 – – – 361(<1) 330(8), 221(10), 191(2), 110(8), 109(100), 108(15), 94(2), 83(2)
11-Oxohaemanthamine (3)* 2585 1.50 tr – – 299(<1) 271(100), 270(37), 240(10), 238(10), 211(23), 181(77), 152(20)
Aulicine (1)* 2607 43.65 5.47 – – 319(100) 304(19), 288(37), 246(18), 233(73), 218(19), 206(26), 163(7)
Haemanthamine (15)* 2641 30.3 71.58 – – 301(14) 272(100), 257(10), 240(16), 181(21), 214(12), 211(14), 128(8)
Tazettine (19)/Pretazettine (20)d,* 2653 tr tr – 0.62 331(31) 316(15), 298(23), 247(100), 230(12), 201(15), 181(11), 152(7)
11-Hydroxyvittatine (18)* 2728 – – – 9.50 287(5) 258(100), 211(15), 186(20), 181(23), 153(13), 128(24), 115(23)
Lycorine (10)* 2746 – 9.26 0.89 41.89 287(31) 286(19), 268(24), 250(15), 227(79), 226(100), 211(7), 147(15)
Homolycorine (7)* 2767 2.43 – 3.21 – 315(<1) 206(<1), 178(2), 109(100), 150(1), 108(22), 94(3), 82(3)
Albomaculine (6)* 2815 7.16 – 66.41 13.39 345(<1) 221(1), 193(1), 165(1), 110(10), 109(100), 108(25), 94(2), 82(3)
Pseudolycorine (11)* 2823 – 0.64 – 4.02 289(23) 270(21), 252(12), 228(100), 214(10), 147(17), 111(18), 82(10)
2a-Methoxyhomolycorine (8)** 2870 – – – 0.64 345(<1) 206(<1), 178(2), 150(1), 139(100), 124(64), 96(5), 94(5), 81(3)
2a,7-Dimethoxyhomolycorine (9)* 2962 – – 0.80 1.88 375(<1) 236(<1), 139(100), 124(54), 221(2), 193(2), 96(3), 94(3), 81(2)
RI: Retention Index.
a Alkaloid percentage in the total mixture of alkaloids from H. aulicum.
b Alkaloid percentage in the total mixture of alkaloids from H. calyptratum.
c Traces <0.20 of TIC.
d Tazettine detection by GC–MS mean identiﬁcation of both alkaloids tazettine (19) and pretazettine (20) (de Andrade et al., 2012b).
* Alkaloids identiﬁed using an in-home MS database.
** Alkaloids identiﬁed using the NIST 05 database; recursive procedure, HR-MS and literature data.
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known with certainty, its absolute stereochemistry still remains
unresolved due to its missing CD and X-ray crystallographic data,
i.e., it is not clear from the literature whether the compound is of
the a- or b-crinane alkaloid series (Kulhánková et al., 2013;
Pacheco et al., 1978; Watson and Zabel, 1982).
A comparison of the 1H-NMR data of 1 with that of hippeasti-
dine revealed that the only striking differences pertained to the
splitting of the H-3 and H-4 protons, both of which are crucial to
the stereochemical relationship between the 3-methoxyl substitu-
ent and the 5,10b-ethano bridge. The resonance at d 1.21 ascribed
to H-4b was split into a quartet with an accompanying large cou-
pling constant (J = 12.4 Hz), indicative of two trans-diaxial cou-
plings (with H-3 and H-4a) and the geminal coupling with H-4a
(Table 2). Large coupling constants were also observed for H-2b.
Thus, the H-4b and H-2b splitting patterns are consistent with a
cis relationship between the 3-methoxyl substituent and the
5,10b-ethano bridge. Interestingly, H-1b was shifted to a lower
ﬁeld when compared to H-1a due to its syn-proximity to the
hydroxyl group at C-10. The complete NMR data set for aulicine
(1) is listed in Table 2. Conﬁrmation of the absolute stereochemis-
try in 1 was arrived at via CD and X-ray crystallography. The CD
spectrum of 1 (Fig. 2A) showed a positive Cotton effect at ca.
250 nm and negative Cotton effect at ca. 290 nm, in agreement
with a crinine-type alkaloid (De Angelis and Wildman, 1969;
Wagner et al., 1996). X-ray crystallographic data analysis was car-
ried out using a copper source (see Materials and methods), lead-
ing to the unambiguous structural assignment of 1 as a crinine-
type alkaloid (Fig. 2B).
The new crinine alkaloid 3-O-methyl-epimacowine (2) from H.
calyptratum exhibited a parent [M+H]+ ion at m/z 288.1595 in its
HRESIMS spectrum, thereby suggesting the molecular formula
C17H22NO3 (calcd. 288.1594). The NMR data of 2 (Table 3) were
similar to those of macowine (Nair et al., 2000), with the only nota-
ble difference arising from the differential substitution pattern at
C-3. An aliphatic methoxyl group was indicated by the chemical
shift and splitting pattern of the resonance at d 3.42 (3H, s), in
accordance with previous studies on 3-substituted alkaloids of
the crinine series (Viladomat et al., 1995). A small H-3/H-4b cou-
pling (J = 4.0 Hz) is consistent with the pseudoaxial orientation
for the 3-hydroxyl substituent in macowine (Nair et al., 2000). By
contrast, in 2, the large coupling constant (J3,4b = 10.5 Hz) sug-
gested a pseudoequatorial disposition for the 3-methoxyl substitu-
ent and therefore a cis relationship between this substituent and
the 5,10b-ethano bridge. The bridge orientation was conﬁrmed
by CD analysis, which showed positive and negative Cotton effects
at ca. 250 and ca. 290 nm, respectively (Fig. 2C).
The remaining two new alkaloids, 11-oxohaemanthamine (3)
and 7-methoxy-O-methyllycorenine (4), were identiﬁed in H. auli-
cum. The HRESIMS of 3 suggested the molecular formula
C17H18NO4 for the parent [M+H]+ ion at m/z 300.1239 (calcd.
300.1230). Its GC–MS fragmentation pattern was similar to that
of an alkaloid tentatively assigned to 11-oxohaemanthamine by
Kreh et al. (1995). The CD data determined for 3 (see Experimental)
were in agreement with those of a crinane-type alkaloid of the
a-series (Wagner et al., 1996). Characteristic 1H-NMR signals
included the following: (1) two para-oriented aryl protons (d
6.83 and 6.52, for H-10 and H-7, respectively), (2) two AB doublets
at d 4.58 and 3.83, correspondent with the C-6 benzylic proton sys-
tem in which H-6b was assigned to a lower ﬁeld due to its cis rela-
tionship with the nitrogen lone pair, and (3) two vicinal oleﬁnic
proton resonances (d 6.54 and d 6.21, J1,2 = 10.0 Hz), the more
shielded of which was assigned to H-2 due to its COSY correlation
with H-3 resonant at d 3.84. The magnitude of the coupling con-
stant between H-2 and H-3 (J2,3 = 5.5 Hz) and the small coupling
constants between H-3 and both H-4 protons (J3,4a  4.0 and
J3,4b = 2.0 Hz) are in agreement with a pseudoequatorial orientation
for H-3, thus suggesting a trans relationship between the 3-meth-
oxyl substituent and the 5,10b-ethano bridge (Pabuççuog˘lu et al.,
1989). The NMR data for 3 (Table 4) are consistent with 11-oxohae-
manthamine, which was recently synthesised by Cedrón et al.
(2012). The isolation of 3 from a natural source is reported here
for the ﬁrst time.
Homolycorine-type alkaloids bearing trimethoxyaryl substitu-
ents were originally reported during the 1950s (Boit and Döpke,
1957; Briggs et al., 1956). The mass fragmentation pattern of 7-
methoxy-O-methyllycorenine (4) was in agreement with patterns
typical for homolycorine-type alkaloids (Kreh et al., 1995;
Schnoes et al., 1962). The HRESIMS data for 4 was consistent with
the molecular formula C20H28NO5 for the parent ion [M+H]+ at m/z
362.1964 (calcd. 362.1962). The 1H-NMR data of 4 (Table 5) were
Table 2
1H NMR, COSY, NOESY, HSQC, and HMBC data of aulicine (1) (400 MHz, CDCl3).
Position dH (J in Hz) COSY NOESY HSQC HMBC
1a (ax) 1.77 td (14.0, 4.4) H-1b, H-2a, H-2b H-1b, H-2a 26.8 t C-2, C-10b, C-11
1b (eq) 3.10–3.20m H-1a, H-2a, H-2b H-1a, H-2b, H-11exo C-10b
2a (eq) 2.04m H-1a, H-1b, H-2b, H-3 H-1a, H-2b, H-3, 3-OMe 27.7 t
2b (ax) 1.44 tdd (13.5, 11.5, 4.0) H-1a, H-1b, H-2a, H-3 H-1b, H-2a, H-4b, H-11exo C-3
3 (ax) 3.10–3.20m H-2a, H-2b, H-4a, H-4b H-2a, H-4a, H-4a 77.6 d 3-OMe
4a (eq) 2.13 br d (12.4) H-3, H-4b, H-4a H-3, H-4b, H-4a, 3-OMe 33.8 t C-10b
4b (ax) 1.21 q (12.4) H-3, H-4a, H-4a H-2b, H-4a, H-11exo, H-12exo C-2, C-3, C-4a
4a 2.93 dd (12.4, 5.2) H-4a, H-4b H-3, H-4a, H-6a 67.9 d C-4, C-6, C-10a, C-11, C-12
6a 4.38 d (16.8) H-6b, H-7 H-4a, H-6b, H-7 62.7 t C-6a, C-7, C-10a, C-12
6b 3.71 d (16.8) H-6a, H-7 H-6a, H-7, H-12endo C-4a, C-6a, C-7, C-10a, C-12
6a 130.1 s
7 6.10 s H-6a, H-6b, 8-OMe H-6a, H-6b, 8-OMe 101.0 d C-6, C-8, C-9, C-10a
8 150.2 s
9 133.9 s
10 146.8 s
10a 126.0 s
10b 43.2 s
11endo 1.90 ddd (12.0, 8.8, 3.2) H-11exo, H-12endo, H-12exo H-11exo, H-12endo 36.5 t C-4a, C-10b
11exo 2.23 ddd (12.4, 10.4, 6.4) H-11endo, H-12endo, H-12exo H-1b, H-2b, H-4b, H-11endo, H-12exo C-1, C-10a, C-10b, C-12
12endo 2.78 ddd (12.8, 8.8, 6.4) H-11endo, H-11exo, H-12exo H-6b, H-11endo, H-12exo 52.2 t C-4a, C-6, C-11
12exo 3.36 ddd (12.8, 10.0, 3.2) H-11endo, H-11exo, H-12endo H-4b, H-11exo, H-12endo C-6
3-OMe 3.38 s (3H) H-2a, H-4a 55.6 q C-3
8-OMe 3.80 s (3H) H-7 H-7 55.7 q C-8
9-OMe 3.87 s (3H) 61.0 q C-9
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similar to of the data for O-methyllycorenine, originally reported
by Codina et al. (1993) and differing only by the presence of a third
aromatic methoxyl group resonance at d 3.89 (3H, s). Thus, the
7,8,9-trimethoxyaryl substitution in 4 was conﬁrmed by the
NOESY correlation evident between H-10 and the N-methyl group.
The C-7 and C-8 methoxyl carbon resonances (d 61.5 and d 61.2,
respectively) were diagnostically downﬁeld shifted from that of
C-9 (d 56.6), as previously indicated (Bastida et al., 1992). The large
coupling constant J4a,10b = 10.0 Hz conﬁrmed a trans-diaxial rela-
tionship between H-4a and H-10b. A cis B/C ring junction was sug-
gested based on the small value of the coupling constant measured
between H-1 and H-10b (J = 2.0 Hz). NOESY correlation between 6-
OMe and H-1 conﬁrmed the b-orientation for H-6, a feature char-
acteristic of hemiacetal functionalised homolycorine alkaloids
(Bastida et al., 2006; Codina et al., 1992). The complete NMR data
of 4 are provided in Table 5.
The structures of nerinine (5) and albomaculine (6) were con-
ﬁrmed by comparing their respective physical and spectroscopic
data with the data available in the literature (Berkov et al., 2011;
Codina et al., 1992; Jeffs and Hawksworth, 1963; Kreh et al.,
1995; Schnoes et al., 1962). However, in both instances, these were
found to be incomplete and are therefore comprehensively
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Fig. 2. CD spectrum (A) and ORTEP projection (B) of alkaloid 1. CD spectrum (C) of alkaloid 2.
Table 3
1H NMR, COSY, NOESY, HSQC, and HMBC data of 3-O-methyl-epimacowine (2) (500 MHz, CDCl3).
Position dH (J in Hz) COSY NOESY HSQC HMBC
1 6.48 dd (10.0, 2.0) H-2 H-2, H-10 129.1 d C-3, C-4a, C-10a, C-11
2 5.84 dt (10.0, 1.5) H-1 H-1, H-3, 3-OMe 129.2 d C-4, C-10b
3 4.00 ddt (10.5, 5.5, 2.0) H-4a, H-4b H-2, H-4a, H-4a, 3-OMe 76.3 d C-1, 3-OMe
4a 2.29m H-3, H-4b, H-4a H-3, H-4a, H-4b 30.8 t C-2, C-3, C-4a, C-10b
4b 1.58 ddd (13.5, 12.0, 10.5) H-3, H-4a, H-4a H-4a, H-11exo, H-12exo C-3, C-4a, C-10b
4a 3.28 dd (13.5, 4.0) H-4a, H-4b H-3, H-4a, H-6a 66.8 d C-12
6a 4.45 d (16.5) H-6b H-4a, H-6b, H-7 61.5 t C-6a, C-7, C-10a, C-12
6b 3.82 d (17.0) H-6a H-6a, H-7, H-12endo C-4a, C-6a, C-7, C-10a, C-12
6a 125.0 s
7 6.59 s H-6a, H-6b 113.0 d C-6, C-9, C-10a
8 144.3 s
9 145.3 s
10 6.78 s H-1, 9-OMe 104.9 d C-6a, C-8, C-10a, C-10b
10a 136.7 s
10b 44.7 s
11endo 2.20 ddd (12.0, 9.0, 4.5) H-11exo, H-12endo, H-12exo H-11exo, H-12endo 44.8 t C-4a, C-10a, C-10b, C-12
11exo 2.12 ddd (12.0, 10.5, 6.0) H-11endo, H-12endo, H-12exo H-4b, H-11endo, H-12exo C-1, C-10a, C-10b, C-12
12endo 2.95 ddd (13.0, 9.0, 6.0) H-11endo, H-11exo, H-12exo H-6b, H-11endo, H-12exo 53.2 t C-4a, C-6, C-10b
12exo 3.50 ddd (13.0, 10.5, 4.5) H-11endo, H-11exo, H-12endo H-4b, H-12endo, H-11exo C-6
3-OMe 3.42 s (3H) H-2, H-3 56.2 q C-3
9-OMe 3.89 s (3H) H-10 56.2 q C-9
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presented here in the Experimental section as well as in Tables 6
and 7.
Aulicine (1)1: white crystals; [a]D24 2,3 (c 0.38, CHCl3); CD
[H]20k : [H]255+ 1043, [H]279 768; UV (MeOH) kmax(log e) 233
(3.50), 273 (2.70) nm; IR (CHCl3) mmax 3291, 2931, 2858, 1605,
1577, 1495, 1455, 1424, 1126, 1103 cm1; 1H-NMR (CDCl3,
400 MHz) and 13C-NMR (CDCl3, 100 MHz) see Table 2; EIMS data
shown in Table 1; HRESIMS of [M+H]+ m/z 320.1864 (calcd for
C18H26NO4, 320.1856).
3-O-Methyl-epimacowine (2): white needles; [a]D22 47 (c
0.42, CHCl3); CD [H]20k : [H]254 +2528, [H]290 2215; UV (MeOH)
kmax(log e) 230 (3.31), 288 (3.23) nm; IR (CHCl3) mmax 2925, 2854,
1507, 1461, 1312, 1277, 1219, 1098, 754 cm1; 1H-NMR (CDCl3,
500 MHz) and 13C-NMR (CDCl3, 125 MHz) see Table 3; EIMS data
shown in Table 1; HRESIMS of [M+H]+ m/z 288.1595 (calcd for
C17H22NO3, 288.1594).
11-Oxohaemanthamine (3): white needles; [a]D20 +44 (c 0.12,
CHCl3); CD [H]20k : [H]255 3429, [H]320 +3298; UV (MeOH) kmax(log
e) 250 (2.94), 295 (2.92), 313 (2.82) nm; IR (CHCl3) mmax 2924, 2854,
1744, 1503, 1481, 1463, 1377, 1238, 1086, 1038 cm1; 1H-NMR
(CDCl3, 500 MHz) see Table 4; EIMS data shown in Table 1; HRESIMS
of [M+H]+ m/z 300.1239 (calcd for C17H18NO4, 300.1230).
7-Methoxy-O-methyllycorenine (4): amorphous solid; [a]D23
+31 (c 0.33, CHCl3); UV (MeOH) kmax(log e) 230 (3.55), 270 (2.75)
nm; IR (CHCl3) mmax 2924, 2853, 2783, 1601, 1460, 1336, 1128,
1053, 1025; 1H-NMR (CDCl3, 500 MHz) and 13C-NMR (CDCl3,
125 MHz) see Table 5; EIMS data shown in Table 1; HRESIMS of
[M+H]+ m/z 362.1964 (calcd for C20H28NO5, 362.1962).
Nerinine (5): amorphous solid; [a]D23 +40 (c 0.33, CHCl3); UV
(MeOH) kmax(log e) 232 (3.59), 273 (2.89) nm; IR (CHCl3) mmax
3145, 2918, 2849, 1587, 1460, 1410, 1336, 1243, 1122,
1018 cm1; 1H-NMR (CDCl3, 400 MHz) and 13C-NMR (CDCl3,
100 MHz) see Table 6; EIMS data shown in Table 1; HRESIMS of
[M+H]+ m/z 348.1807 (calcd for C19H26NO5, 348.1805).
Albomaculine (6): amorphous solid; [a]D23 +25 (c 0.95, CHCl3);
UV (MeOH) kmax(loge) 222 (4.26), 266 (3.86), 298 (3.34) nm; IR
(CHCl3) mmax 2929, 2849, 2783, 1725, 1592, 1334, 1254, 1111,
1022 cm1; 1H-NMR (CDCl3, 400 MHz) and 13C-NMR (CDCl3,
100 MHz) see Table 7; EIMS data shown in Table 1; HRESIMS of
[M+H]+ m/z 346.1651 (calcd for C19H24NO5, 346.1649).
3. Conclusions
In summary, phytochemical investigation of H. aulicum and H.
calyptratum led to the identiﬁcation of 23 Amaryllidaceae
alkaloids. Of these alkaloids, aulicine, 3-O-methyl-epimacowine,
11-oxohaemanthamine and 7-methoxy-O-methyllycorenine are
reported here for the ﬁrst time. The structures of these alkaloids
were determined by physical and spectroscopic methods, includ-
ing GC–MS, NMR, CD and X-ray crystallography. The identiﬁcation
of the b-crinane alkaloids aulicine and 3-O-methyl-epimacowine in
Hippeastrum is of considerable biosystematic signiﬁcance because
previous ﬁndings have revealed that all crinane compounds from
this genus are reminiscent of the a-series. Efforts to further delin-
eate this anomaly via targeted studies of other species of Hippea-
strum are presently underway in our laboratories.
4. Materials and methods
4.1. General procedure
NMR spectra were recorded on a Mercury 400 MHz (Palo Alto,
CA, USA) or a Varian 500 MHz (Palo Alto, CA, USA) instrument
using CDCl3 (CD3OD for 4 and 10) as the solvent and TMS as the
internal standard. Chemical shifts are reported in d units (ppm)
and coupling constants (J) in Hz. The GC–MS spectra were obtained
on an Agilent 6890N GC 5975 inert MSD operating in the EI mode
at 70 eV (Agilent Technologies, Santa Clara, CA, USA) using a DB5
MS column (30 m  0.25 mm  0.25 lm, Agilent Technologies).
The temperature program was as follows: 100–180 C at
15 C min1, 1 min hold at 180 C and 180–300 C at 5 C min1
and 40 min hold at 300 C. The injector temperature was 280 C.
The ﬂow rate of carrier gas (helium) was 0.8 ml min1, and the split
ratio was 1:20. HRESIMS spectra were obtained on a LC/MSD-TOF
(2006) mass spectrometer (Agilent Technologies, Santa Clara, CA,
USA) by direct injection of the compounds dissolved in H2O-MeCN
(1:1). Optical rotations were carried out on a Perkin-Elmer 241
polarimeter (Waltham, MA, USA). A Jasco-J-810 Spectrophotome-
ter (Easton, MD, USA) was used to run CD spectra, all recorded in
MeOH. UV spectra were obtained on a DINKO UV2310 instrument
(Barcelona, Spain) and IR spectra were recorded on a Nicolet Avatar
320 FT-IR spectrophotometer (Waltham, MA, USA). Silica gel (Kie-
selgel – mesh 0.15/0.30, Val-de-Reuil, France) was used for all vac-
uum liquid chromatography procedures (VLC). For thin layer
chromatography (TLC), silica gel F254 was used as the stationary
phase with a plate dimension of 20 cm  20 cm  0.20 mm for
analytical TLC and 20 cm  20 cm  0.25 mm for semi-preparative
TLC (SPTLC) (Val-de-Reuil, France). Exclusion chromatography was
carried out using a Sephadex LH-20 (Uppsala, Sweden).
4.2. Plant material
Bulbs of H. aulicum Herb. and H. calyptratum Herb. were col-
lected in October 2011 during the ﬂowering period from a popula-
tion located in Cunha City, Sao Paulo Province (Brazil). Both species
were identiﬁed by Mr. Mauro Peixoto and Dr. Jullie Dutilh (Univer-
sity of Campinas, Unicamp, Brazil). The voucher specimens of H.
aulicum were deposited in the herbarium at the Plantarum Insti-
tute under the reference number HPL 13043. The voucher speci-
mens of H. calyptratum were deposited in the Herbarium of the
University of Campinas (Unicamp, Brazil) under the reference
number UEC 59648.
4.3. Extraction and isolation of alkaloids
Dried bulbs (370 g) of H. aulicum were crushed and thrice
extracted for 48 h with MeOH at room temperature, and the com-
bined macerate was ﬁltered and evaporated under reduced pres-
sure. The crude extract (90 g) was acidiﬁed with sulphuric acid
(2%) to pH 2 and extracted with Et2O (4  250 ml) and EtOAc
Table 4
1H NMR, COSY, and HSQC data of 11-oxohaemanthamine (3) (500 MHz, CDCl3).
Position dH (J in Hz) COSY HSQC
1 6.54 d (10.0) H-2 126.8 d
2 6.21 ddd (10.0, 5.5, 1.5) H-1, H-3 129.5 d
3 3.84 ddd (5.5, 3.5, 2.0) H-2, H-4a; H-4b 71.8 d
4a 1.47 td (14.0, 4.0) H-3; H-4b, H-4a 29.8 t
4b 2.25 br d (14.0) H-3; H-4a, H-4a
4a 3.55 m H-4a; H-4b 61.5 d
6a 3.83 d (17.0) H-6b, H-7 60.6 t
6b 4.58 d (17.0) H-6a, H-7
7 6.52 s H-6a, H-6b 106.9 d
10 6.83 s 104.2 d
12endo 3.27 dd (18.5, 1.5) H-12exo 59.3 t
12exo 3.56 d (18.5) H-12endo
3-OMe 3.37 s (3H) 56.8 q
OCH2O 5.92 2d (1.5) 101.3 t
1 CCDC 963600 contains the supplementary crystallographic data for this paper.
These data can be obtained free of charge via http://www.ccdc.cam.ac.uk/conts/
retrieving.html (or from the CCDC, 12 Union Road, Cambridge CB2 1EZ, UK; fax: +44
1223 336033; e-mail: deposit@ccdc.cam.ac.uk)
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(4  250 ml) to remove neutral material. The aqueous solution was
basiﬁed with ammonia (25%) up to pH 10 and extracted with
n-hexane (8  250 ml) to give extract IA (0.86 g). Another extrac-
tion using EtOAc (8  250 ml) produced extract IIA (2.0 g), wherein
lycorine (10) precipitated spontaneously. A ﬁnal extraction using
EtOAc–MeOH (3:1, 3  250 ml) showed negative results for alka-
loids as conﬁrmed by Dragendorff’s reagent stain and GC–MS.
Extract IA was subjected to VLC (2.5  6 cm) on silica gel (10 g),
starting with n-hexane (100%), gradually enriching with EtOAc
(0? 100%), and ﬁnally with MeOH (0? 30%). A total of 150,
50 ml fractions were collected, monitored by analytical TLC (Drag-
endorff’s reagent, UV light k 254 nm) and combined after TLC anal-
ysis. Nerinine (5, 15 mg) was isolated by precipitation of fractions
65–86, and the supernatant was submitted to SPTLC (EtOAc–Me2-
CO–n-hexane–MeOH – 6:2:1:1, in NH3 atmosphere), which
allowed for the isolation of 7-methoxy-O-methyllycorenine (4,
6.5 mg) and galanthamine (13, 10 mg). Fractions 87–118 gave hae-
manthamine (15) and aulicine (1) again by precipitation and fur-
ther puriﬁcation by SPTLC (n-hexane–EtOAc–Me2CO–MeOH–n-
BuOH – 4:3:3:2:1, in NH3 atmosphere). The supernatant was
loaded onto a VLC column (1.5  4 cm) of silica gel (3 g), using n-
hexane (100%) as the starting solvent, gradually enriched with
EtOAc (0? 100%), and ﬁnally with MeOH (0? 30%), ultimately
yielding 250 fractions (each 10 ml). After combining the fractions
according to the TLC proﬁles, 11-oxohaemanthamine (3, 5.3 mg)
was isolated from pooled fractions 93–113 using SPTLC (n-hex-
ane–Me2CO–EtOAc–MeOH – 15:10:5:2, in NH3 atmosphere).
Fractions 222–250 were combined and subjected to SPTLC
(n-hexane–EtOAc–Me2CO–MeOH–n-BuOH – 4:3:3:2:1, in NH3
atmosphere), after which 1 and 15 were again isolated.
Alkaloid 15 precipitated spontaneously from extract IIA after
resuspension in MeOH. The supernatant (700 mg) was puriﬁed
by silica gel VLC (2  6 cm column, 10 g), starting with n-hexane
(100%), gradually enriching with EtOAc (0? 100%) and ﬁnally with
MeOH (0? 30%), ultimately yielding 200 fractions (50 ml each)
that were then pooled according to TLC proﬁle analysis. SPTLC
(n-hexane–EtOAc–Me2CO–MeOH–n-BuOH – 4:3:3:2:1, in NH3
atmosphere) of fractions 134–190 gave 1 (152 mg), 15
Table 5
1H NMR, COSY, NOESY, HSQC, and HMBC data of 7-methoxy-O-methyllycorenine (4) (500 MHz, CD3OD).
Position dH (J in Hz) COSY NOESY HSQC HMBC
1 4,40 br d (6.5) H-2a, H-2b, H-3, H-10b H-2a, H-2b, H-10b, 6-OMe 67.0 d C-3, C-4a, C-6, C-10a
2a 2,67 ddt (19.0, 6.5, 3.0) H-1, H-2b, H-3, H-4a H-1, H-2b, H-3 32.5 t
2b 2,29 dt (19.5, 3.0) H-1, H-2a, H-3, H-4a H-1, H-2a, H-3
3 5,55 br s H-1, H-2a, H-2b, H-4a, H-11a/b H-2a, H-2b, H-11a/b 118.1 d
4 140.2 s
4a 2,92 br d (10.0) H-2a, H-2b, H-3, H-10b NMe 69.2 d
6b 5,52 s 6-OMe 97.8 d C-1, C-7, C-6a, C-10a, 6-OMe
6a 121.7 s
7 153.2 s
8 142.9 s
9 154.7 s
10 6.85 s 9-OMe H-10b, 9-OMe, NMe 110.0 d C-6a, C-8, C-9, C-10a, C-10b, C-7
10a 134.1 s
10b 2.47 dd (10.0, 2.0) H-1, H-4a H-1, H-10, H-12a 44.1 d C-4a, C-6a, C-10, C-10a
11a/b 2.49–2.58 m H-3, H-12a, H-12b H-3, H-12a 28.6 t
12a 3.22 ddd (10.5, 7.5, 3.0) H-11a/b, H-12b H-10b, H-11a/b, H-12b, NMe 57.7 t
12b 2.42 m H-11a/b, H-12a H-12a, NMe
6-OMe 3.51 s (3H) H-1, H-6b 55.6 q C-6
7-OMe 3.89 s (3H) 61.5 q C-7
8-OMe 3.82 s (3H) 61.2 q C-8
9-OMe 3.87 s (3H) H-10 H-10 56.6 q C-9
NMe 2.11 s (3H) H-4a, H-10, H-12a, H-12b 44.0 q C-4a, C-12
Table 6
1H NMR, COSY, NOESY, HSQC, and HMBC data of nerinine (5) (400 MHz, CDCl3).
Position dH (J in Hz) COSY NOESY HSQC HMBC
1 4.52 ddd (5.6, 2.0, 1.0) H-2a, H-2b, H-10b H-2a, H-2b, H-10b 66.3 d C-3, C-4a, C-6
2a 2.65 ddt (19.2, 6.0, 2.8) H-1, H-2b, H-3 H-1, H-2b, H-3 31.9 t
2b 2.34 dt (19.2, 2.5) H-1, H-2a, H-3 H-1, H-2a, H-3
3 5.47 br m H-2a, H-2b, H-4a, H-11a/b H-2a, H-2b, H-11a/b 115.8 d
4 141.1 s
4a 2.73 d (9.6) H-3, H-10b H-6b, H-12b, NMe 67.5 d
6b 6.14 s H-4a, 7-OMe 89.8 d C-1, C-7, C-10a
6a 121.2 s
7 151.3 s
8 141.2 s
9 153.1 s
10 6.77 s H-10b, 9-OMe, NMe 109.1 d C-6a, C-8, C-9, C-10b
10a 133.6 s
10b 2.41 dd (9.6, 1.5) H-1, H-4a H-1, H-10 44.5 d C-4a, C-6a, C-10, C-10a
11a/b 2.44–2.51 br m H-3, H-12a, H-12b H-3, H-12a, H-12b 28.4 t
12a 3.14 m H-11a/b, H-12b H-11a/b, H-12b, NMe 57.1 t C-4, C-4a
12b 2.24 q (9.2) H-11a/b, H-12a H-4a, H-11a/b, H-12a, NMe NMe
7-OMe 3.99 s (3H) H-6b 61.4 q C-7
8-OMe 3.87 s (3H) 61.0 q C-8
9-OMe 3.86 s (3H) H-10, NMe 56.3 q C-9
NMe 2.06 s (3H) H-4a, H-10, H-12a, H-12b, 9-OMe 44.6 q C-4a, C-12
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(161.1 mg) and 10 (135 mg), while a small quantity of tazettine
(19, 3.2 mg) precipitated from fractions 191–205. GC–MS spectra
of the remaining fractions indicated the presence of only known
compounds (Table 1), which therefore precluded the need for fur-
ther chromatographic analyses.
Dried bulbs (135 g) of H. calyptratum were crushed and
extracted by stirring with MeOH at room temperature for 48 h
(repeating three times), and the combined macerate was ﬁltered
and evaporated under reduced pressure. The crude extract (50 g)
was acidiﬁed with sulphuric acid (2%) to pH 2 and extracted with
Et2O (4  250 ml) and EtOAc (4  250 ml) to remove neutral mate-
rial. The aqueous solution was then basiﬁed with ammonia (25%)
up to pH 10 and extracted with n-hexane (8  250 ml) to give
extract IC (100 mg). Extraction with EtOAc (8  250 ml) gave
extract IIC (300 mg). A ﬁnal extraction using EtOAc-MeOH (3:1)
showed negative results for alkaloids as conﬁrmed by
Dragendorff’s reagent and GC–MS analysis.
Extracts IC and IIC (400mg) were combined after GC–MS showed
them to be similar. Alkaloid 10 precipitated after re-suspension in
MeOH and the supernatant was puriﬁed by VLC (2.5 4 cm column,
10 g of silica gel) using the same solvent systemas that forH. aulicum.
Alkaloid 10 (115 mg) precipitated directly from fractions 93–140.
Fractions 71–170 were combined (250mg) and subjected to VLC
(1.5 4 cm column) in silica gel (3 g) using n-hexane (100%) fol-
lowed by EtOAc (0? 100%) and ﬁnally with MeOH (0? 30%), ulti-
mately yielding 250 fractions (10 ml each). Only fractions 145–200
(110mg) showed alkaloids with unknown GC–MS fragmentation
patterns and were therefore selected for further VLC, which was car-
ried out on silica gel (3 g) using a 1.5  4 cm column, starting with n-
hexane (100%) and increasing solvent polarity with EtOAc (0? 50%).
Thereafter, CHCl3 and EtOAc were gradually added until a CHCl3-
EtOAc ration of 1:1 was reached. Finally, the system was gradually
enriched with MeOH (0? 30%), ultimately yielding 200 fractions
(10 ml each). Albomaculine (6, 19.3 mg) was isolated from fractions
69–88 by SPTLC (Me2CO-CH2Cl2 – 3:10, in NH3 atmosphere) together
with 2a,7-dimethoxyhomolycorine (9, 3.2 mg). Likewise, 3-O-
methyl-epimacowine (2, 18.3 mg) and alkaloid 13 (7.7 mg) were
isolated from fractions 89–148 using SPTLC (EtOAc-Me2CO-CH2Cl2-
MeOH – 3:1:1:0.5, in NH3 atmosphere).
4.4. Identiﬁcation of alkaloids by GC–MS
The alkaloids were identiﬁed by comparing their GC–MS spec-
tra and Kovats retention indices (RI) with our library database. This
library has been regularly updated with alkaloids isolated and
unequivocally identiﬁed via physical and spectroscopic means
(Berkov et al., 2008; de Andrade et al., 2011, 2012b; Giordani
et al., 2011; Llabrés et al., 1986). NMR data for the known alkaloids
described here closely matched those reported elsewhere (Bastida
et al., 2006; Kobayashi et al., 1980). Mass spectra were deconvo-
luted using the AMDIS 2.64 software (NIST) (WA, USA), and RIs
were recorded using a standard n-hydrocarbon calibration mixture
(C9-C36). The proportion of individual components in the alkaloid
fractions are expressed as a percentage of total alkaloid content.
GC–MS peak areas are dependent on the concentration of the
injected alkaloid as well as the intensity of its mass spectral frag-
mentation. Although the data given in Table 1 are not representa-
tive of a validated alkaloid quantiﬁcation method, these data can
be used for relative comparison purposes.
4.5. Crystals of aulicine (1)
Compound 1 was dissolved in a MeOH-CHCl3 (1:1) mixture
under a pentane atmosphere. After 14 days standing at5 C, small
crystals of 1 formed and were selected for X-ray crystallography.
4.6. X-ray analysis
A prismatic crystal (0.1  0.1  0.2 mm) was selected and
mounted on a Bruker D8 Venture four-circle diffractometer
(Karlsruhe, Germany). Intensities were collected with a multilayer
monochromator and a Cu high brilliance microfocus sealed tube
using the / andx scan-technique. A total of 24158 reﬂections were
measured in the range of 2.93 6 h 6 74.32, with 6377 of the reﬂec-
tions non-equivalent by symmetry (Rint(on I) = 0.031). Overall,
6028 reﬂections were assumed to be as observed by applying the
condition I > 2r(I). Lorentz-polarisation and absorption corrections
were performed.
The structure was solved by direct methods, using the SHELXS
computer program (and reﬁned by a full-matrix least-squares
method with the SHELX97 computer program (Sheldrick, 2008))
and 24158 reﬂections, (very negative intensities were not
assumed). The function minimised was R w ||Fo|2  |Fc|2 |2, where
w = [r2(I) + (0.0343P)2 + 0.8335P]1, and P = (|Fo|2 + 2 |Fc|2)/3, f, f0
and f00 were taken from the International Tables of X-ray
Crystallography (1974). All H atoms were computed and reﬁned
using a riding model, with an isotropic temperature factor equal
to 1.2 times the equivalent temperature factor of the atoms that
Table 7
1H NMR, COSY, NOESY, HSQC, and HMBC data of albomaculine (6) (400 MHz, CDCl3).
Position dH (J in Hz) COSY NOESY HSQC HMBC
1 4.68 br m H-2a/b, H-3, H-10b H-2a/b, H-10b 76.3 d C-3, C-4a, C-10a
2a/b 2.55–2.60 br m H-1, H-3, H-11a/b H-1, H-3 31.0 t C-1, C-3, C-10b
3 5.48 br m H-1, H-2a/b, H-4a, H-11 a/b H-2a/b, H-11a/b 115.6 d
4 140.6 s
4a 2.72 d (10.0) H-3, H-10b NMe 66.0 d
6 162.4 s
6a 111.6 s
7 156.3 s
8 142.7 s
9 157.2 s
10 6.78 s H-10b, 9-OMe, NMe 107.4 d C-6a, C-8, C-10b
10a 140.8 s
10b 2.63 d (10.0) H-1, H-4a H-1, H-10 45.5 d
11a/b 2.45–2.53 br m H-2a/b, H-3, H-12a, H-12b H-3, H-12a, H-12b 28.1 t C-4
12a 3.13 ddd (9.6, 7.2, 3.6) H-11a/b, H-12b H-11a/b, H-12b, NMe 56.6 t
12b 2.23 q (9.6) H-11a/b, H-12a H-11a/b, H-12a C-11, NMe
7-OMe 3.99 s (3H) 62.1 t C-7
8-OMe 3.89 s (3H) 61.3 t C-8
9-OMe 3.91 s (3H) H-10, NMe 56.5 t C-9, C-10
NMe 2.05 s (3H) H-4a, H-10, H-12a, 9-OMe 43.7 t
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are linked. The ﬁnal R(on F) factor was 0.0298, wR(on |F|2) = 0.074
and goodness of ﬁt = 1.042 for all observed reﬂections. The number
of reﬁned parameters was 423. Max. shift/esd = 0.00, Mean shift/
esd = 0.00. Max. and min. peaks in the ﬁnal difference synthesis
were 0.215 and 0.164 eÅ3, respectively.
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4. Discussion 
The thesis is mainly focused on the study of alkaloids from the genera Lycoris and 
Hippeastrum. I have divided this chapter into three separate sections: first, analysis of 
bioactive Amaryllidaceae alkaloid profiles of Lycoris species by GC-MS; second, 
isolation and characterization of new alkaloids of the species Hippeastrum papilio; and 
finally, research on new alkaloids from Hippeastrum calyptratum. 
4.1. Alkaloid profiles of the genus Lycoris  
As previously described, the genus Lycoris from the Amaryllidaceae family 
includes 22 species and one hybrid, which are principally found in temperate woodlands 
of Eastern Asia. Notably, fifteen of these species grow in China, of which 10 are 
endemic. GC-MS is a rapid and sensitive tool for investigation and identiﬁcation of 
complex alkaloid mixtures of different groups from numerous plants, requiring a low 
quantity of plant samples and no derivatization step. It therefore constitutes an 
appropriate technical support for analyzing the numerous alkaloids of different Lycoris 
species. 
In the present work, nine species, Lycoris albiflora, L. aurea, L. chinensis, L. 
haywardii, L. incarnata, L. longituba, L. radiata, L. sprengeri, and L. squamigera, and 
one variety (L. radiata var. pumila) were evaluated by GC-MS.  
GC-MS analysis of the bulbs of different species of Lycoris resulted in the 
identification of 31 alkaloids belonging to the lycorine, homolycorine, haemanthamine, 
narciclasine, tazettine, montanine and galanthamine types, together with one unusual 
alkaloid known as cherylline. In general, the results coincided with previously reported 
alkaloids found in the genus. The alkaloid profile of the extracts of all the studied 
species was dominated by alkaloids arising from ortho-para’ (lycorine-type) and 
para-ortho’ (galanthamine-type) oxidative coupling of O-methylnorbelladine. The 
number of alkaloids detected varied among extracts, from 10 in L. incarnata and L. 
radiata var. pumila to 20 in L. longituba. 
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In all the species, lycorine- and galanthamine-type alkaloids were predominant. L. 
longituba and L. sprengeri showed the highest content of lycorine-type compounds, 
with values above 2.5 mg GAL/g DW. The maximum level of galanthamine-type 
alkaloids was detected in L. longituba bulbs (4.75 mg GAL/g DW), while the lowest 
level was found in the bulbs of L. radiata var. pumila (0.4 mg GAL/g DW). 
Tazettine-type alkaloids were present in all the species, with the exception of L. 
incarnata, while the montanine type was not detected in five of the ten extracts 
analyzed. Homolycorine-type alkaloids were only found in L. radiata, L. radiata var. 
pumila and L. haywardii. Narciclasine-type alkaloids were present as traces in L. 
longituba and L. sprengeri. Although in low quantities (values less than 0.29 mg GAL/g 
DW), the haemanthamine type alkaloids were detected in five species, L. aurea, L. 
chinensis, L. radiata, L. sprengeri and L. squamigera (Table 4.1; Figure 4.1). 
Figure 4.1 shows the alkaloid profile of each extract as a bar graph. The results are 
grouped into 3 main bars: two of them comprise lycorine- and galanthamine-type 
alkaloids, colored blue and red, respectively, to highlight their predominance, whereas  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: Alkaloid and alkaloid-type predominance in extracts of the genus Lycoris. 
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Table 4.1: Alkaloid profiles of studied species. Values are expressed as μg GAL/g DW. 
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Lycorine-type    863.2 1445.9 1113.1 1280.1 1291.7 2572.4 2037.9 976.4 2514.3 1912.2 
lycorine 287 226 2766.1 370.7 502.8 360.8 349.7 337.6 656.9 923.8 298.7 687.4 257.1 
pseudolycorine 289 228 2837.2 - - - - - 224.8 - - - - 
galanthine 317 242 2703.4 trace 222.0 trace 228.0 239.8 - - - 337.4 467.5 
pluviine 287 242 2571.7 - - - trace - 237.3 - 223.1 - trace 
norpluviine 273 228 2602.2 trace - - - - - - - trace - 
caranine 271 226 2537.4 245.4 248.5 264.3 236.3 237.7 260.1 299.3 trace 267.1 trace 
methylpseudolycorine 303 242 2792.3 - - - - - 490.8 - - - 233.1 
incartine 333 332 2457.8 trace trace trace trace 224.4 - - - 446.9 265.1 
2-dehydroxylycorine 271 250 2551.3 - trace - - - 222.2 226.2 - 224.3 - 
galanthine derivative* 315 240 2782.1 - trace trace trace - - - - trace 240.5 
anhydrolycorine 251 250 2516.2 trace 222.0 228.0 221.3 trace 226.7 283.8 222.7 227.2 216.1 
11,12-dehydroanhydrolycorine 249 248 2622.1 247.1 250.7 259.9 244.7 252.2 253.7 304.7 231.9 324.0 232.9 
assoanine 267 266 2581.4 - - - - - trace - - - - 
Homolycorine-type    - - - 550.5 - - 1408.8 534.2 - - 
homolycorine 315 109 2765.0 - - - 238.0 - - 256.8 245.7 - - 
8-O-demethylhomolycorine 301 109 2822.0 - - - 312.5 - - 659.3 288.4 - - 
hippeastrine 315 125 2903.4 - - - - - - 266 - - - 
O-methyllycorenine 331 109 2487.9 - - - - - - 226.7 - - - 
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Haemanthamine-type    - 251.5 224.3 - trace - trace - 286.2 trace 
haemanthamine 301 272 2644.3 - 251.5 224.3 - trace - trace - 286.2 - 
haemanthidine 317 317 2731.0 - - - - - - - - - trace 
Narciclasine-type    - - - - - trace - - trace - 
trisphaeridine 233 233 1866.0 - - - - - trace - - trace - 
Tazettine-type    221.1 238.3 368.5 275.7 - 863.3 692.1 226.4 331.9 300.8 
tazettine 331 247 2655.0 221.1 238.3 368.5 275.7 - 863.3 692.1 226.4 331.9 300.8 
deoxytazettine 315 231 2546.6 - - - - - trace trace - - - 
Montanine-type    260.3 314.9 353.8 - - 831.3 - - - 327.0 
montanine 301 301 2637.3 260.3 314.9 353.8 - - 607.2 - - - 327.0 
pancratinine C 287 176 2600.2 - - - - - 224.1 - - - - 
Galanthamine-type    721.6 1455.6 1786.1 895.5 722.4 4754.3 2386.5 411.7 2425.2 1804 
galanthamine 287 286 2403.7 trace 674.1 618.0 227.1 227.4 836.0 425.0 trace 289.9 501.1 
sanguinine 273 273 2427.6 - 550.9 380.0 - - 241.5 - - - - 
lycoramine 289 288 2430.3 458.5 230.6 538.0 668.4 264.3 1808.6 1694.7 411.7 1870 1046.4 
O-demethyllycoramine 274 275 2459.7 - - - - - 344.9 - - - - 
norlycoramine 274 275 2471.7 263.1 - 249.4 - 230.7 1523.3 266.8 - 265.4 256.5 
narwedine 285 284 2485.3 trace - - - - trace - - - trace 
Other-type    - - trace - - - - - - - 
cherylline 285 242 2574.0 - - trace - - - - - - - 
Total    2066.2 3706.2 3845.8 3001.8 2014.1 9021.3 6525.3 2148.6 5557.6 4343.9 
*Although not reported in the literature, the MS of this compound indicates a structure derived from galanthine
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the third one represents all the remaining skeleton types (including tazettine-, 
homolycorine-, haemanthamine- and montanine-). The lycorine, galanthamine and 
lycoramine alkaloids are represented by different shades of red or blue, and tazettine is 
in green, given that these are the most frequently found structures. 
4.2. Alkaloids from Hippeastrum papilio 
Hippeastrum papilio was collected during the flowering period (November, 2012) 
in the South of Brazil (Caxias do Sul - RS). The dried bulbs (220 g) were crushed and 
extracted with methanol. After purification, three novel Amaryllidaceae alkaloids from 
Hippeastrum papilio were isolated: hippapiline, papiline and 
3-O-(3’-hydroxybutanoyl)haemanthamine. Additionally, the known alkaloids 
haemanthamine, galanthamine, narwedine, 11β-hydroxygalanthamine, apogalanthamine  
and 9-O-demethyllycosinine B were identified (Figure 4.2). 
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Figure 4.2: Alkaloids from Hippeastrum papilio. 
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4.2.1. GC-MS analysis of Hippeastrum papilio  
The results of GC-MS analysis revealed that galanthamine was the main 
constituent in the n-hexane extract (86.3 %), also appearing as one of the major 
components in the EtOAc extract (39.0 %), together with haemanthamine (26.9 %). 
Apogalanthamine and 9-O-demethyllycosinine B are reported in this species for the first 
time, while narwedine was detected only in small quantities (Table 4.2). 
Table 4.2: GC-MS analysis of the alkaloid content of Hippeastrum papilio. 
Alkaloid RI %A* %B* M+ MS 
apogalanthamine  2253 - 3.12 269(88) 268(32), 254(26), 226(61), 211(54), 194(32), 
193(50), 166(29), 165(100), 152(30) 
hippapiline  2301 - 1.68 317(-) 110(8), 109(100), 108(18), 107(2), 94(24), 
81(2), 77(2), 42(2) 
galanthamine  2335 86.26 39.01 287(82) 288(14), 286(100), 270(13), 244(26), 
230(13), 216(36), 174(30), 115(13) 
narwedine  2402 1.31 0.52 285(85) 286(15), 284(100), 242(22), 216(23), 
214(10), 199(26), 185(13), 181(12), 178(15), 
174(43), 161(11), 153(13), 141(10), 128(22), 
115(22), 77(13), 42(22) 
9-O-demethyllycosinine B  2499 0.24 5.72 283(100) 284(19), 256(11), 255(70), 254(72), 240(30), 
239(13), 223(11), 222(33), 210(11), 194(17), 
167(10), 44(16) 
11β-hydroxygalanthamine  2510 traces 7.02 303(21) 302(12), 231(21), 230(100), 213(28), 
181(13), 174(13), 115(13), 44(13) 
haemanthamine  2556 1.92 26.87 301(12) 273(18), 272(100), 242(15), 240(16), 
214(13), 212(14), 211(15), 181(26), 153(10), 
128(12), 115(11) 
papiline  2565 1.08 10.98 345(-) 286(3), 177(3), 165(1), 122(1), 110(6), 
109(100), 108(14), 96(1), 82(3), 81(2), 44(1), 
43(3), 42(2) 
3-O-(3’-hydroxybutanoyl)haemanthamine  3030 - 1 373(5) 345(21), 344(95), 270(24), 269(37), 268(25), 
240(55), 226(20), 225(30), 224(25), 212(53), 
211(27), 210(16), 182(20), 181(100), 
153(33), 128(16), 115(17), 45(21) 
% A: Alkaloid percentage in the total mixture of alkaloids extracted with n-hexane. % B: Alkaloid percentage in the total mixture of 
alkaloids extracted with EtOAc. All values are expressed as a relative percentage of TIC. 
 
As metioned before, Galanthamine, an AChE inhibitor marketed as a 
hydrobromide salt (Razadyne®, Reminyl®) for the treatment of Alzheimer’s disease 
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(AD), is obtained from Amaryllidaceae plants, especially those belonging to the genera 
Leucojum, Narcissus, Lycoris and Ungernia. The growing demand for galanthamine has 
prompted searches for new sources of this compound, as well as other bioactive 
alkaloids for the treatment of AD (de Andrade et al., 2011). H. papilio could be 
considered as a potential commercial source of bioactive alkaloids due to its high 
content of galanthamine (86.26% of n-hexane alkaloids extraction and 39.0% in the 
total mixture of alkaloids extracted with EtOAc). 
4.2.2. Hippapiline 
The alkaloid hippapiline showed HRESIMS [M+H]
+
 at m/z 318.1706 (calc. for 
C18H24NO4 – 318.1700) and a base peak at m/z 109 by GC-MS analysis, which is 
characteristic of the hexahydroindol ring in the homolycorine series, without a 
substitution at C-2 (Berkov et al., 2008). Although the basic structure of a 
homolycorine-type compound was established by NMR data, an unusual shifting and 
splitting pattern in comparison with the compound 8-O-demethyl-6-O-methyllycorenine 
(Wang et al., 2007b) was noticed, which proved to be crucial for the correct 
characterization of hippapiline.  
It was also noteworthy that the 
1
H NMR data of hippapiline showed some atypical 
characteristics: two para-oriented aromatic protons attributed to H-7 and H-10, the latter 
assigned to the highly deshielded singlet at δ 8.41 (confirmed by NOESY correlation 
with the N-methyl group); an uncommon coupling constant (J = 4.5 Hz) observed 
between H-1 and H-10b and the absence of the distinctive trans-diaxial coupling 
constant between H-10b and H-4a; a NOESY correlation between H-4a and H-1. All 
these data were essential for the correct assignment of hippapiline, consistent with a 
-orientation of H-1 and H-10b. 
 Furthermore, CD analysis was carried out to confirm the consequent cis-4 B/C 
ring fusion in hippapiline, wherein the positive, negative, and positive Cotton effects, 
observed at ca. 225, 250, and 290 nm, respectively, were completely opposite to those 
observed for the representative cis-3 B/C fusion of other homolycorine-type compounds 
(Wagner et al., 1996). Consequently, the CD analysis and NMR data were in agreement 
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with a cis-4 B/C ring fusion. 
4.2.3. Papiline 
The HRESIMS of papiline suggested a molecular formula C19H24NO5 for [M+H]
+
 
with a parent ion at m/z 346.1643 (calcd. 346.1649). The EIMS showed a molecular ion 
[M]
+
 at m/z 345 and a loss typical of an acetoxy group (m/z 286, [M-59]
+
).  
Characteristic NMR signals included: (i) a singlet at  9.91, indicative of an 
aldehyde function, as occurs in nonfused dihydroindol lycosinine derivatives (Sebben, 
2005; Yang et al., 2005), and a signal at δ 191.7 in 13C NMR confirmed the aldehyde 
carbonyl group; (ii) two para-oriented aromatic protons at δ 7.32 and 7.29, the more 
deshielded of which was assigned to H-7, due to its NOESY correlation with H-6; (iii) 
the acetoxy substituent was assigned at C-1, due to the strong deshielding effect 
observed for H-1 (δ 5.45), confirmed by HMBC; (iv) the magnitude of the coupling 
constant (J4a,10b = J1,10b = 4.5 Hz), together with the observed NOESY correlations 
confirmed the same orientation for H-1, H-10b and H-4a. Moreover, its IR spectrum 
displayed strong absorbance at 1738 and 1674 cm
-1
, indicating two C=O groups 
ascribed as acetoxy and aldehyde groups, respectively. All data were in agreement with 
a new compound bearing a nonfused hexahydroindol nucleus.  
4.2.4. 3-O-(3’-hydroxybutanoyl)haemanthamine 
The new alkaloid 3-O-(3’-hydroxybutanoyl)haemanthamine exhibited a parent 
[M+H]
+ 
ion at m/z 374.1603 in its HRESIMS spectrum, suggesting the molecular 
formula C20H24NO6 (calcd. 374.1598). The 
1
H NMR data were very similar to those of 
haemanthamine, even though the presence of a 3’-hydroxybutanoyl substituent was also 
observed (carbonyl group at δ 172.4). Furthermore, a loss of 29 units from the 
molecular ion observed by GC-MS (m/z 344, [M-29]
+
) is typical of haemanthamine 
derivatives bearing a hydroxyl group at C-11 (Kreh et al., 1995). The assignment of H-3 
at lower fields (δ 5.44), 1.62 ppm more deshielded than its homologue in 
haemanthamine, supported another 3-O-(3’-hydroxybutanoyl) alkaloid. The magnitude 
of CD spectra established the -orientation of the 5,10b-ethano bridge.  
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4.3. Alkaloids from Hippeastrum calyptratum 
A crinine-type alkaloid, 3-O-methyl-epimacowine was identificated in the 
indigenous Brazilian species Hippeastrum calyptratum. Furthermore, the ongoing 
search for alkaloids in the Amaryllidaceae species using GC-MS resulted in the 
identiﬁcation of 18 alkaloids (Table 4.3, Figure 4.3). 
Table 4.3: GC-MS analysis of the alkaloid content of Hippeastrum calyptratum. 
Alkaloid RI %A* %B* M+ MS 
ismine  2280 - 0.45 257(35) 238(100), 211(6), 196(8), 168(6), 154(3), 106(4), 77(3) 
trisphaeridine  2282 - tr 223(100) 222(38), 167(8), 165(9), 164(14), 138(20), 137(9), 111(13) 
galanthamine  2395 12.93 6.6 287(83) 286(100), 270(13), 244(24), 230(12), 216(33), 174(27), 115(12) 
3-O-methyl-epimacowine  2477 14.68 13.45 287 (100) 272(39), 256(34), 217(71), 203(21), 174(18), 157(18), 128(14) 
narwedine  2483 0.72 tr 285(84) 284(100), 242(18), 216(20), 199(18), 174(31), 128(16), 115(16) 
galanthindol  2487 - 1.11 281(100) 280(7), 264(13), 263(17), 262(20), 252(15), 204(7), 191(14), 
132(8) 
anhydrolycorine  2501 - 5.31 251(43) 250(100), 192(13), 191(11), 165(4), 164(3), 139(2), 124(7) 
nerinine  2509 0.36 0.91 347(˂1) 222(1), 207(2), 179(1), 164(1), 110(8), 109(100), 108(18), 94(2) 
8-O-demethylmaritidine  2510 - tr 273(100) 256(22), 230(20), 201(83), 189(42), 174(22), 128(23), 115(24) 
tazettine /pretazettine  2653 - 0.62 331(31) 316(15), 298(23), 247(100), 230(12), 201(15), 181(11), 152(7) 
11-hydroxyvittatine  2728 - 9.5 287(5) 258(100), 211(15), 186(20), 181(23), 153(13), 128(24), 115(23) 
lycorine 2746 0.89 41.89 287(31) 286(19), 268(24), 250(15), 227(79), 226(100), 211(7), 147(15) 
homolycorine  2767 3.21 - 315(˂1) 206(˂1), 178(2), 109(100), 150(1), 108(22), 94(3), 82(3) 
albomaculine  2815 66.41 13.39 345(˂1) 221(1), 193(1), 165(1), 110(10), 109(100), 108(25), 94(2), 82(3) 
pseudolycorine  2823 - 4.02 289(23) 270(21), 252(12), 228(100), 214(10), 147(17), 111(18), 82(10) 
2α-methoxyhomolycorine  2870 - 0.64 345(˂1) 206(˂1), 178(2), 150(1), 139(100), 124(64), 96(5), 94(5), 81(3) 
2α,7-dimethoxyhomolycorine  2962 0.8 1.88 375(˂1) 236(˂1), 139(100), 124(54), 221(2), 193(2), 96(3), 94(3), 81(2) 
% A: Alkaloid percentage in the total mixture of alkaloids extracted with n-hexane. % B: Alkaloid percentage in the total mixture of 
alkaloids extracted with EtOAc. All values are expressed as a relative percentage of TIC. 
4.3.1. 3-O-methyl-epimacowine 
The new crinine alkaloid 3-O-methyl-epimacowine from H. calyptratum exhibited 
a parent [M+H]
+
 ion at m/z 288.1595 in its HRESIMS spectrum, suggesting the 
molecular formula C17H22NO3 (calcd. 288.1594). The NMR data were similar to those 
of macowine (Nair et al., 2000), the only notable difference arising from the differential 
substitution pattern at C-3. An aliphatic methoxyl group was indicated by the chemical 
shift and splitting pattern of the resonance at δ 3.42 (3H, s), in accordance with previous 
studies on 3-substituted alkaloids of the crinine series (Viladomat et al., 1995). A small 
H-3/H-4 coupling (J = 4.0 Hz) is consistent with the pseudoaxial orientation for the 
3-hydroxyl substituent in macowine (Nair et al., 2000). By contrast, in 3-O-methylepi- 
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macowine the large coupling constant (J3,4β = 10.5 Hz) suggested a pseudoequatorial 
disposition for the 3-methoxyl substituent and therefore a cis relationship with the 
5,10b-ethano bridge. The bridge orientation was confirmed by CD analysis, which 
showed positive and negative Cotton effects at ca. 250 and ca. 290 nm, respectively. 
N
OMe
MeO
HO
H
1
2
3
4
11
12
4a
10b
10a
10
9
8 6a
67  
 
O
R2
MeN
MeO
MeO
H
H
H
R1
R3 R4
 
3-O-methyl-epimacowine R1=H; R2=OMe; R3=OH; R4=H nerinine 
 R1=H; R2=OMe; R3+R4=O albomaculine 
 R1=R2=H; R3+R4=O homolycorine 
 R1=OMe; R2=H; R3+R4=O 2α-methoxyhomolycorine 
 R1=OMe; R2=OMe; R3+R4=O 2α,7-dimethoxyhomolycorine 
 
O
NMe
MeO
H R2
R1
 
N
R3O
R4O
R1
R2
R5
H
 
R1=OH; R2=H    galanthamine R1=OH; R2=H; R3=Me;R4=R5=H  8-O-demethylmaritidine 
R1+R2=O     narwedine R1=OH; R2=H; R3+R4=CH2; R5=OH  11-hydroxyvittatine 
 
N
OH
HO
H
H
R1O
R2O  
O
NMe
O
O
H
R3
R1 R2
OMe
 
R1+R2=CH2 lycorine R1=R2=H; R3=OH tazettine 
R1=H, R2=Me  pseudolycorine R1=OH; R2=H; R3=Hβ pretazettine 
 
NHMe
OH
O
O
 
MeN
OH
O
O
 N
O
O  
N
O
O  
   ismine galanthindol anhydrolycorine trisphaeridine 
Figure 4.3: Alkaloids from Hippeastrum calyptratum. 
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4.4. Parasitic protozoa in vitro assays  
Parasites are organisms that live in or on other organisms (their hosts) and benefit 
by obtaining nutrients at their hosts’ expense. They continue to present a threat for the 
wellbeing of man and his domesticated animals in all parts of the world. There are over 
45000 named species of protozoa and about 10000 are parasitic in invertebrates and in 
almost every species of vertebrate (Machocho, 2000).  
The assays on parasitic protozoa were carried out at the Swiss Tropical Insitute 
(STI), Basel. Table 4.4 lists the parasites, the parasite strain and stage, and the standard 
used for each parasite. The values are expressed in inhibitory doses (IC50) in μg/ml. 
Cytotoxicity was evaluated by use of L-6 myoblast cells, and expressed in inhibitory 
doses (IC50) in μg/ml as well (Table 4.4).  
Table 4.4: Parasitic protozoa in vitro assays. 
Parasite Strain(s) Stage Reference drug 
Trypanosoma brucei rhodesiense STIB 900 trypomastigotes melarsoprol 
Trypanosoma cruzi Tulahuen C4 amastigotes benznidazole 
Leishmania donovani MHOM-ET-67/L82 amastigotes miltefosine 
Plasmodium falciparum NF54 IEF chloroquine 
Cytotoxicity L-6  podophyllotoxin 
Values expressed in μg/ml. 
4.4.1. Trypanosoma brucei rhodesiense 
Trypanosoma brucei rhodesiense is a protozoan subspecies causing Rhodesian 
trypanosomiasis; it is transmitted by tsetse flies, especially Glossina morsitans in 
humans; various game animals can act as reservoir hosts. 
Table 4.5: In vitro assays against T.b.rhodesiense. 
Compound T.b.rhodesiense (IC50) 
melarsoprol 0.0035 
hippapiline 17 
papiline 0.523 
3-O-(3’-hydroxybutanoyl)haemanthamine 2.13 
Values expressed in μg/ml. 
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Four alkaloids were tested against Trypanosoma brucei rhodesiense (strain STIB 
900, stage trypomastigotes). The alkaloid papiline showed favorable activity with an 
IC50 of 0.523 μg/ml. Melarsoprol, which was used as standard, had an IC50 of 
0.0035μg/ml. The other alkaloids, 3-O-(3’-hydroxybutanoyl)haemanthamine, and 
hippapiline, showed very low activities with an IC50 of 2.13 and 17 μg/ml, respectively 
(Table 4.5).  
4.4.2. Trypanosoma cruzi 
Trypanosoma cruzi is a species of parasitic euglenoid protozoan, which infects 
millions of people in South and Central America and is effective in about 100-150 
species of wild and domesticated mammals (Machocho, 2000). 
The new alkaloids from H. papilio were tested against T. cruzi (strain Tulahuen C4, 
stage amastigotes). The alkaloid 3-O-(3’-hydroxybutanoyl)haemanthamine showed mild 
activity with an IC50 of 2.965 μg/ml. Hippapiline and papiline showed no activity. The 
standard benznidazole had an IC50 of 0.6595μg/ml (Table 4.6). 
Table 4.6: In vitro assays against T. cruzi. 
Compound  T.cruzi (IC50) 
benznidazole 0.6595 
hippapiline 61.85 
papiline 47.7 
3-O-(3’-hydroxybutanoyl)haemanthamine 2.965 
Values expressed in μg/ml. 
4.4.3. Leishmania donovani 
Leishmania donovani is one of the leishmania parasites that is prevalent throughout 
tropical and temperate regions including Africa (mostly in Sudan), China, India, Nepal, 
southern Europe, Russia and South America. It is responsible for thousands of deaths 
every year and has spread to 88 countries, with 350 million people at constant risk of 
infection and 0.5 million new cases a year (Machocho, 2000; Desjeux, 2004). 
Papiline and 3-O-(3’-hydroxybutanoyl)haemanthamine showed low activity 
against L. donovani (stain MHOM-ET-67/L82, stage amastigotes) with an IC50 of 2.83, 
4.62 μg/ml, respectively. Miltefosine, the standard, had an IC50 of 0.085 μg/ml (Table 
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4.7).  
Table 4.7: In vitro assays against L.donovani. 
Compound  L.donovani (IC50) 
miltefosine 0.085 
hippapiline 19.85 
papiline 2.83 
3-O-(3’-hydroxybutanoyl)haemanthamine 4.62 
Values expressed in μg/ml. 
4.4.4. Plasmodium falciparum 
Plasmodium falciparum is one of the parasites causing malaria, which is a serious 
disease in the world, with over 500 million people at risk in tropical and subtropical 
regions, especially in Africa (Machocho, 2000). 
Table 4.8: In vitro assays against P. falciparum. 
Compound  P. falciparum (IC50) 
chloroquine 0.002 
hippapiline 30.8 
papiline 17.3 
3-O-(3’-hydroxybutanoyl)haemanthamine 0.987 
Values expressed in μg/ml. 
The alkaloids were tested against P. falciparum (strain NF54, stage IEF). The 
alkaloid 3-O-(3’-hydroxybutanoyl)haemanthamine showed low activity with an IC50 of 
0.987 μg/ml. Hippapiline and papiline showed no activity. The standard is chloroquine, 
which had an IC50 of 0.002 μg/ml (Table 4.8).  
4.4.5. Cytotoxicity  
Cytotoxicity is the quality of being toxic to cells. The cytotoxicity of the alkaloids 
was evaluated on myoblasts (L-6 cells). 3-O-(3’-hydroxybutanoyl)haemanthamine 
showed very low activity against L-6 cells with an IC50 of 1.731 μg/ml compared with 
the standard podophyllotoxin, which had an IC50 of 0.005μg/ml (Table 4.9).  
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Table 4.9: In vitro assays of cytotoxicity against myoblasts (L-6 cells). 
Compound  Cytotoxicity L-6 (IC50) 
podophyllotoxin 0.005 
hippapiline 55.4 
papiline 44.5 
3-O-(3’-hydroxybutanoyl)haemanthamine 1.731 
Values expressed in μg/ml. 
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5. Conclusions 
 Information about the variability and quantity of Lycoris alkaloids has been 
provided. Specifically, the alkaloid profiles of nine species of the genus Lycoris, L. 
albiflora, L. aurea, L. chinensis, L. haywardii, L. incarnata, L. longituba, L. radiata, 
L. sprengeri, and L. squamigera, and one variety (L. radiata var. pumila), have been 
evaluated by GC-MS. Structures belonging to the lycorine-, homolycorine-, 
haemanthamine-, narciclasine-, tazettine-, montanine- and galanthamine-series were 
identified and quantified. Galanthamine- and lycorine-type alkaloids predominating 
and usually showing a high relative abundance in comparison with other alkaloids 
of the extracts.  
 L. longituba could be considered as a potential commercial source of bioactive 
alkaloids (such as galanthamine and lycorine) due to its high content in comparison 
with the other species.  
 The GC-MS technology has been confirmed as sufficiently sensitive for the 
detection and identification of Amaryllidaceae alkaloids, allowing the application of 
quantitative methodologies to obtain valuable information in relatively short 
periods of time. 
 The phytochemical investigation of the Brazilian species Hippeastrum papilio led 
to the identification of nine alkaloids, among which hippapiline, papiline, and 
3-O-(3’-hydroxybutanoyl)haemanthamine are reported here for the first time. An 
unusual cis-B/C ring fusion in the homolycorine alkaloid hippapiline was 
confirmed by NMR and CD spectroscopy. 
 A new crinine-type alkaloid, 3-O-methyl-epimacowine, was indentified in the 
species Hippeastrum calyptratum. In addition, the absolute stereochemistry of the 
5,10b-ethano bridge in the crinine variants was determined by circular dichroism 
and X-ray crystallographic analysis, affording the first direct evidence for the 
presence of crinine-type alkaloids in the genus Hippeastrum. 
112 Research on the Alkaloids of Amaryllidaceae Plants: Genera Lycoris and Hippeastrum 
 
 Parasitic protozoa in vitro assays were performed on the new alkaloids from H. 
papilio. The alkaloid papiline showed favorable activity against Trypanosoma 
brucei rhodesiense but low activity against Leishmania donovani. Additionally, 
3-O-(3’-hydroxybutanoyl)haemanthamine showed mild activity against T. cruzi, 
low activity against L. donovani and Plasmodium falciparum and also showed low 
cytotoxicity against myoblasts (L-6 cells). 
 
Overall, the research has once again demonstrated the enormous potential of the 
Amaryllidaceae (subfamily Amaryllidoideae) plants as sources of bioactive products 
and novel alkaloids, and confirmed the importance of continuing research on species not 
yet explored.
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ABSTRACT
In recent years alkaloids from the genus Hippeastrum have been shown to exhibit 
a broad spectrum of biological activities, including antiparasitic, antiproliferative, 
apoptosis-induced, psychopharmacological, acetylcholinesterase-inhibitory, among 
others. This work presents a brief chemical and biological review of the alkaloids 
found in the genus Hippeastrum. 
Keywords: Amaryllidaceae, “hippeastroid” clade, Hippeastrum, montanine, candi-
mine, 11β-hydroxygalanthamine.
RESUMEN
En los últimos años, los alcaloides aislados del género Hippeastrum han mostrado 
un amplio espectro de actividades incluyendo, entre otras, la antiparasitaria, an-
tiproliferativas, inductoras de apoptosis, psicofarmacológicas y como inhibidores 
de la acetilcolinesterasa. En este trabajo se presenta una breve revisión química 
y biológica de los alcaloides del género Hippeastrum. 
Palabras clave: Amaryllidaceae, clado “hippeastroid”, Hippeastrum, montanina, 
candimina, 11β-hidroxigalantamina.
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1. INTRODUCTION
Hippeastrum is a well-known ornamental 
Amaryllidaceae genus from South Ameri-
ca, particularly Brazil. The Amaryllidaceae 
family is one of the 20 most important 
alkaloid-containing plant families, compri-
sing about 1100 perennial bulbous species 
classified in 85 genera. A particular cha-
racteristic of Amaryllidaceae plants is the 
consistent presence of a large, exclusive 
and still expanding group of isoquinoline 
alkaloids, the majority of which are not 
known to occur in any other plant family 
(Bastida et al., 2006).
Their highly particular skeleton arrange-
ments and broad spectrum of biological ac-
tivities have prompted numerous chemical 
and pharmacological studies of this group 
of alkaloids. As an example, the well-known 
Amaryllidaceae alkaloid galanthamine (50) 
is a long-acting, selective, reversible and 
competitive inhibitor of the acetylcholi-
nesterase enzyme (Thomsen et al., 1998) 
as well as acting as an allosterically po-
tentiating ligand in nicotinic acetylcholine 
receptors (Maelicke et al., 2001). Due to 
these attributes, galanthamine (50) is one 
of the most important drugs used for the 
clinical management of Alzheimer’s disease 
(AD) and is also useful in poliomyelitis and 
other neurological diseases. It is marketed 
as a hydrobromide salt under the name of 
Razadyne® (formerly Reminyl®). As a result 
of these and other activities demonstrated 
by the other skeleton-types (da Silva et al., 
2006; McNulty et al., 2007; Giordani et al., 
2010a, 2011a), plants from the Amaryllida-
ceae family are currently seen as an impor-
tant source of new and bioactive molecules.
The Amaryllidaceae are found mainly 
in the Southern Hemisphere, especially in 
South Africa and South America, which are 
considered to be the primary and secondary 
centers of diversification, respectively, of 
this family (Ito et al., 1999). Recent nrDNA 
ITS sequence studies have divided the Ame-
rican Amaryllidaceae species in Andean 
tetraploid and extra-Andean “hippeastroid” 
clades. In addition, a probable Brazilian 
origin of the Hippeastrum genus has been 
accepted, based on its nrDNA ITS sequen-
ces (Meerow et al., 2000). The Hippeastrum 
genus comprises approximately 70 species 
(Judd et al., 1999), 34 being found in Brazil 
with 22 endemics (Dutilh, 2010). Although 
few of them have been studied to date, 
compounds with remarkable biological 
activity have been isolated in Hippeastrum 
species. Presented here is a brief overview 
of the phytochemical and biological studies 
of the Hippeastrum genus up to May, 2012.
2. GEOGRAPHICAL DISTRIBUTION, 
TAXONOMICAL ASPECTS
The Hippeastrum genus is distributed from 
Mexico and the West Indies to Argentina, 
the majority in eastern Brazil, the Peruvian 
Andes and Bolivia. It basically consists of 
large herbs of annual leaves, mostly hys-
teranthous, sessile, rarely persistent, and 
subpetiolate. Generally, the leaves are more 
than 2 cm wide. The scape is hollow with 2 
free bracts. The flowers (2-13) are usually 
large and mostly purple or red. They are 
funnelform, zygomorphic, declinate, usua-
lly with a short tube and paraperigonal 
fibriae or with a callose ridge present at 
the throat. The stamens are fasciculate and 
declinate-ascendent. The stigma is trifid or 
shortly 3-lobed. The seeds are dry, flatte-
ned, obliquely winged or irregularly discoid, 
hardly ever turgid and globose or subglobo-
se, with a brown or black phytomelanous 
testa (Dahlgren et al., 1985; Meerow and 
Snijman, 1998).
A diploidism of 2n=22 is characteristic 
of the Hippeastrum genus, which is inar-
guably monophyletic with the exception 
of a single species, Hippeastrum blumena-
vium. This was first described as Griffinia 
blumenavia Koch and Bouche ex Carr and 
further studies are required to clarify its 
correct position (Meerow et al., 2000). 
Alkaloids from the Hippeastrum genus: chemistry and biological activity Rev. Latinoamer. Quím. 40/2(2012)   27
The beauty of their flowers has led 
to numerous Hippeastrum species being 
grown as ornamentals after hybridization 
(Meerow and Snijman, 1998), although in 
horticultural circles the use of the name 
“Amaryllis” for this genus persists (Meerow 
et al, 1997).
3. BIOSYNTHESIS AND STRUCTURAL TYPES 
OF AMARYLLIDACEAE ALKALOIDS
As mentioned above, the consistent pre-
sence of an exclusive group of isoquinoline 
alkaloids is the outstanding feature of the 
Amaryllidaceae plant species. Amaryllida-
ceae alkaloids are formed biogenetically by 
intramolecular oxidative coupling of the key 
intermediate O-methylnorbelladine, derived 
from the amino acids L-phenylalanine and 
L-tyrosine (Bastida et al., 2006). Most of 
them can be classified into nine skeleton-
types (Figure 1), namely lycorine, crinine, 
haemanthamine, narciclasine, galantha-
mine, tazettine, homolycorine, montanine 
and norbelladine (Bastida et al., 2006). 
Ortho-para’ phenol oxidative coupling of 
the precursor O-methylnorbelladine re-
sults in the formation of a lycorine-type 
skeleton, from which homolycorine-type 
compounds proceed. Para-para’ phenol 
oxidative coupling leads to the formation 
of crinine, haemanthamine, tazettine, nar-
ciclasine and montanine structures. The 
galanthamine-type skeleton is the only 
one that originates from para-ortho’ phenol 
oxidative coupling (Bastida et al., 2006). In 
the present review, the numbering system 
according to Ghosal et al. (1985) has been 
adopted for the structures (Figure 1).
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Figure 1. Biosynthetic pathway of the main skeleton-type found in the genus Hippeastrum.
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Some new structural subgroups have 
been proposed recently (Ünver, 2007). 
Graciline and plicamine-type alkaloids 
have been found in species of Galanthus, 
Cyrthanthus and Narcissus (Ünver et al., 
1999; Brine et al., 2002; de Andrade et al., 
2012). The biogenetic pathway of gracilines 
possibly originates from the 6-hydroxy de-
rivatives of haemanthamine-type alkaloids 
(Noyan et al., 1998), while plicamine-type 
alkaloids most probably proceed from the 
tazettine-type skeleton, considering their 
structural similarities. Augustamine-type 
alkaloids represent a very rare structure 
found in Crinum species (Ali et al., 1983; 
Machocho et al., 2004). Galanthindole (62) 
is another example of an unusual com-
pound isolated from the Galanthus genus 
and also found in Hippeastrum genus. It 
has been classified as a new skeleton-type 
(Ünver et al., 2003), although the possibility 
that it is an artifact from the homolycori-
ne series should be considered. Another 
uncommon alkaloid found in Hippeastrum 
was a simple carboline, isolated from Hip-
peastrum vittatum (Youssef, 2001).
A few alkaloids commonly found in other 
plant families have also been described in 
Amaryllidaceae plants, for example, the 
mesembrane-type alkaloids, which were 
isolated in Narcissus species (Bastida et 
al., 2006) despite being typical of the ge-
nus Sceletium (Aizoaceae). Phtalideisoqui-
noline-, benzyltetrahydroisoquinoline- and 
aporphine-type alkaloids were found in Ga-
lanthus trojanus (Kaya et al., 2004, 2011), 
being most commonly associated with 
Papaveraceae and Fumariaceae. Tyramine-
type protoalkaloids, which are biosynthe-
sized in Poaceae, Cactaceae, some algae 
and fungi, have also been found in Galan-
thus and Leucojum species (Berkov et al., 
2008, 2011a, 2011b). However, it should be 
borne in mind that these unusual alkaloids 
have always been isolated together with 
typical Amaryllidaceae alkaloids. To date, 
nearly 500 alkaloids have been isolated 
from amaryllidaceous plants (Zhong, 2005).
4. DISTRIBUTION OF ALKALOIDS IN THE 
GENUS HIPPEASTRUM
Phytochemical studies of the genus Hip-
peastrum, as well as of other genera of the 
Amaryllidaceae family, started in the early 
1950s. The alkaloids reported in the genus 
Hippeastrum are summarized in Table 1 
and their respective structures are shown 
in Figure 2. The first phytochemical study 
was described with varieties of H. vittatum, 
which yielded the alkaloids tazettine (39) 
and lycorine (1) (Boit, 1954). Two years la-
ter, a new phytochemical study of the same 
species yielded the alkaloids haemantha-
mine (26), homolycorine (14), hippeastrine 
(15), and vittatine (27), as well as tazettine 
(39) and lycorine (1) (Boit, 1956). In 1957, 
a study of H. bifidum only yielded lycorine 
(1) (Boit and Döpke, 1957). One year later, 
galanthamine (50) was found for the first 
time in a Hippeastrum species, specifically 
in H. rutilum, although it was isolated as 
a minor compound (Boit et al., 1958). The 
work carried out in the 1950s and 60s was 
notable for the isolation of montanine (33) 
in H. aulicum along with some crinine-type 
representatives (Boit and Döpke, 1959). The 
main research on the genus in these two 
decades can be found by searching for the 
authors Boit, HG and Döpke, W. 
There was little phytochemical research 
on Hippeastrum species between the 1970s 
and 1990s. An interesting study was car-
ried out with H. vittatum grown in Egypt 
in different years, which allowed the elu-
cidation of the alkaloids pancracine (32) 
(formerly hippagine) and hippadine (8) (El 
Mohgazi et al., 1975; Ali et al., 1981, 1984). 
A phytochemical study of H. añañuca from 
Chile yielded a new alkaloid but with un-
defined stereochemistry (Pacheco et al., 
1978). Quirion et al., (1991) isolated the 
new compound 3-O-acetylnarcissidine 
(11) from H. puniceum, and Döpke et al., 
(1995a) isolated a new phenantridone alka-
loid named phamine (48) from H. equestre. 
Several known alkaloids were also isolated 
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from H. equestre and submitted to circular 
dichroism studies (Wagner et al., 1996). 
A few years later, H. equestre yielded an-
other new alkaloid, egonine (64) (Pham et 
al., 1999). This structure has been related 
as a typical Sceletium mesembrine-type 
alkaloid (Aizoaceae), although its simila-
rity with tazettine-type skeleton should be 
considered.
Phytochemical studies of H. vittatum 
flowers in 2001 yielded a representative 
alkaloid of the carboline group named 
vittacarboline (61), as well as the new 
alkaloid O-methylismine (60) (Youssef, 
2001). A rapid phytochemical study of H. 
glaucescens provided lycorine (1), preta-
zettine (41) and tazettine (39), but not all 
alkaloid fractions were studied (Hoffman 
et al., 2003). In the last decade, most Hip-
peastrum studies have been focused on 
the biological activity of alkaloids isolated 
from the genus, although the new alka-
loids 2α,7-dimethoxyhomolycorine (24) and 
11β-hydroxygalanthamine (57) found in H. 
morelianum and H. papilio, respectively, 
should be mentioned (Giordani et al., 
2011b, de Andrade et al., 2011).
In the last decade, the GC-MS technique 
has proved to be very effective for rapid 
separation and identification of complex 
mixtures of Amaryllidaceae alkaloids ob-
tained from low mass samples (Kreh et al., 
1995, Berkov et al., 2008, 2011a). The high 
resolution ability of the capillary column 
and numerous EI-MS spectra available in 
the literature allow the identification and 
quantification of known Amaryllidaceae 
alkaloids, avoiding time-consuming and 
laborious isolation procedures. This techni-
que has been much applied with the genera 
Pancratium, Galanthus, Leucojum and Nar-
cissus (Kreh et al., 1995; Torras-Claveria et 
al., 2010; Berkov et al., 2011b; de Andrade 
et al., 2012). The only study applying GC-
MS in the genus Hippeastrum, carried out 
with species from South Brazil, identified 
more compounds than had been isolated 
previously and two species were found to 
produce significant levels of galanthamine 
(50) (de Andrade et al., Personal commu-
nication, 12 June 2012).
To the best of our knowledge, 19 spe-
cies, including hybrids, from the genus Hip-
peastrum have been phytochemically stud-
ied to date. Sixty-four different alkaloids 
with defined structures have been isolated, 
while fourteen remain undefined (Boit and 
Döpke, 1959, 1960a, 1960b; Pacheco et 
al., 1978; de Andrade et al., Personal com-
munication, 12 June 2012). Table 1 and 
Figure 2 summarize the alkaloids found in 
the genus Hippeastrum.
5. BIOLOGICAL AND PHARMACOLOGICAL 
ACTIVITIES OF THE ALKALOIDS FOUND IN 
HIPPEASTRUM
Like most Amaryllidaceae alkaloids, the 
compounds found in the genus Hippeas-
trum have been little evaluated for their 
biological activity. However, some of them 
have demonstrated a broad spectrum of 
interesting properties.
5.1. Ortho-para’ phenolic coupling
5.1.1 Lycorine-type
Lycorine (1) is probably the most frequent 
occurring alkaloid in Amaryllidaceae plants 
and has been found in almost all Hippeas-
trum species. This compound possesses a 
vast array of biological properties, being 
reported as a potent inhibitor of ascorbic 
acid synthesis, cell growth and division, 
and organogenesis in higher plants, algae 
and yeasts, inhibiting the cell cycle du-
ring the interphase (Bastida et al., 2006). 
Additionally, lycorine (1) exhibits antiviral, 
anti-inflammatory, antifungal and anti-
protozoan activities (Çitoğlu et al., 1998; 
McNulty et al., 2009; Giordani et al., 2010b, 
2011a). Lycorine (1) has also been shown to 
have insect antifeedant activity (Evidente et 
al., 1986), as does 3-O-acetylnarcissidine 
(11), isolated from H. puniceum, which is 
particularly active against the polyphagous 
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insect Spodora littoralis but not against the 
olphage Leptinotarsa decemlineata (Santa-
na et al., 2008).
As a potential chemotherapeutic drug, 
lycorine (1) has been studied as an antipro-
liferative agent against a number of cancer 
cell lines (Likhitwitayawuid et al., 1993; 
McNulty et al., 2009). The in vitro mode 
of action in a model HL-60 leukemia cell 
line is associated with suppressing tumor 
cell growth and reducing cell survival via 
cell cycle arrest and induction of apopto-
sis. Furthermore, lycorine (1) was able to 
decrease tumor cell growth and increase 
survival rates with no observable adverse 
effects in treated animals, thus being a good 
candidate for a therapeutic agent against 
leukaemia (Liu et al., 2004, 2007; Liu et 
al., 2009). 
Lycorine (1) isolated from H. santaca- 
tarina showed remarkable inhibitory activ-
ity of the enzymes NTPDase and ecto-5’-
nucleo- tidase from Trichomonas vaginalis, 
which contributes to an increased suscepti-
bility of this parasite to the host immune re-
sponse (Giordani et al., 2010b). Lycorine (1) 
was also demonstrated to have anti-T. vagi-
nalis activity, involving a mechanism of cell 
death induction associated with paraptosis 
rather than the apoptosis observed in tu-
mor cells. This mechanism also differs from 
the one associated with other pro-apoptotic 
compounds tested against T. vaginalis such 
as staurosporine, doxorubicin, etoposide 
and methyl jasmonate. The authors have 
called for additional molecular studies for 
a better characterization of the different 
cell death mechanisms (Giordani et al., 
2011a). Lycorine (1) has also been tested 
in vitro against human immunodeficiency 
virus type 1 (HIV-1), results of antiviral 
showed low inhibition of the replication 
of HIV-1(NL4-3) with an EC50> 0.5 mg/ml 
with infected lymphoid MT-4 human cells 
(Reyes-Chilpa et al., 2011).
Compared to other lycorine-type al-
kaloids, anhydrolycorine (12) showed a 
greater ability to inhibit ascorbic acid syn-
thesis (Evidente et al., 1986). Analgesic, 
hypotensive and antiparasitic activities 
have been reported for galanthine (3). Un-
geremine (13) has shown acetylcholineste- 
rase inhibitory activity (Bastida et al., 
2006). In summary, the lycorine skeleton-
type is a promising target for further bio-
logical assessments.
5.1.2 Homolycorine-type
Homolycorine (14), 8-O-demethylhomo-
lycorine (20) and hippeastrine (15) are 
well-known cytotoxic alkaloids. Homolyco-
rine (14) has also shown high antiretroviral 
activity, while hippeastrine (15) is active 
against Herpes simplex type 1. Homolyco-
rine (14) and 8-O-demethylhomolycorine 
(20) have a hypotensive effect on normo-
tensive rats. In addition, hippeastrine (15) 
shows antifungal activity against Candida 
albicans and also possesses a weak insect 
antifeedant activity (Bastida et al., 2006). 
Candimine (17), first found in H. candidum 
(Döpke, 1962), has been tested against 
Trichomonas vaginalis and found to inhi-
bit the T. vaginalis enzymes NTPDase and 
ecto-5’-nucleotidase to a greater extent 
than lycorine (1) (Giordani et al., 2010b). 
Candimine (17) was also active against T. 
vaginalis, apparently inducing cell death 
by paraptosis, as in the case of lycorine 
(1) (Giordani et al., 2010a). Homolycorine 
(14) and 8-O-demethylhomolycorine (20) 
were tested against the parasitic protozoa 
Trypanosoma cruzi, Trypanosoma brucei 
rhodesiense, Leishmania donovani and 
Plasmodium falciparum but showed no 
significant activity (de Andrade et al., 
2012). However, the bioactivity of most 
homolycorine-type alkaloids is largely 
unknown.
5.2. Para-para’ phenolic coupling 
5.2.1. Haemanthamine-type
Haemanthamine (26), as well as crina-
mine, has proven to be a potent inducer 
of apoptosis in tumor cells at micromolar 
concentrations (McNulty et al., 2007). This 
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compound also possesses antimalarial acti-
vity against strains of chloroquine-sensitive 
Plasmodium falciparum, hypotensive effects 
and antiretroviral activity (Bastida et al., 
2006; Kaya et al., 2011). Vittatine (27), iso-
lated from H. vittatum, and maritidine (30), 
have shown cytotoxic activity against HT29 
colon adenocarcinoma, lung carcinoma and 
RXF393 renal cell carcinoma (Bastida et al., 
2006; da Silva et al., 2008). Vittatine (27) 
also showed antibacterial activity against 
Gram-positive Staphylococcus aureus and 
Gram-negative Escherichia coli, as well as 
11-hydroxyvittatine (29) (Kornienko and 
Evidente, 2008).
5.2.2. Crinine-type
The alkaloids crinine, 6-hydroxybuphani-
drine and 6-ethoxybuphanidrine showed 
antiproliferative effects against human 
tumor cell lines, crinine being the most 
active (Berkov et al., 2011c). A comparative 
study of skeleton-types concluded that the 
crinine-type alkaloid buphanamine was the 
most promising, since it showed important 
anti-proliferative effects and was well tole-
rated even at high concentration (Evidente 
et al., 2009). Further evaluations are nee-
ded to gain more insight into the biological 
activity of the crinine-type skeleton.
5.2.3. Tazettine-type
The alkaloids 3-epi-macronine (42) and 
tazettine (39) showed moderate cytotoxic 
activity. Tazettine (39) is an isolation ar-
tefact of chemically labile pretazettine (41) 
(de Andrade et al., 2012), the latter being 
far more interesting due to its antiviral and 
anticancer activities (Bastida et al., 2006). 
Pretazettine (41) shows cytotoxicity against 
fibroblastic LMTK cell lines and inhibits 
HeLa cell growth, being therapeutically 
effective against advanced Rauscher leu-
kemia, Ehrlich ascites carcinoma, spon-
taneous AKR lymphocytic leukemia, and 
Lewis lung carcinoma (Bastida et al., 2006). 
Pretazettine (41) isolated from H. psittaci-
num was tested for its ability to inhibit the 
AChE enzyme but showed no significant 
result (Pagliosa et al., 2010). 
5.2.4. Montanine-type
This group has very few representatives. 
The alkaloids montanine (33) and pancra-
cine (32) have been isolated in different 
periods from Hippeastrum species growing 
in Europe and South America, such as H. 
vittatum. In recent work montanine (33) 
showed anxiolytic-, antidepressant- and 
anticonvulsant-like effects in mice (da Silva 
et al., 2006). Montanine (33) and vittatine 
(27) were also submitted to an antiprolifera-
tive study, the former showing the highest 
level of cytotoxicity (da Silva et al., 2008). 
Furthermore, montanine (33) significantly 
inhibited AChE activity at concentrations of 
1 milimolar, and 500 and 100 micromolar 
using the Ellman method (Pagliosa et al., 
2010). Pancracine (32) showed antibacte-
rial activity against Staphylococcus aureus 
and Pseudomonas aeruginosa, as well as 
weak activity against Trypanosoma brucei 
rhodesiense, Trypanosoma cruzi and Plas-
modium falciparum (Bastida et al., 2006). 
The montanine-type skeleton represents 
one of the most interesting alkaloids for 
biological evaluations due to its remarkable 
and broad spectrum of activities. 
5.2.5. Narciclasine-type
Trisphaeridine (49) has a high retroviral 
activity but a low therapeutic index (Bas-
tida et al., 2006). Narciclasine and pan-
cratistatin are the most studied alkaloids 
of this group but they have never been 
found in the Hippeastrum genus. Both 
compounds show strong antimitotic and 
antitumoral activities (Bastida et al., 2006). 
No biological evaluation of the alkaloids N-
methylcrinasiadine (47) and phamine (48) 
has been carried out to date.
5.3. Para-ortho’ phenolic coupling
5.3.1. Galanthamine-type
Galanthamine (50) is a long-acting, selec-
tive, reversible and competitive inhibitor of 
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acetylcholinesterase (AChE) and an allos-
teric modulator of the neuronal nicotinic 
receptor for acetylcholine. Its action increa-
ses acetylcholine levels, thus facilitating 
cholinergic synapses and helping in the 
management of patients suffering certain 
stages of AD (Maelicke et al., 2001; Basti-
da et al., 2006; Heinrich and Teoh, 2004). 
Galanthamine (50), therefore, is the most 
studied Amaryllidaceae alkaloid in terms 
of biological activity, clinical response, 
tolerance and safety, being marketed as a 
hydrobromide salt under the name of Ra-
zadine®, formerly Reminyl®. Galanthamine 
(50) has superior pharmacological profiles 
and higher tolerance than the original 
AChE inhibitors physostigmine or tacrine 
(Grutzendler and Morris, 2001).
After the therapeutic success of ga-
lanthamine (50), the search for new 
AChE inhibitors has intensified. Epi-ga-
lanthamine, with a hydroxyl group at the 
α-position, and narwedine (56), with a keto 
group at C3, are also active AChE inhibi-
tors, but about 130-times less powerful 
than galanthamine (50) (Thomsen et al., 
1998). The loss of the methyl group at the 
N atom, as in N-demethylgalanthamine 
(54), decreases the activity 10-fold. The 
alkaloids habranthine and its new epimer 
11β-hydroxygalathamine (57), isolated 
from H. papilio, which shows a hydroxyl-
substituent at C11, were both also ca. 
10-times less active than galanthamine 
(50) (López et al., 2002; de Andrade et al., 
2011). Hydrogenation of the C4-C4a double 
bond, as in lycoramine, results in a com-
plete loss of AChE inhibitory activity (López 
et al., 2002). 
On the other hand, sanguinine (53), 
which has a hydroxyl group at C9 instead 
of a methoxyl group, is ca. 10 times more 
active than galanthamine (50). Recently, 
N-alkylated galanthamine derivatives 
were isolated from Leucojum species and 
were also ca. 10 times more active than 
galanthamine (50). It has been suggested 
that these naturally occurring AChE inhi-
bitors can act as ecological pesticides, sin-
ce the AChE-inhibitory activity of synthe-
tic pesticides, such as phospho-organic 
derivatives, is non-reversible (Houghton 
et al., 2006). 
Galanthamine (50) has also been tested 
in vitro against human immunodeficiency 
virus type 1 (HIV-1), results of antiviral 
assays indicated that galanthamine (50), 
as well as its structural isomer chlidan-
thine (51) and galanthamine N-oxide, did 
not showed inhibition of the replication of 
HIV-1(NL4-3) with infected lymphoid MT-4 
human cells, but they were also not toxic to 
non infected cells showing EC50, and CC50 > 
20 mg/ml), respectively (Reyes-Chilpa et al., 
2011). The galanthamine-type skeleton is 
currently the most studied group in terms 
of biological activity.
5.4. Miscellaneous
Ismine (59) shows a significant hypoten-
sive effect on rats and cytotoxicity against 
Molt 4 lymphoid and LMTK fibroblastic 
cell lines (Bastida et al., 2006). Recently, 
extracts from H. breviflorum showing diffe-
rent ratios between lycosinine B (63) and 
lycorine (1) by HPLC demonstrated signi-
ficant anti-Trichomonas vaginalis activity 
(Vieira et al., 2011). To date, the alkaloids 
vittacarboline (61), galanthindole (62) and 
O-methylismine (60) have not been biolo-
gically evaluated.
6. CONCLUSION
Over the last 50 years, the bulbous genus 
Hippeastrum has yielded 64 different alka-
loids, together with others whose structu-
res remain undefined. Further studies on 
the isolation of these compounds are called 
for, especially after recent biological studies 
showing their significant antiparasitic, psy-
chopharmacological and AChE-inhibitory 
activities. Notably, some Hippeastrum spe-
cies are able to produce a high level of ga-
lanthamine (50), comparable with species 
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of other genera currently being used for the 
commercial production of this alkaloid. The 
lack of biological activity shown by most 
of the alkaloids found in the Hippeastrum 
genus may be due to the small amounts 
isolated. Consequently, their synthesis or 
in silico studies will facilitate further bioac-
tivity assessment.  
ACKNOWLEDGEMENTS
The authors are grateful to the Generalitat 
de Catalunya (2009 - SGR1060) for finan-
cial support of this work. J.P.A. is thankful 
to the Agencia Española de Cooperación 
Internacional para el Desarollo (BECAS-
MAEC-AECID) for a doctoral fellowship.
REFERENCES
Alam, A.H.M., Murav’eva, D.A. (1982) Alkaloids of the underground organs of Hippeastrum 
equestre. Khimiya Prirodnykh Soedinenii 3: 401.
Ali, A.A., Mesbah, M.K., Frahm, A.W. (1981) Phytochemical investigation of Hippeastrum vittatum 
growing in Egypt. Part III: structural elucidation of hippadine. Planta Medica 43: 407-409.
Ali, A.A., Hambloch, H., Frahm, A.W. (1983) Relative configuration of the alkaloid augustamine. 
Phytochemistry 22: 283-287.
Ali, A.A., Mesbah, M.K., Frahm, A.W. (1984) Phytochemical investigation of Hippeastrum vit-
tatum. Part IV: stereochemistry of pancracine, the first 5,11-methano-morphanthridine 
alkaloid from Hippeastrum – structure of “hippagine”. Planta Medica 50: 188-189. 
Bastida, J., Codina, C., Porras, C.L., Paiz, L. (1996) Alkaloids from Hippeastrum solandriflorum. 
Planta Medica 62: 74-75.
Bastida, J., Lavilla, R., Viladomat, F. (2006) Chemical and biological aspects of Narcissus 
alkaloids. In Cordell, G. (eds) The Alkaloids: Chemistry and Biology. The Netherlands: 
Elsevier Inc, pp. 87-179.
Berkov, S., Bastida, J., Sidjimova, B., Viladomat, F., Codina, C. (2008) Phytochemical diffe-
rentiation of Galanthus nivalis and Galanthus elwesii: a case study. Biochemical Systematic 
and Ecology 36: 638-645.
Berkov, S., Bastida, J., Sidjimova, B., Viladomat, F., Codina, C. (2011a) Alkaloid diversity in 
Galanthus elwesii and Galanthus nivalis. Chemistry and Biodiversity 8: 115-130.
Berkov, S., Bastida, J., Viladomat, F., Codina, C. (2011b) Development and validation of a GC-
MS method for a rapid determination of galanthamine in Leucojum aestivum and Narcissus 
ssp.: A metabolomic approach. Talanta 83: 1455-1465.
Berkov, S., Romani, S., Herrera, M., Viladomat, F., Codina, C., Momekov, G., Ionkova, I., 
Bastida, J. (2011c) Antiproliferative alkaloids from Crinum zeylanicum. Phytotheraphy 
Research 25: 1686-1692.
Boit, H.G. (1954) Alkaloids of the Amaryllidaceae. VI. The alkaloids of Nerine sarniensis, Cri-
num moorei, Hippeastrum vittatum and Clivia miniata. Chemische Berichte 87: 1704-1707.
Boit, H.G. (1956) Amaryllidaceous alkaloids. XI. Alkaloids of Chlidanthus fragrans, Vallota 
purpurea, Nerine undulate, and Hippeastrum vittatum. Chemische Berichte 89: 1129-1134.
Boit, H.G., Döpke, W. (1957) Alkaloids of the Amaryllidaceae. XVIII. Alkaloids from Urceolina, 
Hymenocallis, Elisena, Calostemma, Eustephia, and Hippeastrum. Chemische Berichte 90: 
1827-1830.
Boit, H.G., Döpke, W., Stender, W. (1958) Alkaloids from Hippeastrum rutilum, Lycoris albiflora, 
Zephyranthes andersoniana, and Sternbergia fischeriana. Naturwissenschaften 45: 390.
Alkaloids from the Hippeastrum genus: chemistry and biological activity Rev. Latinoamer. Quím. 40/2(2012)   37
Boit, H.G., Döpke, W. (1959) Alkaloids from Hippeastrum brachyandrum and Hippeastrum 
rutilum. Chemische Berichte 92: 2582-2584.
Boit, H.G., Döpke, W. (1960a) Alkaloids from Hippeastrum aulicum var. robustum. Naturwis-
senschaften 47: 109.
Boit, H.G., Döpke, W. (1960b) New alkaloids from Hippeastrum hybrids and Nerine flexuosa. 
Naturwissenschaften 47: 470-471.
Brine, N.D., Campbell, W.E., Bastida, J., Herrera, M.R., Viladomat, F., Codina, C., Smith, P.J. 
(2002) A dinitrogenous alkaloid from Cyrthanthus obliquus.  Phytochemistry 61: 443-447.
Çitoğlu, G., Tanker, M., Gümüşel, B. (1998) Antiinflammatory effects of lycorine and haeman-
thidine. Phytotherapy Research 12: 205-206.
da Silva, A.F.S., de Andrade, J.P., Bevilaqua, L.R., de Souza, M.M., Izquierdo, I., Henriques, 
A.T., Zuanazzi, J.A.S. (2006) Anxiolytic-, antidepressant- and anticonvulsivant-like effects 
of the alkaloid montanine isolated from Hippeastrum vittatum. Pharmacology, Biochemistry 
and Behaviour 85: 148-54.
da Silva, A.F.S., de Andrade, J.P., Machado, K.R.B., Rocha, A.B., Apel, M.A., Sobral, M.G.E., 
Henriques, A.T., Zuanazzi, J.A.S. (2008) Screening for cytotoxic activity of extracts and 
isolated alkaloids from bulbs of Hippeastrum vittatum. Phytomedicine 15: 882-885.
Dahlgren, R.M.T., Clifford, H.T., Yeo, P.F. (1985) The families of the monocotyledons. Structure, 
evolution, and taxonomy. 1st Edition. Springer-Verlag, Berlin pp. 199-206.
de Andrade, J.P., Berkov, S., Viladomat, F., Codina, C., Zuanazzi, J.A.S., Bastida, J. (2011) 
Alkaloids from Hippeastrum papilio. Molecules 16: 7097-7104.
de Andrade, J.P., Pigni, N.B., Torras-Claveria, L., Berkov, S., Codina, C., Viladomat, F., Bastida, 
J. (2012) Bioactive alkaloid extracts from Narcissus broussonetii: mass spectral studies. 
Journal of Pharmaceutical and Biomedical Analysis 70: 13-25.
de Andrade, J.P. GC-MS approach and acetylcholinesterase inhibition of some Brazilian Ama-
ryllidaceae species. (Personal communication, 12 June 2012).
Döpke, W. (1962) Alkaloids of the Hippeastrum type. Archiv der Pharmazie und Berichte der 
Deutschen Pharmazeutischen Gesellschaft 295: 920-924.
Döpke, W., Bienert, M. (1966) Alkaloids from Amaryllidaceae; structure of oduline. Pharmazie 
21: 323-324.
Döpke, W., Pham, L.H., Gruendemann, E., Bartoszek, M., Flatau, S. (1995a) Alkaloids from 
Hippeastrum equestre; Part I: phamine, a new phenanthridone alkaloid. Planta Medica 
61: 564-566.
Döpke, W., Pham, L.H., Gruendemann, E., Bartoszek, M., Flatau, S. (1995b) Alkaloids from 
Hippeastrum equestre Herb. Pharmazie 50: 511-512.
Dutilh, J.H.A. (2010) Amaryllidaceae. In: Andrea Jakobsson Estúdio: Instituto de Pesquisas 
Jardim Botânico do Rio de Janeiro (eds). Catálogo de Plantas e Fungos do Brasil. Rio de 
Janeiro, Brasil: Sindicato Nacional de Editores de Livros, pp. 596-599.
El Mohgazi, A.M., Ali, A.A., Mesbah, M.K. (1975) Phytochemical investigation of Hippeastrum 
vittatum growing in Egypt. II. Isolation and identification of new alkaloids. Planta Medica 
28: 336-342.
El Mohgazi, A.M., Ali, A.A. (1976) Microchemical identification of Amaryllidaceae alkaloids. Part 
I. Crinidine, vittatine, crinamine, powelline, hippacine, lycorine and B II. Planta Medica 
30: 369-374.
Evidente, A., Arrigoni, O., Luso, R., Calabrese, G., Randazzo, G. (1986) Further experiments on 
structure-activity relationships among lycorine alkaloids. Phytochemistry 25: 2739-2743.
Evidente, A., Kireev, A.S., Jenkins, A.R., Romero, A.E., Steelant, W.F.A., Slambrouck, S.V., 
38 J.P. de andrade, n. B. Pigni, l. torras-Claveria, et al.
Kornienko, A. (2009) Biological evaluation of structurally diverse Amaryllidaceae alkaloids 
and their synthetic derivatives: discovery of novel leads for anticancer drug design. Planta 
Medica 75: 501-507.
Ghosal, S., Saini, K.S, Razdan, S. (1985) Crinum alkaloids: their chemistry and biology. Phyto-
chemistry 24: 2141-2156.
Giordani, R.B., Vieira, P.B., Weizenmann, M., Rosember, D.B., Souza, A.P., Bonorino, C., de 
Carli, G.A., Bogo, M.R., Zuanazzi, J.A.S., Tasca, T. (2010a). Candimine-induced cell death 
of the amitochondriate parasite Trychomonas vaginalis. Journal of Natural Products 73: 
2019-23.
Giordani, R.B., Weizenmann, M., Rosember, D.B., de Carli, G.A., Bogo, M.R., Zuanazzi, J.A.S., 
Tasca, T. (2010b) Trychomonas vaginalis nucleoside triphosphate diphosphohydrolase 
and ecto-5’-nucleotidase activities are inhibited by lycorine and candimine. Parasitology 
International 59: 226-231.
Giordani, R.B., Vieira, P.B., Weizenmann, M., Rosember, D.B., Souza, A.P., Bonorino, C., de 
Carli, G.A., Bogo, M.R., Zuanazzi, J.A.S., Tasca, T. (2011a) Lycorine induces cell death 
in the amitochondriate parasite, Trichomonas vaginalis, via an alternative non-apoptotic 
death pathway. Phytochemistry 72: 645-50.
Giordani, R.B., de Andrade, J.P., Verli, H., Dutilh, J., Henriques, A.T., Berkov, S., Bastida, J., 
Zuanazzi, J.A.S. (2011b). Alkaloids from Hippeastrum morelianum Lem. (Amaryllidaceae). 
Magnetic Resonance in Chemistry 49: 668-72.
Grutzendler, J., Morris, J.C. (2001) Cholinesterase inhibitors for Alzheimer’s Disease. Drugs 
61: 41-52.
Heinrich, M., Teoh, H.L. (2004) Galanthamine from snowdrop – the development of a modern 
drug against Alzhemeir’s disease from local Caucasian knowledge. Journal of Ethnophar-
macology 92: 147-162.
Hofmann Jr. A.E., Sebben, C., Sobral, M., Dutilh, J.H.A., Henriques, A.T., Zuanazzi, J.A.S. 
(2003) Alkaloids of Hippeastrum glaucescens. Biochemical Systematics and Ecology 31: 
1455-1456.
Houghton, P., Ren, Y., Howes, M.J. (2006) Acetylcholinesterase inhibitors from plants and 
fungi. Natural Products Reports 23: 181-199.
Ito, M., Kawamoto, A., Kita, Y., Yukawa, T., Kurita, S. (1999) Phylogenetic relationships of 
Amaryllidaceae based on matk sequence data. Journal of Plant Research 112: 207-216.
Judd, W.S., Campbell, C.S., Kellogg E.A., Stevens, P.F. (1999) Plant Systematics: A phylogenic 
approach. Sinauer Associates, Inc: Sunderland, USA pp. 190-191.
Kaya, G.I., Ünver, N., Gözler, B., Bastida, J. (2004) ( - )-Capnoidine and (+)-bulbocapnine from 
an Amaryllidaceae species, Galanthus nivalis subsp. cilicicus. Biochemical Systematics and 
Ecology 32: 1059-1062.
Kaya, G.I, Sarikaya, B., Onur, M.A, Ünver, N., Viladomat, F., Codina, C., Bastida, J., Lauinger, 
I.L., Kaiser, M., Tasdemir, D. (2011) Antiprotozoal alkaloids from Galanthus trojanus. Phy-
tochemistry Letters 4: 301-305.
Kornienko, A., Evidente, A. (2008) Chemistry, biology and medicinal potential of narciclasine 
and its congeners. Chemical Reviews 108: 1982-2014.
Kreh, M., Matusch, R., Witte, L. (1995). Capillary gas chromatography-mass spectrometry of 
Amaryllidaceae alkaloids. Phytochemistry 38: 773-76.
Likhitwitayawuid, K., Angerhofer, C.K., Chai, H., Pezzuto, J.M., Cordell, G.A. (1993) Cytotoxic 
and antimalarial alkaloids from the bulbs of Crinum amabile. Journal of Natural Products 
56: 1331-1338.
Liu, J., Hu, W.X., He, L.F., Ye, M., Li, Y. (2004) Effects of lycorine on HL-60 cells via arresting 
Alkaloids from the Hippeastrum genus: chemistry and biological activity Rev. Latinoamer. Quím. 40/2(2012)   39
cell cycle and inducing apoptosis. FEBS Letters 578: 245-250.
Liu, J., Li, Y., Tang, L.J., Zhang, G.P., Hu, W.X. (2007) Treatment of lycorine on SCID mice 
model with human APL cells. Biomedicine and Pharmacotherapy 61: 229-234.
Liu, X.S., Jiang, J., Jiao, X.Y., Wu, Y.E., Lin, J.H., Cai, Y.M. (2009) Lycorine induces apoptosis 
and down-regulation of Mcl-1 in human leukemia cells. Cancer Letters 274: 16-24.
López, S., Bastida, J., Viladomat, F., Codina, C. (2002) Acetylcholinesterase inhibitory activity 
of some Amaryllidaceae alkaloids and Narcissus extracts. Life Sciences 71: 2521-2529.
Maelicke, A., Samochocki, M., Jostock, R., Fehrenbacher, A., Ludwig, J., Albuquerque, E.X., 
Zerlin, M. (2001) Allosteric sensitization of nicotinic receptors by galantamine, a new treat-
ment strategy for Alzheimer’s disease. Biology Psichiatry 49: 279-288.
Machocho, A.K., Bastida, J., Codina, C., Viladomat, F., Brun, R., Chhabra, S.C. (2004) Augus-
tamine type alkaloids from Crinum kirkii. Phytochemistry 65: 3143-3149.
McNulty, J., Nair, J.J., Codina, C., Bastida, J., Pandey, S., Gerasimoff, J., Griffin, C. (2007) 
Selective apoptosis-inducing activity of crinum-type Amaryllidaceae alkaloids. Phytoche-
mistry 68: 1068-1074.
McNulty, J., Nair, J.J., Bastida, J., Pandey, S., Griffin, C. (2009) Structure-activity studies 
on the lycorine pharmacophore: a potent inducer of apoptosis in human leukemia cells. 
Phytochemistry 70: 913-919.
Meerow, A.W., Scheepen, J., Dutilh, J.H.A. (1997) Transfer from Amaryllis to Hippeastrum 
(Amaryllidaceae). Taxon 46: 15-19.
Meerow, A.V., Snijman, D.A. (1998) Amaryllidaceae. In Kubitzki, K. (eds) The Families and 
Genera of Vascular Plants. Berlin: Springer-Verlag, pp. 83-110.
Meerow, A.V., Guy, C.L., Li, Q.B., Yang, S.L. (2000) Phylogeny of the American Amaryllidaceae 
based on nrDNA ITS sequences. Systematic Botany 25: 708-726.
Mügge, C., Schablinski, B., Obst, K., Döpke, W. (1994) Alkaloids from Hippeastrum hybrids. 
Pharmazie 49: 444-447.
Murav’eva, D.A., Alam, A.H.M. (1982) Alkaloids of the aboveground organs of Hippeastrum 
equestre. Khimiya Prirodnykh Soedinenii 4: 533.
Noyan, S., Rentsch, G.H., Önur, M.A., Gözler, T., Gözler, B., Hesse, M. (1998) The gracilines: 
a novel subgroup of the Amaryllidaceae alkaloids. Heterocycles 48: 1777-1791.
Pagliosa, L.B., Monteiro, S.C., Silva, K.B., de Andrade, J.P., Dutilh, J., Bastida, J., Cammarota, 
M., Zuanazzi, J.A.S. (2010). Effect of isoquinoline alkaloids from two Hippeastrum species 
on in vitro acetylcholinesterase activity. Phytomedicine 17: 698-701.
Pacheco, P., Silva, M., Steglich, W., Watson, W.H. (1978) Alkaloids of Chilean Amaryllidaceae. 
I. Hippeastidine and epi-homolycorine, two novel alkaloids. Revista Latinoamericana de 
Química 9: 28-32.
Pham, L.H., Grundemann, E., Döpke, W. (1997) Alkaloids from Hippeastrum equestre. Part 3. 
Pharmazie 52: 160-162.
Pham, L.H., Grundemann, E., Wagner, J., Bartoszek, M., Döpke, W. (1999) Two novel Amary-
llidaceae alkaloids from Hippeastrum equestre Herb.: 3-O-demethyltazettine and egonine. 
Phytochemistry 51: 327-332.
Quirion, J.C., Husson, H.P., Weniger, B., Jiménez, F., Zanoni, T.A. (1991) (–)-3-O-acetylnarcissidi-
ne, a new alkaloids from Hippeastrum puniceum. Journal of Natural Products 54: 1112-1114.
Rao, R.V.K., Nazar, A., Vimaladevi, R. (1971) Phytochemical studies on Hippeastrum johnsonii 
bulbs. Indian Journal of Pharmacy 33: 56-58. 
Rao, R.V.K., Vimaladevi, R. (1972) Crystalline alkaloids from Hippeastrum equestre [Amaryllis 
belladonna]. Planta Medica 21: 142-143.
Reyes-Chilpa, R., Berkov, S., Hernández-Ortega, S., Jankowski, C.K., Arseneau, S., Clotet-
40 J.P. de andrade, n. B. Pigni, l. torras-Claveria, et al.
Codina, I., Esté, J.A., Codina, C., Viladomat, F., Bastida, J. (2011). Acetylcholinesterase 
inhibiting alkaloids from Zephyranthes concolor. Molecules 16: 9520-9533.
Santana, O., Reina, M., Anaya, A.L., Hernández, F., Izquierdo, M.E., González-Coloma, A. 
(2008) 3-O-acetyl-narcissidine, a bioactive alkaloid from Hippeastrum puniceum Lam. 
(Amaryllidaceae). Zeitschrift fuer Naturforschung, C: Journal of Biosciences 63: 639-643.
Sepúlveda, B.A., Pacheco, P., Silva, M.J., Zemelman, R. (1982) Alkaloids of the Amarillidaceas 
chilensis. III. Chemical study and biological activity in Hippeastrum bicolor (RetP) Baker. 
Boletín de la Sociedad Chilena de Química 27: 178-180.
Thomsen, D., Bickel, U., Fischer, J., Kewitz, H. (1998) Stereoselectivity of cholinesterase 
inhibition by galanthamine and tolerance in humans. European Journal of Clinical Phar-
macology 39: 603-605.
Torras-Claveria, L., Berkov, S., Jáuregui, O., Caujapé, J., Viladomat, F., Codina, C., Bastida, 
J. (2010) Metabolic profiling of bioactive Pancratium canariense extracts by GC-MS. Phyto-
chemical Analysis 21: 80-88.
Ünver, N., Gözler, T., Walch, N., Gözler, B., Hesse, M. (1999) Two novel dinitrogenous alkaloids 
from Galanthus plicatus subsp. byzantinus (Amaryllidaceae), Phytochemistry 50: 1255-1261.
Ünver, N., Kaya, G.I., Werner, C., Verpoorte, R., Gözler, B. (2003) Galanthindole: a new indole 
alkaloid from Galanthus plicatus ssp. byzantinus. Planta Medica 69: 869-871.
Ünver, N. (2007) New skeletons and new concepts in Amaryllidaceae alkaloids. Phytochemical 
Reviews 6: 125-135.
Vieira, P.B., Giordani, R.B., De Carli, G.A., Zuanazzi, J.A.S., Tasca, T. (2011) Screening and 
bioguided fractionation of Amaryllidaceae species with anti-Trychomonas vaginalis activity. 
Planta Medica 77: 1054-1059.
Wagner, J., Pham, H.L., Döpke, W. (1996) Alkaloids from Hippeastrum equestre Herb.-5. Cir-
cular dichroism studies. Tetrahedron 52: 6591-6600.
Youssef, D.T.A. (2001) Alkaloids of the flowers of Hippeastrum vittatum. Journal of Natural 
Products 64: 839-841.
Zhong, J. (2005) Amaryllidaceae and Sceletium alkaloids. Natural Products Reports 22: 111-126.
Appendices 153 
 
 
7.2. AppendixⅡ: Supplementary data for new alkaloids 
7.2.1. Hippapiline 
O
MeO
HO
MeN
OMe
H
HH
1
2
3
4
4a
66a
7
8
9
10
11
12
10b
10a
 
Hippapiline (1): [α]24D +33 (c 0.15, CHCl3); CD [θ]
20
λ: [θ]227 +1330, [θ]247.5 −455, 
[θ]281.5 +89, [θ]305.5 −176; UV (MeOH) λmax (log ε) 316 (2.90), 282 (3.30), 228 (3.64), 
205 (4.27) nm;
 
IR (CHCl3) νmax: 3380, 2924, 1733, 1509, 1449, 1275, 1130, 1058, 1043, 
960, 913, 880, 802, 758 cm
-1
; HREIMS of [M+H]
+
 m/z 318.1706 (calcd. for C18H24NO4, 
318.1700). 
Figure S1: Physical and spectroscopic data of compound 1. 
 
 
 
 
 
 
 
Figure S2: GC-MS spectrum of compound 1. 
RI: 2301 
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Figure S3: CD spectrum of compound 1. 
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Table S1: 
1
H NMR, COSY, NOESY, HMBC (500MHz, CDCl3) and 
13
C NMR(125MHz, CDCl3) data of compound 1. 
Position H δ (J in Hz) COSY NOESY    C δ      HMBC 
1 4.29 ddd (9.8, 6.8, 4.5) H-2α, H-2β, H-10b H-2a, H-2β, H-4a, H-10b 70.5 d   
2α 2.41-2.47 m H-1, H-2β, H-3, H-4a, H-11 H-1, H-2β, H-3, 6-OMe 28.9 t   
2β 2.25-2.29 m H-1, H-2α, H-3, H-4a, H-11 H-1, H-2α, H-3   
3 5.07 br s H-2α, H-2β, H-4a, H-11 H-2α, H-2β, H-11 115.2 d   
4    138.4 s   
4a 2.94 br s H-2α, H-2β, H-3, H-10b; H-11 H-1, H-10b, H-12β, NMe 70.6 d   
6β 5.44 s H-7 H-7, H-10b, 6-OMe 97.1 d  C-1, C-10a, 6-OMe 
6a    127.8 s   
7 6.88 s H-6β H-6β 112.4 d  C-6, C-8, C-9, C-10a 
8    143.7 s   
9    145.9 s   
10 8.41 s H-10b 9-OMe, NMe 110.6 d  C-6a, C-8 
10a    126.7 s   
10b 3.32 t (4.5) H-1, H-4a, H-10 H-1, H-4a, H-6β, NMe 35.4 d  C-1, C-4, C-4a, C-6a 
11 (2H) 2.28-2.36 m H-2α, H-2β, H-3, H-4a, H-12α, H-12β H-3, H-12α,,H-12β 28.6 t   
12α 3.21 ddd (8.7, 6.7, 2.0) H-11, H-12β H-11, H-12β, NMe 56.1 t  C-4, C-4a 
12β 2.18 dt (9.8, 8.6) H-11, H-12α H-4a, H-11, H-12α, NMe   
6-OMe 3.57 s  H-2α, H-6β 55.3 q  C-6 
9-OMe 3.80 s  H-10 55.7 q  C-9 
NMe 2.44 s  H-4a, H-10, H-10b, H-12α, H-12β 40.0 q  C-4a, C-12 
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Figure S4: 
1
H NMR spectrum of compound 1. 
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Figure S5: NOESY spectrum of compound 1. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S6: NOESY enlargement of compound 1.
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Figure S7: 
13
C NMR spectrum of compound 1.
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7.2.2. Papiline 
OAc
MeO
HO
MeN
O
H
HH
1
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Papiline (2): [α]24D −29 (c 0.26, CHCl3); CD [θ]
20
λ: [θ]237 171, [θ]253 -72, [θ]260 81, [θ]268 
-67, [θ]278 94, [θ]289 -131; UV (MeOH) λmax (log ε) 318 (3.27), 280 (3.48), 236 (3.76), 
205 (4.20) nm; IR (CHCl3) νmax: 2925, 2854, 1738, 1674, 1595, 1557, 1514, 1455, 1378, 
1260, 1148, 1099, 1020, 800 cm
-1
; HREIMS of [M+H]
+ 
m/z 346.1643 (calcd. for 
C19H24NO5, 346.1649). 
Figure S8: Physical and spectroscopic data of compound 2. 
 
 
 
 
 
 
 
Figure S9: GC-MS spectrum of compound 2. 
 
 
RI: 2565 
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Figure S10: IR spectrum of compound 2.
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Table S2: 
1
H NMR, COSY, NOESY, HMBC (500MHz, CDCl3) and 
13
C NMR(125MHz, CDCl3) data of compound 2. 
Position H δ (J in Hz) COSY NOESY C δ  HMBC 
1 5.45 ddd (10.0, 5.0, 5.0) H-2α, H-2β, H-10b H-2β, H-4a, H-10b 70.9 d  C-10a, MeCO 
2α 2.00-2.06 m H-1, H-2β, H-3, H-4a, H-11 H-2β, H-3, H-10 27.9 t  MeCO 
2β 2.44 dddd (16.5, 5.5, 4.5, 2.5) 
 2.5) 2.5) 
H-1, H-2α, H-3, H-4a, H-11 H-1, H-2α, H-3   
3 5.54 m H-2α, H-2β, H-4a, H-11 H-2α, H-2β, H-11 116.1 d   
4    131.1 s   
4a 3.10 s H-2α, H-2β, H-3, H-10b, H-11 H-1, H-10b, H-12β, NMe 69.5 d   
6 9.91 s  H-7, H-10b 191.7 d   
6a    127.2 s   
7 7.32 s  H-6 116.2 d  C-8, C-9, C-10a 
8    144.6 s   
9    150.1 s   
10 7.29 s 9-OMe H-2α, H-11, 9-OMe 112.5 d  C-6a, C-8, C-9, C-10b 
10a    129.0 s   
10b 4.74 t (4.5) H-1, H-4a H-1, H-4a, H-6, NMe 35.3 d  C-1, C-4a, C-10 
11 (2H) 2.55 m H-2α, H-2β, H-3, H-4a, H-12α, H-12β H-3, H-10, H-12α,,H-12β 28.0 t   
12α 3.26 br s H-11, H-12β H-11, H-12β, NMe 56.3 t   
12β 2.33 q (9.0) H-11, H-12α H-4a, H-11, H-12α, NMe  NMe 
9-OMe 3.84 s H-10 H-10 55.8 q  C-9 
MeCO 1.90 s   21.2 q  MeCO 
MeCO    170.6 s   
NMe 2.20 s  H-4a, H-10b, H-12α, H-12β 40.9 q  C-4a, C-12 
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Figure S11: 
1
H NMR data of compound 2.
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Figure S12: NOESY spectrum of compound 2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S13: NOESY enlargement of compound 2. 
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Figure S14: NOESY enlargement of compound 2.
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Figure S15: 
13
 C NMR spectrums of compound 2.
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7.2.3. 3-O-(3’-Hydroxybutanoyl)haemanthamine 
 
1
2
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O OH
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3-O-(3’-Hydroxybutanoyl)haemanthamine (3): amorphous solid; [α]24D −13 (c 0.49, CHCl3); 
CD [θ]20λ: [θ]249 −2375, [θ]275 +1569; UV (MeOH): λmax (log ε) 292 (3.46), 238 (3.36), 206 
(4.40) nm; IR (CHCl3) νmax: 3377, 2925, 1727, 1504, 1484, 1376, 1295, 1239, 1173, 1064, 
1037, 988, 936, 853, 758 cm
-1
; HREIMS of [M+H]
+
 m/z 374.1603 (calcd. for C20H24NO6, 
374.1598).  
Figure S16: Physical and spectroscopic data of compound 3. 
 
 
 
 
 
 
 
Figure S17: GC-MS spectrum of compound 3. 
 
 
RI: 3030 
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Figure S18: CD spectrum of compound 3.
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Table S3: 
1
H NMR, COSY, NOESY, HMBC (500MHz, CDCl3) and 
13
C NMR(125MHz, CDCl3) data of compound 3. 
Position H δ (J in Hz) COSY NOESY C  HMBC 
1 6.52 d (10.1) H-2 H-2, H-10 129.3 d  C-3, C-4a, C-10a, C-10b 
2 6.31 ddd (10.1, 5.1, 0.7) H-1, H-3 H-1, H-3 130.2 d  C-3, C-4, C-10b 
3 5.44 td (4.8, 1.7) H-2, H-4α, H-4β H-2, H-4α, H-4β 67.2 d  C-1, C-2, C-4a, C-1’ 
4α 2.37 td (14.0, 4.6) H-3, H-4β, H-4a H-3, H-4β, H-4a H-12exo 29.5 t 
 
 C-4a  
4β 1.91 dd (14.0, 4.6) H-3, H-4α, H-4a H-3, H-4α, H-4a   C-2, C-3, C-4a, C-10b 
4a 3.36 dd (13.5, 4.5) H-4α, H-4β H-4α, H-4β, H-6β 63.0 d  C-6, C-12, C-11 
6α 3.72 d (17.0) H-6β, H-7 H-6β, H-12endo, H-7 61.5 t 
 
 C-4a, C-6a, C-7, C-10a 
6β 4.35 d (17.0) H-6α, H-7 H-4a, H-6α, H-7  C-6a, C-7, C-8, C-10a, C-11, C-12 
6a    126.9 s   
7 6.51 s H-6α, H-6β H-6α, H-6β 107.1 d  C-6, C-9, C-10a 
8    146.6 s   
9    146.8 s   
10 6.84 s  H-1 103.4 d  C-6a, C-8, C-10b 
10a    134.8 s   
10b    50.2 s   
11 4.03 ddd (6.5, 3.5, 1.5) H-12exo, H-12endo H-12endo 80.3 d  C-4a 
12exo 3.27 dd (14.0, 3.0) H-11, H-12endo H-4α, H-12 endo 63.6 t 
 
 C-4a, C-6, C-11 
12endo 3.41 dd (14.0, 6.5) H-11, H-12exo H-6α, H-11, H-12 exo  C-6, C-4a, C-10b, C-11 
OCH2O 5.91 d (7.5)   101.1 t  C-8, C-9 
1’    172.4 s  C-2’ 
2’a 2.45 dd (16.5, 3.0) H-2’b, H-3’ H-2’b 43.0 t  C-1’, C-3’, C-4’ 
2’b 2.36 dd (16.5, 9.0) H-2’a, H-3’ H-2’a  C-1’, C-3’, C-4’ 
3’ 4.17 ddq (9.5, 6.3, 3.3) H-2’a, H-2’b, H-4’ H-4’ 64.4 d   
4’ 1.19 d (6.3) H-3’ H-3’ 22.6 q  C-2’, C-3’ 
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Figure S19: 
1
H NMR spectrum of compound 3. 
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Figure S20: 
13
C NMR spectrum of compound 3.
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7.2.4. 3-O-methyl-epimacowine 
 
N
OMe
MeO
HO
H
1
2
3
4
11
12
4a10b
10a
10
9
8 6a 6
7  
3-O-Methyl-.epimacowine (4): [α]22D -47 (c 0.42, CHCl3); CD [Θ]
20
λ: [Θ]254 +2528, [Θ]290 
+2214; UV (MeOH) λmax(log ε) 230 (3.31), 288 (3.23) nm; IR (CHCl3) νmax 2925, 2854, 1507, 
1461, 1312, 1277, 1218, 1097, 753 cm
-1
; HRESIMS of [M + H]
+
 m/z 288.1595 (calcd for 
C17H22NO3, 288.1594). 
Figure S21: Physical and spectroscopic data of compound 4. 
 
 
 
 
 
 
 
 
 
 
 
Figure S22: GC-MS spectrum of compound 4. 
 
 
 
 
 
 
RI: 2477 
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Figure S23: CD spectrum of compound 4. 
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Table S4: 
1
H NMR, COSY, NOESY, HMBC (500MHz, CDCl3) and 
13
C NMR (125MHz, CDCl3) data of compound 4. 
POSITION δH (J in Hz) COSY NOESY HSQC HMBC 
1 6.48 dd (10.5, 2.0) H-2 H-2, H-10 128.9 d C-3, C-4a, C-10a 
2 5.84 dt (10.0, 1.5) H-1 H-1, H-3, 3-OMe 129.0 d C-4, C-10b 
3 4.00 ddt (10.5, 5.5, 2.0) H-4α, H-4β H-2, H-4α, H-4a, 3-OMe 76.2 d C-1, C-3OMe 
4α 2.29 br dt (12.0, 4.0) H-3, H-4β, H-4a H-3, H-4a, H-4β, 3-OMe 
30.7 t 
C-2, C-3, C-4a, C-10b 
4β 1.58 ddd (13.4, 12.0, 10.5) H-3, H-4α, H-4a H-4α, H-11exo, H-12exo, 3-OMe C-2, C-3, C-4a, C-10b 
4a 3.28 dd (13.0, 4.0) H-4α, H-4β H-3, H-4α, H-6α 66.7 d C-3, C-4, C-6, C-10a, C-11, 
C-12 
6α 4.45 d (17.0) H-6β H-4a, H-6β, H-7 
61.3 t 
C-6a, C-7, C-10a, C-12 
6β 3.82 d (16.5) H-6α H-6α, H-7, H-12endo C-4a, C-6a, C-7, C-10a, C-12 
6a    124.9 s  
7 6.59 s  H-6α, H-6β 112.9 d C-6, C-9, C-10a 
8    144.2 s  
9    145.1 s  
10 6.78 s  H-1, 9-OMe 104.8 d C-6a, C-8, C-10a, C-10b 
10a    136.6 s  
10b    44.5 s  
11endo 2.20 ddd (12.0, 9.0, 4.5) H-11exo, H-12endo, H-12exo H-11exo, H-12endo 
44.7 t 
C-4a, C-10a, C-10b, C-12 
11exo 2.12 ddd (12.0, 10.5, 6.0) H-11endo, H-12endo, H-12exo H-4β, H-11endo, H-12exo C-1, C-10a, C-10b, C-12 
12endo 2.95 ddd (13.0, 9.0, 6.0) H-11endo, H-11exo, H-12exo H-6β, H-11endo, H-12exo 
53.0 t 
C-4a, C-6, C-10b 
12exo 3.50 ddd (12.5, 10.5, 4.5) H-11endo, H-11exo, H-12endo H-4β, H-12endo, H-11exo C-6, C-10b 
3-OMe 3.42 s (3H)  H-2, H-3, H-4α, H-4β 56.0 q C-3 
9-OMe 3.89 s (3H)  H-10 56.1 q C-9 
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Figure S24: 
1
H NMR spectrum of compound 4. 
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Figure S25: 
13
C NMR spectrum of compound 4.  
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7.3. Appendix Ⅲ: Photos of flowers of Amaryllidaceae 
7.3.1. Genus Lycoris  
7.3.1.1. Lycoris albiflora 
 
7.3.1.2. Lycoris aurea 
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7.3.1.3. Lycoris chinensis 
 
 
7.3.1.4. Lycoris haywardii 
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7.3.1.5. Lycoris incarnata 
 
 
7.3.1.6. Lycoris longituba 
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7.3.1.7. Lycoris radiata 
 
 
7.3.1.8. Lycoris radiata var. pumila 
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7.3.1.9. Lycoris sprengeri 
 
 
7.3.1.10. Lycoris squamigera 
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7.3.2. Genus Hippeastrum  
7.3.2.1. Hippeastrum papilio  
 
7.3.2.2. Hippeastrum calyptratum 
 
